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Testicular germ cell apoptosis is a process that begins in early development and 
continues in the adult testis.  It is important during spermatogenesis for maintaining 
homeostasis of different types of germ cells. The number of sperm produced depends on 
the supportive capacity of surrounding Sertoli cells, which provide nutrition and an 
adaptive environment for growth and development of the germ cells. There are two major 
pathways that regulate germ cell apoptosis: extrinsic and intrinsic. We hypothesize that 
Sertoli cells use the extrinsic pathway to eliminate germ cells when exposed to 
phthalates, a common Sertoli cell toxicant.   
Death ligands, which are involved in the extrinsic pathway, were used in this 
research to test this hypothesis. Here, we demonstrate that: 1) the loss of FasL and 
TRAIL protein expression results in decreased production of mature spermatids in the 
adult testis, likely as a result of alterations in germ cell homeostatsis during the first wave 
of spermatogenesis. 2) The high baseline incidence of germ cell apoptosis in peripubertal 
vii	
	
FasL-/- and TRAIL-/- mice is correlated with increases in levels of TRAIL and FasL, 
respectively. 3) The decline in germ cell apoptosis observed after MEHP treatment in 
FasL-/- mice closely corresponds to the occurrence of increased levels of c-FLIP. 4) A 
more predominant role of FasL occurs in controlling the proper number of germ cells 
during the first wave of spermatogenesis in peri-pubertal mice. TRAIL is more critical for 
maintaining long-term homeostasis of the germ cell population in adult testis as well as in 
the reproductive function. 5) Several possible genes are involved in the altered 
spermatogenesis and development in the testis of gene-deficient mice. 6) Findings 
described in Chapter 6 indicate cellular mechanisms triggered by MEHP exposure that 
act to enhance tumor progression/metastasis in testicular embryonal carcinoma cells 
(NT2/D1). 
Taken together, these novel findings provide important mechanistic insights into the 
functional roles of FasL in the testis at distinct developmental periods and further indicate 
that FasL itself is required for the regulation of c-FLIP levels in the testis. Additionally, 
exposure to environmental toxicants, such as the phthalates, can enhance testicular cancer 
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1.1 Overview of the testes 
 
Testes are important parts of the male reproductive organ. In the 
mammalian system, the paired testes are located in the scrotal sac below the main 
trunk of the organism.  The primary functions of testes are the production of 
sperm and the release of sex hormones, such as testosterone.  There are two major 
compartments in each testis: the seminiferous tubule and interstitial space (Figure 
1-1). The interstitial space includes Leydig cells and macrophages cells that reside 
in the space between tubules (Figure 1-2). The prominent cells in this area are 
Leydig cells that serve primarily to secrete testosterone [1].  
  The functional unit in the testis is the seminiferous tubule [2] that provides 
the environment for the spermatogonia to continuously form spermatozoa, a 
repetitive, ongoing process for the male reproductive cycle that is known as 
spermatogenesis [3]. The seminiferous tubules are convoluted loops that both 
begin and end in the specialized region of the testis called the rété testis. The 
straight parts of the tubules lie mostly along the long axis of the testis. Walls of 
the seminiferous tubules are formed by the lymphatic endothelium, the peritubular 




Sertoli cells and germ cells. The Sertoli cells are irregular in shape and extend 
from the basal lamina; different types of germ cells are supported by the Sertoli 
cells. From the basal lamina to the lumen, germ cells at different stages of 
development are spermatogonia, spermatocytes, round spermatids, and elongated 
spermatids. A detailed description and explanation of the functions of Sertoli cells 








Figure 1.1 Morphology of the seminiferous tubule and interstitial space in 
mouse testis.  
The morphology of the seminiferous tubule and the interstitial space are shown in 
a 5μm cross-session of paraffin-embedded mouse testis from a 44-day-old 









Figure 1.2 Section of seminiferous tubules in an adult mouse testis with PAS-
H staining.  
The seminiferous tubule contains Sertoli cells, germ cells, basal lamina, and 
lumen. Leydig cells exist within the interstitial space. The blue line delineates 
different types of germ cells, including spermatogonia, round spermatocytes, 





1.1.1 The Structure and function of Sertoli cells 
 
 
 Enrico Sertoli discovered the Sertoli cell in 1860 when he was an 18-year-
old student at the University of Pavia in Northern Italy [4]. He published his 
observations and this cell was later named “the cells of Sertoli” or “Sertoli cell.”  
The Sertoli cells are the main somatic cells in the seminiferous tubules. The size 
of Sertoli cells is from 75-100 µm, and the volume of Sertoli cells is about 2000-
3000 μm3 to 6000-7000 μm3[1,5]. The cells extend from the basement membrane 
to of the lumen of the seminiferous tubules (Figure 1-3).   The shape of Sertoli 
cells is columnar and the surface is irregular. Enrico Sertoli in his first publication 
used the term “mother cells” to suggest that the function of Sertoli cells is to 
support the development of germ cells [6,7]. Sertoli cells are important for 
spermatogenesis, the process of germ cell maturation. The major functions of 
Sertoli cells include: 1) providing supportive structure for spermatocytes and 
spermatids, 2) delivery of nutrients to the developing spermatozoa, and 3) 










Figure 1.3 Diagram of a portion of a seminiferous tubule. The cytoplasm of 
Sertoli cells extends from the basement membrane to the lumen and is connected 
to different types of germ cells. Spermatogonia are surrounded by the basal 
lamina on one side and Sertoli cells on the other side. Round spermatocytes 
develop the acrosome around the nucleus and then become elongated and 
eventually form the tail structure. Elongated spermatids then become mature 




1.1.2 Germ Cells and Spermatogenesis  
 
 Spermatogenesis is a process by which spermatozoa develop from stem 
cells [1]. Spermatogenesis can be envisioned as having three different phases: the 
proliferative phase (spermatogonia), the meiotic phase (spermatocytes), and the 
differentiation phase (spermatids) (Figure 1-4, 1-5) [1].  
 In the proliferative phase, the spermatogonia can undergo cell replication 
by mitosis to increase the number of cells for later meiosis and differentiation. 
There are three major types of spermatogonia: the spermatogonia stem cell (SSC), 
the proliferative spermatogonia, and the differentiating spermatogonia  [1].  
 Two different spermatogonial development models have been proposed 
[8]. In the first model, suggested by Huckins and Oakberg, the Asingle (As) 
spermatogonia refer to spermatogonia stem cells, which can renew themselves or 
divide to form the next Aparied (Apr) spermatogonia. In their model, Apr 
spermatogonia can further divide to form Aaligned (Aal) spermatogonia and then 
continue to differentiate into type A1 spermatogonia. Further, A2 to A4 
spermatogonia can continue to develop from A1 spermatogonia, and then enter the 
next phase of intermediate (In) spermatogonia. Type B spermatogonia develop 
from In spermatogonia and continue the process of meiosis. 
 Another model, proposed by Clermont and Bustos-Obregon, suggests that 




is thought to maintain quiescence until the loss of proliferative spermatogonia 
stem cells causes the stimulation of a proliferation signal to A0 that, in turn, starts 
the generation of proliferative spermatogonia stem cells [8]. In the first model 
uses A1 to A4 spermatogonia to represent the renewal of stem cells while the 
second model uses A1 instead of A1 to A4 to represent the same stages of stem 
cell renewal. Following the A1 phase are phases A2, A3, and A4, which can 
continue to develop into type B spermatogonia or can dedifferentiate to A1 
spermatogonia.  
 After the proliferative phase, the most mature spermatogonia become 
primary spermatocytes by the process of the meiotic phase. The type B 
spermatogonia will divide into preleptotene spermatocytes (PI), and the PI cells 
will then be the last cells in the cell cycle to have the S-(synthetic) phase. The 
morphology of type B spermatogonia and PI are only slightly different: the size of 
type B spermatogonia is about 30% smaller than PI spermatocytes, and type B 
spermatogonia has more chromatin than PI spermatocytes [1].  
In the meiotic phase, the morphology of nuclear changes is the main 
characteristic that distinguishes different types of spermatocytes.  In this phase, PI 
spermatocytes will lose nuclei chromatin and subsequently form chromatin thread 
in leptotene (L). The chromatin threads are condensed, but the chromosomes are 
not yet paired. The chromosomes pair in the zygotene (Z) cells, and the pairing 




microscopy. When zygotene cells become pachytene (P) cells, the chromosomes 
are almost fully paired and genetic material starts to cross over or exchange. In 
this stage, the sex chromatic may be observed. The diplotene (Di) cells constitute 
the largest primary spermatocytes and germ cells and have the largest 
interchromosomal clear areas.  
The meiosis phase starts with diplotene cells and via the metaphase, 
anaphase, and telophase the diplotene cells become secondary spermatocytes (2) 
that are considered to be meiosis I (M-I). The second meiosis (M-II) can quickly 
proceed and form spermatids. The meiosis I cells (metaphase I, anaphase I, and 
telophase I cells) are similar in size to the diplotene cells, but the meiosis II cells 
are smaller than the meiosis I. 
The spermiogenic phase is important for the development of a flagellum, 
the development of an acrosome, the nuclear condensation, and the elimination of 
cytoplasm. This process of cell transformation changes occurs without cell 
division. When round spermatids are formed, germ cells stop to divide and 
undergo a dramatic differentiation in the nucleus and the cytoplasm to form 
elongated spermatids. In order to become spermatozoa, the nuclear condensation, 
the formation of acrosomes, the development of tails, the formation of 
mitochondrial spiral, and the elimination of extraneous cytoplasm. The 
spermatozoa will be released from Sertoli cells into the lumen and enter the 








Figure 1.4 Diagram of mouse spermatogenesis.  
This figure shows the process of spermatogenesis from stem cell to spermatozoa. 
Ais to B is the spermatogonia phase. PI to 2
o is the spermatocytes phase. 1 to 16 is 
the spermatids phase. A: Type A spermatogonia; Ais: Aisolated; Apr: Apaired; Aal : 
Aaligned; B: Type B spermatogonia; In: Intermediate; PI: Preleptoten spermatocytes;  






Figure 1.5 Diagram of spermatogenesis  
Spermatogenesis is a process that starts from spermatogonia (stem cells) to form 
Spermatozoa.  Spermatogonia stem cells have the ability of self-renew and 
maintain a basic level of population of stem cells. Some spermatogonia can 
continue morphological development to become primary spermatocytes, and then 
the primary spermatocytes can undergo a one-way development process to form 






 Apoptosis is a process of program cell death.  By definition, it is a 
genetically directed process of cell self-destruction. The term apoptosis originated 
from the Greek word apoptōsis, which means a falling off. The first description of 
characteristics of apoptosis was published in the British Journal of Cancer in 
1972 by Dr. Kerr, Wyllie, and Currie [9]. Those characteristics include 
morphological changes in cell type, such as membrane blebbing, cell shrinkage, 
nuclear fragmentation, and chromatin condensation. The apoptosis process 
involves two main signaling pathways: the extrinsic pathway (death receptor 
pathway) and the intrinsic pathway (mitochondrial pathway). 
 
1.2.1 The intrinsic pathway 
 
 In the intrinsic or mitochondrial pathway, cytochrome c is stimulated to be 
released from the mitochondria in response to changes in the permeability of the 
outer membrane of the mitochondria, called mitochondrial outer membrane 
permeabilization (MOMP). The MOMP, in turn, induces the formation of the 
apoptosome complex following activation of a cascade of cysteinyl aspartate 
proteinases (caspases). This process can result in irreversible events in cell death. 




and pro-apoptotic proteins. Those proteins share some Bcl-2 homology domains 
(BH1~BH4). Bcl-2, Bcl-XL, Bcl-w, Bcl-B, Al, and Mcl1 belong to the anti-
apoptotic proteins, which include three or four BH regions. The pro-apoptotic 
proteins are Bax, Bak, Bcl-xs, Bok, Bid, Bim, Bik, Noxa, Puma, Bcl-Gs, Blk, 
Bmf, and Hrk, which share only the BH3 domain.[10] Bax and Bak appear to be 
required for MOMP and are present in most cells in inactive forms but can be 
triggered by other proteins, such as the BH-3 only proteins [11,12,13]. 
Cytochrome c, which can be released following the MOMP occurrence, binds to 
monomeric apoptotic protease activating factor-1 (APAF-1) and induces a 
conformational change in APAF-1 to form the apoptosome. The apoptosome then 
binds to pro-caspase 9 to initiate the intrinsic pathway [14,15].  Auto-cleavage is 
triggered by the oligomerization of pro-caspase 9 on the apoptosome so that pro-
caspase 9 can become active caspase 9, and active caspase 9 can continue to 
cleave the effector caspases, such as caspase 3 and caspase 7, eventually resulting 
in cell death (Figure 1-6). Caspase activity can be modulated by caspase-binding 
proteins of the inhibitor of the apoptosis proteins (IAPs) family, such as human X-
lined IAP (XIAP) [16,17]. Moreover, caspase inhibitors can be antagonized by the 






1.2.2 The extrinsic pathway 
 
The extrinsic signaling pathway is best characterized by the action of the 
tumor necrosis factor (TNF) superfamily of protein ligands on their cognate 
receptors [20]. The intrinsic pathway is distinguished by the release of 
cytochrome c from the mitochondria [21,22,23]. Common to both of these 
signaling pathways is the activation of a family of caspases that results in 
characteristic structural, biochemical, and morphological changes associated with 
cellular apoptosis [24]. A conformational change is induced in the cell membrane 
when death ligands bind to the receptors on the cell surface, and other protein 
molecules join this process of cell death (Figure 1-6).  
Fas ligand (FasL/CD95L/TNFSF6) and Fas receptor (Fas/CD95/TNFRSF6) 
are the best understood proteins of the tumor necrosis factor (TNF) superfamily of 
ligands and receptors [25]. Engagement of homotrimers of Fas by homotrimers of 
FasL recruits the adapter protein, Fas associated death domain protein (FADD), to 
bind to Fas [26]. FADD serves, through its C-terminal death domain (DD), to 
couple Fas receptors to the “initiator” enzyme pro-caspase-8 (also named FADD-
like interleukin 1-beta converting enzyme, FLICE) through the mutual association 
of N-terminal death effector domains (DED) that exist in both FADD and pro-
caspase-8. This complex of Fas, FADD and pro-caspase-8 is referred to as the 




molecules of pro-caspase-8 allows for their further proteolytic processing which 
results in the formation of the active caspase-8 enzyme [29]. Active caspase-8 can 
then cleave other distinct “downstream” caspase enzyme family members, 
resulting in a caspase-cascade that cleaves substrates necessary for the instigation 
of apoptosis (Figure 1-7). The initiation of this caspase cascade at the DISC is 
regulated by the cellular FLICE inhibitor, c-FLIP (c-FLIP, CFLAR), which lacks 
proteolytic caspase activity [30,31,32]. In this way, c-FLIP prevents the 
recruitment and subsequent activation of caspase-8. Although this simplified 
description of death receptor-mediated signaling is widely accepted, there are 
many nuances to its regulation and even evidence of various non-apoptotic 
functions involved in the activation of Fas or by FasL itself [33] Nevertheless, the 
extent of the recruitment of either procaspase-8 or c-FLIP to the DISC is a 
common key determinant for the events keyed off by death receptor activation. 
When the DISC is formatted, pro-caspase-8/pro-caspase-10 (but pro-caspe-10 is 
not available in mice) can cleave and activate the initiator caspases without being 
blocked by c-FLIP. The initiator caspases then activate a second group of 
caspases, as known as effector caspases (pro-caspase 3 ,6, 7; the same effectors in 
the intrinsic pathway), by proteolytic cleavage at specific sites. Activated caspase-
3 cleaves a variety of cellular substrates, such as DNA repair enzymes, cellular 





Another member of the TNF family, tumor necrosis factor related apoptosis-
inducing ligand (TRAIL/Apo2L/TNFSF10) [34], is also expressed in human and 
rodent testis [35,36,37]. TRAIL is a type II transmembrane protein that binds to 
two receptors in humans, DR4 (TRAIL-R1/TNFRSF10A) and DR5 (TRAIL-R2/ 
TNFRSF10B), whereas there is only one receptor in mice, called TRAIL-R 
(MK/mDR5), and it is equally homologous to both human death receptors. 
[38,39]. The interaction between TRAIL and DR5 triggers a signaling pathway 
similar to the Fas-FasL system by transmitting signals through DISC, the 









Figure 1.6 The scheme of apoptosis pathway  
Intrinsic pathway: BH3 molecules release after cell stimulation (DNA damage, 
UV, etc), and release Bax/Bak from the Bcl-2 family. Bax/Bak can induce 
mitochondrial outer membrane permeabilization (MOMP) that can cause 
cytochrome c release from mitochondria, and further bind to APAF-1 to make 
conformation changes. Then this structure recruits caspse-9 to form an 
apoptosome, and it can activate the effector to process cell death. Apoptosome is 
also regulated by IAPs, which can be inhibited by Smac/DIABLO. The detail 





Figure 1.7 The extrinsic apoptosis pathway  
 FasL (TRAIL/TNF) and Fas (TRAIL-R/TNFR) belong to the TNF superfamily. 
First, FasL forms trimmers and then binds to Fas on the cell surface and becomes 
a cluster structure. This structure recruits FADD via recognition of the DD 
domain, and FADD then attracts the pro-caspase-8 through DED domain. The 
death-induced signaling complex (DISC) is then formed and pro-caspase-8 
becomes activated caspase-8. Activated caspase-8 can further activate pro-




1.2.3 Testicular  function of germ cell apoptosis 
 
A low level of spontaneous germ cell apoptosis occurs in the testis of adult 
mammals under various physiological conditions. It is generally believed that 
apoptosis of germ cells serves as a mechanism to delete damaged cells as well as 
to limit the size of the germ cell population to match the supportive capacity of 
the Sertoli cells [41,42,43]. During the peripubertal period, a time when the first 
wave of spermatogenesis is nearing completion, a significantly higher rate of 
apoptosis is seen [1,44]. The mechanisms that control the “physiological” 
testicular germ cell apoptosis in both adult and peripubertal animals have not been 
clearly established. Many articles show that both intrinsic and extrinsic pathways 
may play important roles in the regulation of germ cell apoptosis [45].  
 
1.2.3.1 Regulation of the intrinsic pathway during male germ cell development 
 
 When primordial germ cells (PGCs) migrate to the genital ridge from the 
base of the allantois in the embryonic stage, excess cells are generated to regulate 
apoptosis, and this process is controlled mainly by Bcl-xL and Bax [46]. A 
deficiency of Bax or an overexpression of Bcl-x and Bcl-2 can cause infertility in 
male transgenic mice by the over-accumulation of spermatogonia and 




robotic germ cells [46,47,48]. Low levels of Bcl-xL show increased germ cell 
death similar to Bax over-expression while Bcl-2 deficient mice display normal 
spermatogenesis [49]. The loss of the Bcl-x function can be rescued by deletion of 
both copies of the Bax gene, resulting in a restoration of germ cell survival [46]. 
Therefore, a balance between anti-apoptotic and pro-apoptotic proteins is 
important in contributing to the normal development of spermatogenesis. 
 
1.2.3.2 Regulation by extrinsic pathway during male germ cell development 
 
It has been reported that up-regulation of the Fas receptor is associated with 
spermatocyte apoptosis during the first wave of spermatogenesis [50].  However, 
mice with point mutation of the Fas gene, referred to as homozygous for the 
lymphoproliferation  spontaneous muataion (Faslpr), or with point mutation of the 
FasL gene, referred to as generalized lymphoproliferative disease (gld), are fertile 
with normal spermatogenesis [43]. It appears that the lpr mutation has either no 
effect or, due to tissue-specific regulation or a unique system, is present to restore 
proper levels of Fas. Both testis weight and spermatid heads increase in gld mice, 
but some incidence of germ cell apoptosis occurs [51].  Fas/FasL apoptosis 
system is involved in human hypospermatogenesis, such as maturation arrest (MA) 
and Sertoli cell only syndrome (SCO). The up-regulation of FasL is shown in the 




associated with hypospermatogenesis [52]. It has also been suggested that altered 
meiotic and postmeiotic germ cell maturation may be due to increased Fas 
expression to eliminate defective germ cells in humans [53]. However, the 
detailed mechanism of the extrinsic pathway associated with germ cell 





1.3 Toxicant injury model in the testis – Mono-(2-ethylhexyl) phthalate 




 Phthalates are a group of synthetic chemicals, such as plasticizers, that are 
widely used in industry to give flexibility to polyvinyl chloride (PVC) products, 
such as plastic bags, food packaging, blood-storage containers, medical devices, 
and children’s toys [54,55,56]. Phthalates not only exist in PVC products but also 
can be found in cosmetics, perfumes, and pesticides [55,57,58]. Phthalates are not 
chemically bound to PVC products and be released from products into indoor air, 
foodstuff, and other materials. Therefore, humans may be easily exposed to 
Phthalate compounds in living environments by direct contact or indirect 
contamination. Phthalates have known to cause respiratory tract diseases, such as 
allergy [55,59,60].  
  Phthalates have been broadly studied in animals following oral exposure; 
however, there is limited information about humans [61,62]. To date, the 
evaluation of environmental phthalate exposure to humans is unclear. Although 
most studies are based on animal models with a few reports on human [63], 
results show a positive correlation between phthalate exposure and reproductive 




thyroid gland and reductive organs (testis and Ovaries) based on acute and 
chronic treatment in rodents. In non-cancer effects studies, the data suggest that 
treatments with phthalates are sensitive to reproductive/developmental tracts with 
adverse effects [64]. Andrade and his colleagues reported the effects of DEHP on 
sexual development of male and female offspring in rodent models, and results 
show that changes in androgenic functioning are more sensitive endpoints and 
include a significant delay in the onset of puberty (preputial separation) at doses 
of 15 mg/kg/day and higher [65,66,67,68,69]. Another group of scientists studied 
the effects of DEHP on Leydig cell androgen and estradiol biosynthesis in male 
rats and found that significant decreases in serum testosterone and leutenizing 
hormone (LH) concentrations resulted from in utero exposure [70,71,72]. 
Additionally, decreases in semen quality and quantity may be associated with 
phthalate exposure in humans [73,74], and can impact perinatal testicular and 
genital development [75]. 
Most studies have focused on di(2-ehtylhexyl)phthalate (DEHP) because it 
is the most common phthalate used in plastic products, and most reproductive 
system research is based on the DEHP exposure model, such as cases described in 
the previous paragraph. In 2002, The Food and Drug Administration (FDA) 
published a risk assessment for DEHP by comparing tolerable intake (TI; 
calculated as 600-800 µg/kg/day parenteral and 40 µg/kg/day orally) to exposure 




Environment of European Commission established a lower dose for tolerable 
daily intake (TDI) for DEHP 37 µg/kg/day and while the U.S. Environmental 
Protection Agency set an even lower reference dose at 20 µg/kg/day. In 2006, the 
National Toxicology Program reported the minimal concern dose for reproductive 
toxicity for DEHP to be even lower at 1-30 µg/kg/day. Due to the FDA’s use of 
the classical risk assessment to evaluate the impact of DEHP, other researchers 
and agencies have expressed concern that the FDA may have under-evaluated the 
toxicity of DEHP, especially in endocrine disrupting compounds (EDCs).  
 DEHP is a diester of phthalic acid and the branched-chain 2-ethylhexanol 
and is easy to accumulate in fatty acid, such as adipocytes, due to its lipophilic 
property [76,77]. DEHP is hydrolyzed to mono-(2-ethylhexyl)phthalate (MEHP) 
and 2-ethylhexyanol (2-EH) by lipase and esterase in the intestines, pancreas, 
liver, kidney, and testes [56,78]. MEHP can further oxidize into different sub-
metabolic products (mono-(5-carboxy-2-ethylpentyl)phthalate, mono-(2-ethyl-5-
oxohexyl)phthalate, and mono-(2-ethyl-5-hydroxyhexyl)phthalate)  by 
cytochrome p450, alcohol dehydrogenases, and aldehyde dehydrogenase.  
Therefore, the concentration of MEHP is required by the activity of these 
enzymes in the metabolic rate of DEHP [79].  





1.3.2  Cellular response and testicular injury with MEHP exposure 
 
MEHP, the primary metabolic product of DEHP, which can induce 
testicular toxicity, has been investigated in animals and humans [75,78,79,80]. 
Two	studies	have	addressed	this	issue.	The	first	study	documented	relatively	
good	 reproducibility	 of	 urinary	 phthalate	 monoester	 levels	 in	 two	 first‐
morning	 urine	 specimens	 collected	 for	 two	 consecutive	 days	 from	 46	
African‐American	 women;	 day‐to‐day	 intra‐class	 correlation	 coefficients	
ranged	 from	 0.5	 to	 0.8	 [81].	 Recently,	 the	 temporal	 variability	 in	 urinary	
phthalate	metabolite	 levels	 among	 11	men	who	 collected	 up	 to	 nine	 urine	
samples	 each	 during	 a	 three	 month	 period	 was	 evaluated	 [82].	 The severe 
vacuolation of Sertoli cell cytoplasm and early sloughing of spermatids and 
spermatocytes can be observed in the testis in rodents after DEHP/MEHP 
exposure [79,83,84].  Further studies have demonstrated that the Sertoli cells are 
initial and primary targets that result in disruption of the balance, connection, and 
interaction between Sertoli cells and germ cells [84,85,86,87]. DEHP and MEHP 
can also inhibit Sertoli cell proliferation in neonatal rats resulting in a decrease in 
the number of Sertoli cells in the testis and alteration of the supportive capacity of 
Sertoli cells during spermatogenesis [88,89,90]. It has been reported that MEHP 
can reduce Follicle-stimulating hormone (FSH)-stimulated cAMP accumulation 




[91,92,93,94]. In addition, MEHP can decrease the level of transferrin and 
androgen binding protein (ABP) in Sertoli cells and reduce fluid secretion in 
seminiferous tubules, which can impair germ cells development and 
differentiation [95,96]. Not only Sertoli cells are injured by MEHP exposure but 
also the function of steroidgenesis of Leydig cells are impaired following 
DEHP/MEHP treatment, which may impact the male reproductive system. The 
number and size of Leydig cells are decreased by DEHP exposure in young rats, 
resulting in a decrease in the level of testosterone [97].    High dose MEHP (250 
µM) can directly inhibit the production of testosterone in primary rat Leydig cells, 
which may be regulated by steroidogenic acute regulatory (StAR) protein. 
However, even a low dose of MEHP (25-100 µM) can stimulate basal steroid 
synthesis in mouse Leydig tumor cells, suggesting that  anti-steroidgenic effects 
of DEHP may prematurely initiate the onset of puberty and theoretically affect the 
hypothalamic-pituitary-gonadal axis by MEHP exposure [98].  
 
1.3.3 Model of MEHP-induced germ cell apoptosis  
 
 Apoptosis naturally occurs during germ cell development in the testis and 
is involved in both the extrinsic and intrinsic apoptotic pathways. Germ cell 
apoptosis is important for controlling the appropriate number of germ cells so that 




growth [42,99,100]. When germ cells are abnormal or have been injured by 
environmental toxicants, apoptosis is triggered to eliminate the abnormal cells 
[101]. We hypothesize that the Fas/FasL signaling may play a primary role to 
reduce damaged germ cells in response to MEHP exposure in the testis. The 
mechanism of MEHP may induce Sertoli cell injury and lead to an increase in the 
incidence of testicular germ cells apoptosis [43,51,102,103,104,105]. Although 
Sertoli cells express a basal level of FasL, the expression of FasL protein is 
increased when Sertoli cells are treated with MEHP. The ability of Sertoli cells to 
support a certain number of germ cells is reduced after injury by toxicants and 
more FasL can bind to Fas to form trimer superstructure so that cell death occurs 
via the classical extrinsic apoptotic pathway, described in session 1.2.2 (Figure 1-
7). Gld mice, with a point mutation in C terminal of FasL gene, show a significant 
reduction in apoptosis after MEHP treatment, thus indicating that the Fas/FasL 
signaling system may participate in the apoptosis of toxicant-induced germ cells 
[51]. However, details about the mechanism of MEHP induced FasL expression 
in Sertoli cells remain unclear. If another death ligand TRAIL is involved in the 
toxicant induced model, that mechanism is also not well understood. Even though 
the effects of phthalates on human health are controversial due to variations in 
exposure time, dosage, and different animal models, it is important to unmask the 
issue of how phthalates may cause health problems in humans  [60,73]. Therefore, 




after MEHP exposure, and how these processes relate to Sertoli cell injury and 





1.4 Testicular cancer and testicular dysgenesis syndrome 
 
Testicular cancer is most prevalent in young adult men ages 15-40 years 
(about 1~2% of all cancers in men) and is approximately 5 times more common in 
Caucasians than in other races [106,107,108]. Correlations of this disease has 
been reported to occur with other common testicular disorders that likely arise 
from shared mechanisms, such as poor semen quality and reduced sperm numbers, 
undescended testis, and hypospadias [109]. The incidence of these diseases has 
dramatically increased over the past 50 years, and it has been hypothesized that 
environmental influences, rather than genetic defects, account for this increase 
[109]. Together, cryptorchidism, hypospadias, subfertility, and testicular germ 
cell tumor are thought to comprise testicular dysgenesis syndrome (TDS) 
[109,110]. Therefore, a better understanding of the underlying mechanisms that 
lead to testicular cancer development and/or testicular tumor progression induced 
by environmental toxicants may offer insights into the etiology of other testicular 
diseases. Phthalates have been shown to induce hepatotoxicity and cause 
hepatocelluar tumorigenesis through several mechanisms [111,112,113], but little 
is known about the incidence of testicular cancer formation or the mechanism(s) 
that accounts for tumor promotion triggered by environmental stimuli. Recently, it 
has been shown that in utero dibutyl phthalate (DBP) exposure to rats exhibits 




infertility, reduced spermatogenesis, and multinucleated gonocytes [114,115]. 
MEHP exposure also results in a decrease in testosterone levels and insulin-like 






1.5 Dissertation aims 
 
 
 Spermatogenesis is a process critical for germ cell division and 
morphologic development for the formation of spermatozoa. For a normal 
function of spermatogenesis it is important to understand how the Sertoli cells 
maintain a homeostasis environment for germ cell development. Germ cell 
apoptosis occurs during the period of testis development. First, we will discuss 
how apoptosis in a mouse model impacts spermatogenesis when there is a loss of 
a death ligand (FasL/TRAIL) (Chapter3~5).  As introduced in previous sections, 
spermatogenesis may be disrupted by environmental toxicants, such as phthalates.  
Based on this idea, we will use the MEHP model to test whether total loss of a 
death ligand can provide better protection from toxicant treatments and how loss 
of a death ligand may influence the extrinsic pathway when one of the death 
ligands is absent (Chapter 3~5). In previous studies we showed that expression of 
c-Myc gene can be altered following MEHP exposure in the testes. Recent reports 
also discuss how environmental toxicants may cause or enhance the results of 
TDS in male reproduction. These findings have led us to hypothesize that MEHP 
may enhance the progression of testicular cancer, which is a TDS (Chapter 6).    
  The novel observation in this dissertation is that 1) The loss a death ligand 
can cause even more germ cell death in the testis, which infers that the death 




The loss of a death ligand may also play another role during the first wave of 
spermatogenesis. 2) The apoptotic rate is decreased in FasL gene deficient mice 
with MEHP treatment and that reduction in the apoptosis of germ cells may be 
due to the loss of FasL in Sertoli cells that promotes the expression c-FLIP in 
germ cells. 3) We found that MEHP may have the ability to alter adhesion 
molecules and promote invasion and migration in testicular cancer cells. 
Therefore, this dissertation provides a more detailed understanding about how the 
death of ligands can influence germ cell apoptosis during normal development of 
testis as well as during treatment for environment toxicants. We also point out 
factors that many toxicologists may overlook when toxicants are not classified as 
carcinogens and those toxicants are, therefore, considered safe below certain 
exposure concentrations. For example, in instances where testicular cancer 
patients continue to be exposed to environmental toxicants, the development of 






Chapter 2 .Materials and Methods 
 
 
2.1  Animals 
 
All mice used in this study were maintained at the University of Texas 
Animal Resource Center. Mice were housed at a constant temperature (22±0.5°C) 
at 35-70% humidity with a 12L:12D photoperiod. Mice were given standard lab 
chow and water ad libitum. All procedures involving mice were performed in 
accordance with the guidelines of the University of Texas at Austin’s Institutional 
Animal Care and Use Committee in compliance with guidelines established by 
the National Institutes of Health. Breeding pairs of wild-type C57BL/6J mice 
were purchased from The Jackson Laboratory (Bar Harbor, ME). Breeding pairs 
of FasL heterozygous mice (FasL+/-), that are on a C57BL/6 background, were 
provided by Dr. Saoussen Karray, INSERM, Paris, FR [118]. FasL gene deficient 
mice (FasL-/-) on a C57BL/6J background were generated by mating FasL+/- mice 
and their genotypes were confirmed by genomic PCR as described previously 
[118]. Breeding pairs of TRAIL gene deficient mice (TRAIL-/-) were provided by 
Amgen Inc. (Thousand Oaks, CA; originally created by the laboratory of Dr. Lisa 
M. Sedger)[119].  In order to characterize the basic testicular phenotype, 




inhalation. The testes were rapidly removed and either frozen in liquid nitrogen 
and stored at -80°C for protein analysis, or immersion-fixed overnight in Bouin’s 
solution (Polysciences, Inc., Warrington, PA), washed in 70% ethyl alcohol-
Li2CO3 saturated solution and embedded in paraffin for histology analysis.  
 
2.2  Cell line 
 
The human testicular embryonal carcinoma cell line, NTERA-2 cl. D1 
(NT2/D1), was purchased from American Type Culture Collection (ATCC, 
Manassas, VA), and cultured in Dulbecco’s modified Eagle’s media (DMEM, 
ATCC) supplemented with 10% fetal bovine serum and 1% penicillin-
streptomycin (all Invitrogen, Carlsbad, CA) at 37°C with 5% CO2.  
 
2.3  Total protein preparation for cell line and testis and western blot analysis  
 
Cultured cells were trypsinized with 0.25% trypsin-EDTA and centrifuged at 
1200 rpm for 5 minutes at 4 . Pellets were resuspended in homogenization 
buffer containing RIPA buffer (1% NP-40, 0.5% Sodium dexoycholate and 0.1% 
SDS in 1X PBS) with 100 μM Na3Vo4, 10μM E64 and protease inhibitor cocktail 




centrifugation at 14,000 rpm for 20 minuted 4 , the supernatant containing total 
proteins was collected and stored at -80 . 
 Testis were freshly collected from mice or stock samples from -80 ℃,	 and	
testis	were	 transferred	 to	 homogenizer	with	 500	 μl	 homogenization	 buffer	
on	 ice	 3	 ml	 RIPA	 buffer,	 90	 μl	 	 Aprotinin 0.3	 mg/ml 	 ,30	 μl	 Na3Vo4 (10	
mg/ml ,	15	μl	PMSF	 10mg/ml ,	0.6	μl	Leupertion	 10mg/ml ,	and	3	ul	E64.	
The	testis	were	ground	several	times,	and	a	small	fraction	were	collected	in	
the	Eppendorf	on	ice	for	30	minutes.	The	samples	were	centrifuged	at	14,000	
rpm	 for	 20	 minutes	 at	 4	 ℃,	 and	 the	 supernatant	 was	 collected	 and	
transferred	 to	new	Eppendorf	 tubes.	 	This	 step	was	repeated	several	 times	
until	the	lysate	became	clean.	The	supernatant	was	collected	and	stored	at	‐
80	℃.	
	 The concentration of total proteins was measured by the Lowery Method. 
The total proteins (30μg) were separated by gradient SDS page and transferred to 
PVDF membrane. Total cellular proteins were detected using primary antibodies 
against FasL (1:500, Santa Cruz Biotenchnology Inc., Santa Cruz, CA), TRAIL 
(1:250, Invitrogen), c-FLIP (1:1000, Enzo, NY), c-Myc, MMP-2, MMP-9 (1:1000, 
Abcam Inc., Cambridge, MA), -tubulin , -actin (1:500, Santa Cruz 
Biotenchnology Inc., Santa Cruz, CA) coupled with horseradish peroxidase-




1:1000, Cell Signaling Inc, MA). The ECL chemiluminescent substrate 
(Amersham Bioscicence, Piscataway, NJ) was used as the detection reagent and 
-tubulin or β-actin as the internal control for gel loading. Images of western 
blots were captured using a Kodak Gel Logic 100 Imaging system (Kodak, 
Rochester, New York). Densitometry for bands on western blots was determined 
by ImageJ software (National Institute of Mental Health, Bethesda, Maryland).  
All experiments were performed in triplicate and repeated at least three times.  
 
2.4  MEHP treatment  
 
MEHP exposure in peri-pubertal rodents has been reported to be a good 
model to test the interaction between Sertoli cells and germ cells by decreasing 
Sertoli cell support [103,120,121,122]. PND 28 FasL-/- and C57BL/6J mice were 
given a single dose of MEHP (1 g/kg, TCI America, Portland, OR) by oral gavage 
at a volume equal to 4 ml/kg, a standard procedure for investigating the 
consequences of MEHP-induced Sertoli cell injury [123]. Control animals 
received a similar volume of vehicle (corn oil). Both control and MEHP-treated 






2.5 Physiologic characterization of the testis 
 
 The body and testis weights of mice at PND 28 and 44 were measured. The 
number of mice used by types: PND 28 C57BL/6J mice (n=26), FasL-/- mice 
(n=40), and TRAIL-/- mice (n=34); PND 44 C57BL/6J mice (n=8), FasL-/- mice 
(n=16), and TRAIL-/- mice (n=10). 
 
2.6 Testicular histopathology  
 
Cross-sections (5 µm) of paraffin-embedded testes were evaluated for 
morphological changes by using periodic acid-Schiffs-Hematoxylin (PAS-H) 
staining. Testis cross-sections were imaged using a Nikon E800 microscope and 
captured with a Canon 5D digital camera (Canon U.S.A. Inc., NY). The number 
of mice by type used for the evaluation of testicular morphology: PND 28 
C57BL/6J mice (n=7), FasL-/- mice (n=8), and TRAIL-/- mice (n=4); PND 44 
C57BL/6J mice (n=6), FasL-/- mice (n=6), and TRAIL-/- mice (n=3). 
 
2.7 Testicular spermatid head counts 
 
Testicular spermatid head counts were performed as previously described 




homogenized in DMSO/saline solution containing 0.9% (w/v) NaCl and 10% (v/v) 
DMSO, and then homogenization-resistant spermatid heads were counted using a 
hemocytometer. The average number of spermatid heads was determined from 12 
C57BL/6J mouse testes, 13 FasL-/- mouse testes, and 8 TRAIL-/- mouse testes. 
Each testis sample was counted three times. The daily sperm production per testis 
was calculated by using 4.84 days as the time divisor [124].  
 
2.8 Terminal deoxy-nucleotidyl transferase-mediated digoxigenin-dUTP nick end 
labeling (TUNEL) assay 
 
Apoptotic fragmentation of DNA in mouse paraffin-embedded testis cross 
sections was determined by TUNEL analysis using the ApopTagTM kit (Chemicon, 
Temecula, CA).  The apoptotic index (AI) was calculated as the percentage of 
essentially round seminiferous tubules in a cross-section that contained more than 
three TUNEL-positive germ cells. At least two testicular cross-sections per mouse 
were analyzed. The apoptotic index was determined from 6 C57BL/6J mice and 7 
FasL-/- mice at PND 28 and 4 C57BL/6J mice and 5 FasL-/- mice at PND 44. The 
number of each group for MEHP-treated C57BL/6J mice: 0h (n=7), 1h (n=3), 3h 
(n=3), 6h (n=4), 12h (n=3) and 24h (n=3). The number of each group for MEHP-





2.9  Immunohistochemistry 
 
Expression of cleaved caspase-9 in the germ cells was determined by 
immunohistochemstry. Cross-sections (5 µm) of paraffin-embedded testes from 
PND 28 C57BL/6J and FasL-/- mice were deparaffinized and rehydrated, and 
antigens were unmasked by heating in 10 mM sodium citrate solution. Sections 
were incubated with 3% H2O2 to block endogenous peroxidase activity and then 
incubated in blocking buffer containing 10% horse serum. The primary antibody 
used in this study was rabbit-anti-cleaved-caspase-9 (1:100, Cell Signaling, 
Danvers, MA). Sections were incubated in primary antibody at 4  overnight. 
Immuno-detection was performed by standard procedures using the VectaStain 
ABC kit (Vector Labs, Burlingame, CA) and DAB as the substrate (Vector Labs). 
At least two testicular cross-sections per mouse were analyzed. The number of 
each group for MEHP-treated C57BL/6J mice: 0h (n=3), 12h (n=3). The number 
of each group for MEHP-treated FasL-/- mice: 0h (n=4), 12h (n=3). All sections 
were observed using a Nikon E800 microscope. The percentage of cleaved 
caspase-9 positive germ cells was calculated as the number of positive germ 






2.10  Immunofluorescence 
 
Expression and localization of c-FLIP in testis cross sections was 
determined by immunofluorescence detection of c-FLIP antibody (rabbit-anti-c-
FLIP; 1:100, Cell Signaling). Cross-sections (5 µm) of paraffin-embedded testes 
from C57BL/6J and FasL-/- mice were deparaffinized, rehydrated, heated in 10 
mM sodium citrate and incubated in blocking buffer containing 10% horse serum, 
followed by overnight incubation in primary antibodies at 4 . Sections were then 
incubated in Alexa Fluor conjugated anti-rabbit antibody (1:500, Molecular 
Probes, Gaithersburg, MD) for 1 h and mounted in Vectashield Mounting 
Medium (Vector Labs). Fluorescent signals were detected using 
excitation/emission wavelength of 495 nm/521 nm. Images were captured by a 
Nikon E800 microscope captured with a Nikon Cool-SNAP digital camera, and 
processed using MetaMorph Imaging software (v. 4.1) (Downingtown, PA). Two 
testicular cross-sections per mouse were analyzed. The number of each group for 
MEHP-treated C57BL/6J mice: 0h (n=3), 12h (n=3). The number of each group 






2.11 Gelatin zymography   
 
The MMP-2 and MMP-9 gelatinolytic activity in media derived from 
NT2/D1 cells was assayed by gelatin zymography with minor modifications [122]. 
Briefly, 12 h after the addition of MEHP (200 μM) to 2x106 NT2/D1 cells, 
conditioned media were collected and directly applied to a 10% Zymogram gel 
(Invitrogen). After electrophoresis, the gels were washed twice for 15 min with 
2.5% Triton X-100 in 50mM Tris-HCl (pH 7.5) to remove the SDS and restore 
enzyme activity and incubated in developing buffer (50 mM Tris-HCl, pH 7.5, 
200 mM NaCl, 10 mM CaCl2 and 0.02% sodium azide) overnight at 37˚C. The 
gels were then stained with 30% methanol/10% acetic acid containing 0.5% (w/v) 
Coomassie Brilliant blue R-250 for 30 min and destained in the same solution 
without dye. Clear bands shown on the blue background indicated enzyme 
activity. 
 
2.12 Measurement of soluble  
 
MMP-2 levels - NT2/D1 cells (2x106) were exposed to MEHP for various 
time periods. The culture media were collected and centrifuged to remove cellular 




ELISA (R&D Systems, Inc.) following the manufacture’s protocol. The cell 
number was counted to normalize the protein expression assayed by ELISA.  
 
2.13  Invasion assay   
 
The in vitro invasion assay was performed using transwell chambers with 
8 μm pores in the polycarbonate filters (Costar, Cambridge, MA) as previously 
described [125]. Transwell membranes were coated with Matrigel diluted in 
serum-free media (1:3 dilution, BD Biosciences, San Diego, CA). Non-treated or 
MEHP-treated NT2/D1 cells (1x105) were seeded on Matrigel and incubated at 
37˚C for 18 h. Membranes coated with Matrigel were wiped with Q-tips, fixed 
with methanol and stained with 20% Giemsa solution (sigma, St. Louis, MO). 
Cells attached to the lower surface of the filters were then counted under a light 
microscope (x200 magnification). Cells are photographed by Canon-5D digital 
camera attached to a light microscope. 
 
2.14 Migration assay   
 
Cell migration was estimated by a wound-healing test in NT2/D1 cells. 
Non-treated or MEHP-treated NT2/D1 cells (5x105) were seeded into 6-cm 




used to scratch cell monolayer to generate the cell-free zone in the middle of 
culture plates. Cell debris was removed by washing with PBS. Cells were then 
incubated at 37˚C for up to 36 h. The number of cells migrating into the cell-free 
zone was counted under a light microscope (x200 magnification). Cells were 
photographed by Canon-5D digital camera attached to a light microscope. 
 
2.15 Gelatinase inhibitor SB-3CT treatment in vitro 
 
It has been shown that SB-3CT is able to inhibit the activity of endogenous 
gentalinases, including MMP-2 [126]. NT2/D1 cells (5x105) were treated with 10 
μM of SB-3CT (Chemicon, Temecula, CA) in the presence of MEHP (200 μM) 
for 12 h. Treated cells were then used for invasion and migration assays. 
 
2.16 Microarray and data analysis  
 
Microarray analysis was performed using Human and Mouse Whole 
Genome OneArray v.5 manufactured by Phalanx Biotech Group (Belmont, CA), 
carrying 29,187 human genome probes (26423 probes for mouse)  and 1,088 
experimental control probes (872 control probes for mouse). Total RNA from 
mouse testis treated with MEHP for 12 hours, and from NT2/D1 cells treated with 




CA). Array hybridization, image processing, signal intensity acquisition and data 
normalization were performed by Phalanx Biotech Service Group. Normalized 
values for each data point were averaged using three biological replicates. 
Significant expression differences were defined as a p-value <0.05 and genes with 
a value greater than 2-fold or 4-fold change were selected by Cluster Software 
(Stanford University and Massachusetts Institute of Technology). Selected genes 
were grouped according to their biological function and clustered using a 
hierarchical cluster method (TreeView, Stanford University and Massachusetts 
Institute of Technology). 
 
2.17 Semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) 
 
To confirm the results derived from the microarray analysis, 11 
differentially expressed genes were randomly selected from the cluster analysis, 
and their mRNA levels were measured by semi-quantitative RT-PCR. First strand 
cDNA was prepared using 5 μg of total RNA with Superscript II reverse 
transcriptase and oligo-dT primer (all Invitrogen). The primers used to amplify 
differentially expressed genes are listed in Table 2.1 Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was quantified as an internal control. PCR reaction was 
performed by 28 cycles of 92°C for 30 sec, 54°C for 1 min and 72°C for 30 sec 




were separated on 1.5% agarose gel and images were captured using a Kodak Gel 
Logic 100 Imaging system. Densitometry for bands on PCR products was 
determined by ImageJ software. The relative expression level of each gene was 
normalized by the value of GAPDH.  
 
2.18 Statistical analysis 
 
In this study, the minimum number of animals necessary to achieve 
statistical significance were used after performing statistical power analysis 
(=0.05, =0.05) to test if the power of sample size was sufficient [127,128]. 
Statistical results were presented as the individual means  SEM. The data were 
subjected to a Student t-test or parametric one-way analysis of variance (ANOVA) 
and statistical significance using Fisher's protected least significant difference was 








Table 2.1 Nucleotide sequence of RT-PCR primers designed to generate MEHP-regulated genes  
 
   
Gene name Accession No. Primer sequence (5’→3’) 
Neurotensin (NTS) NM_006183.3 F: aagcacatgttccctcttgg 
  R: aagccctgctgtgacagatt 
Inhibitor of DNA binding 1 
(ID1) 
NM_002165.2 F: cggatctgagggagaacaag 
  R: ctgagaagcaccaaacgtga  
Vinculin (VCL) NM_014000.2 F: ctttgctgctacaggggaag 
  R: ggatatgggacgggaagttt 
Gap junction protein alpha 1 
(GJA1) 
NM_000165.3 F: atgagcagtctgcctttcgt 





NM_002304.2 F: cctgtgtcatagccccaagt 
R: ctccccactcagaagagctg 
Interleukin 17 receptor D 
(IL17RD) 
NM_017563.3   F: ctgtctctgccactgatgga 
  R: ccaagatctgctttgcatga 
   
Claudin 6 (CLDN6) NM_021195.4 F: ttttgtttctgcctcctgct 
  R: gcctccgcattagttccata 
β1-Catenin (CTNNB1) NM_001904.3 F: gaaacggctttcagttgagc 
  R: ctggccatatccaccagagt 
Methionyl-tRNA synthetase 
(MARS) 
NM_004990.2 F: cctgcagtatcctgctgaca 
  R: tccatcagcgcttgtatctg 
Matrix metalloproteinase 2 
(MMP2) 
NM_004530.4 F: atgacagctgcaccactgag 
  R: atttgttgcccaggaaagtg 
Inhibitor of DNA binding 3 
(DDIT3) 
NM_001195053.1 F: gcgcatgaaggagaaagaac 
Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) 
NM_002046.3 F: gagtcaacggatttggtcgt 
R: ttgattttggagggatctcg 






Chapter 3:  FasL Gene–Deficient Mice Display a Limited Disruption in 
Spermatogenesis and Inhibition of Mono-(2-ethylhexyl) Phthalate–Induced 
Germ Cell Apoptosis 
 




3.1. Introduction and Rationale  
 
The mechanisms responsible for the control of physiological apoptosis of 
germ cells in the testis have not been clearly resolved, but the direct involvement 
of FasL/Fas signaling in triggering germ cell apoptosis has been described in 
rodents after exposure to the Sertoli cell toxicant mono-(2-ethylhexyl) phthalate 
(MEHP) [43,123]. The functional participation of FasL/Fas signaling in MEHP-
induced germ cell apoptosis has been shown experimentally by challenging gld 
(generalized lymphoproliferative disease) mutant mice with MEHP [51]. The gld 
mice have a mutation that causes a single amino acid change in FasL, preventing 
it from binding to and activating its receptor Fas [129]. Although these mice are 
fertile and show similar basal germ cell apoptotic rates as wild-type mice, a 
significant reduction in the incidence of germ cell apoptosis has been seen in the 




mice [51]. However, since the protection from MEHP-induced germ cell 
apoptosis was not complete, it is thought that the mutant form of FasL in gld mice 
may retain some of its activity.  
In this chapter, to adequately test the hypothesis that FasL is required for the 
regulation of germ cell apoptosis during distinct peripubertal periods, we 
evaluated the testis of FasL gene deficient (FasL-/-) mice during the first wave of 
spermatogenesis (PND 28, the peripubertal age) as well as the period directly 
after the completion of the first wave of spermatogenesis (PND 44, adulthood). In 
addition, the sensitivity of PND 28 FasL-/- mice to the testicular effects MEHP 








3.2.1 Assessment of testicular parameters in FasL-/- and C57BL/6J wild-type mice 
In order to initially characterize the testis of FasL-/- mice, the body weights, 
testis weights, and testicular spermatid head counts were measured in peripubertal 
(PND 28) and adult (PND 44) mice (Table 3.1). No significant differences in 
body weights or testis weights were evident between FasL-/- and C57BL/6J mice 
at PND 28 (Table 3.1). In adults (PND 44), the body weights of FasL-/- were 
significantly increased compared to the C57BL/6J mice (22.150.27 g and 
19.50.54 g, respectively), while no differences were observed between their 
testis weights. The testis/body weight ratio in adult FasL-/- mice was not 
significantly decreased as compared to C57BL/6J mice (0.0035 and 0.0038, 
respectively). Measurements of spermatid head counts revealed that adult FasL-/- 







Table 3.1 Comparison of C57BL/6J wild-type and FasL-/- mice baseline testicular parameters a 
 
a Data represent the mean ± SEM, and numbers of examined mice and testis in each strain are indicated in parentheses. 
b p<0.05, by ANOVA followed by Fisher’s protected least significant differences test. 




 PND 28 PND 44 PND 28 PND 44 PND 44 
C57BL/6J 14.53±0.40 (26) 19.50±0.54 (8) 0.0528±0.0026 (26) 0.0744±0.0024 (8) 40.24±0.68 (12) 




3.2.2 Abnormal testicular histopathology in young FasL-/- mice 
 
Evaluation of the histology of testicular cross sections from PND 28 FasL-/- mice 
revealed that 7 out of 10 FasL-/- mice had abnormal tubules and about 3% of the 
seminiferous tubules showed a significant loss of germ cells. However, only 1 out of 10 
C57BL/6J mice showed some similar abnormal tubules. The most severely affected 
seminiferous tubules were populated by only Sertoli cells and few spermatogonia (Fig 
3.1A-D). In contrast, the testes of adult PND 44 FasL-/- mice showed numerous germ 
cells and apparently normal histology (Fig 3.2A-D), despite the lower number of mature 
spermatids produced. These observations indicate that the seminiferous epithelium of 
adult FasL-/- mice is able to partially recover from the drastic germ cell loss seen in the 
peripubertal period. 
 
3.2.3 Increased basal apoptotic rate in germ cells in FasL-/- mice 
 
Contrary to our expectations, FasL-/- mice at both PND 28 (Fig 3.1E) and PND 44 
(Fig 3.2E) showed dramatic increases in the basal numbers of TUNEL-positive germ 
cells as compared to C57BL/6J wild-type mice. The testis of FasL-/- mice showed a basal 
germ cell apoptotic index (AI) of 20.58 at PND 28, and 5.26 at PND 44. The testis of 








Fig 3.1 Testicular histopathology of PND 28 C57BL/6J and FasL gene-deficient 
(FasL-/-) mice. Cross-sections (5 µm) of paraffin-embedded testis tissues were stained 
with periodic acid-Schiffs-Hematoxylin (PAS-H) staining (A-D) or TUNEL assay (E, F). 
A, B, E: C57BL/6J wild-type mice; C, D, F: FasL-/- mice; B, D: the magnification of one 
seminiferous tubule of A and C (boxed area). Arrow heads indicate Sertoli cell 
vacuolization. Arrows indicate TUNEL-positive germ cells (brown spots). The bar 
represents 100 µm. G: the germ cell apoptotic rate by TUNEL assay. PND 28 FasL-/- 








Fig 3.2 Testicular histopathology in PND 44 C57BL/6J and FasL-/- mice. Cross-
sections (5 µm) of paraffin-embedded testis tissues from PND 44 mice were stained with 
PAS-H staining (A-D) and TUNEL assay (E, F). A, B, E: C57BL/6J mice; C, D, F: FasL-
/- mice; B, D: the magnification of one seminiferous tubule of A and C (boxed area). 
Arrows indicate TUNEL-positive germ cells (brown spots). The bar represents 100 µm. 
G: the apoptotic rate in germ cells by TUNEL assay. PND 44 FasL-/- mice have a 




3.2.4 Germ cell apoptosis decreased in FasL-/- mice after MEHP exposure 
In order to evaluate the effect of MEHP on germ cell apoptosis, PND 28 FasL-/- and 
C57BL/6J mice were treated with 1 g/kg of MEHP for various time periods; a treatment 
paradigm that has been employed for the evaluation of death-receptor dependent germ 
cell apoptosis was used [76]. In C57BL/6J mice, increases in the number of apoptotic 
germ cells were apparent in a time-dependent manner after MEHP exposure (Fig 3.3); 
these findings were consistent with previous reports [51,122]. As described above, the 
basal AI in the testis of FasL-/- mice was 20±4.59, a level very near the maximal AI seen 
in MEHP treated C57BL/6J mice (Fig 3.1G). In response to MEHP exposure, this high 
basal AI FasL-/- mice was found to significantly decrease at 6 hours after exposure and 
remain at this decreased level at both the 12 and 24 hour time points (Fig 3.3). The 
maximal difference in the AI between the FasL-/- and C57BL/6J mice was observed at the 
12 hour time point with ~50% difference (10.09 and 23.86, respectively). 
 
3.2.5 MEHP exposure does not result in an increase in the cleavage of caspase 9 in  
FasL-/- mice. 
 In order to assess the participation of the intrinsic pathway in FasL-/- mice after 
MEHP exposure, we evaluated the level of cleaved caspase-9, the active form of this 
enzyme, in testicular cross-sections by immunohistochemistry. The level of cleaved 
caspase-9 decreased in C57BL/6J mice after MEHP treatment, but no significant 







Fig 3.3 Germ cell apoptotic index (AI) in peripubertal FasL gene-deficient mice 
after MEHP exposure. The AI in mouse paraffin-embedded testis cross sections was 
determined by TUNEL assay. PND 28 mice were treated with MEHP for various periods 
of time. Testicular cross-sections show TUNEL-positive germ cells as brown spots 
(arrows) in MEHP-treated C57BL/6J mice (A) and FasL-/- mice (B) at 12 h of exposure. 
The bar represents 100 μm. (C) C57BL/6J wild-type mice displayed an increase in germ 
cell apoptosis at 12 h of MEHP exposure. The apoptotic rate of germ cell in FasL-/- mice 







Fig 3.4 Immunohistochemical detection of cleaved caspase-9 in mice testes. Cross-
sections (5 µm) of paraffin-embedded testis tissues from C57BL/6J and FasL-/- mice 
(PND 28) were analyzed. (A) Non-treated C57BL/6J mice; (B) C57BL/6J mice treated 
with MEHP for 12 h; (C) Non-treated C57BL/6J mice; (D) C57BL/6J mice treated with 
MEHP for 12 h. The arrows indicate the cleaved-caspase-9-positive germ cells. The bar 
represents 100 µm. (E) Testis cross-sections showed that the level of cleaved caspase-9 
was reduced in C57BL/6J mice after MEHP exposure but remained the same expression 




3.2.6  Expression of TRAIL protein in the testis of young FasL-/- mice  
 
Western blot analysis of testis samples from FasL-/- (PND 28) mice showed that the 
expression of TRAIL was 1.3-fold higher than that seen in C57BL/6J (PND 28) mice 
(Fig 3.5A and 3.5B). After MEHP exposure, TRAIL levels increased at 12 hours in the 
testis of C57BL/6J mice but no significant changes in TRAIL levels were measured in the 
testis of FasL-/- mice at any time point. 
 
3.2.7 Increased c-FLIP expression in FasL-/- mice after MEHP exposure 
 
Western blot analysis of testis samples from both C57BL/6J (PND 28) and FasL-/- 
(PND 28) mice indicated that the basal levels of c-FLIP was very low (Fig 3.5A and 
3.5C). However, in response to MEHP exposure, the levels of c-FLIP were found to be 
significantly increased in the FasL-/- mice (~2.3-fold) at each of the measured time points 
but not at any of the time points in C57BL/6J mice.  
 
3.2.8 Localization of c-FLIP in the seminiferous tubules 
 
 Immunofluorescence detection of c-FLIP in testis cross-sections revealed that it is 
localized within the cytoplasm of spermatocytes and round spermatids but not in 
spermatogonia in PND 28 C57BL/6J mouse testes (Fig 3.6A). However, PND 28 FasL-/- 




C57BL/6J mice (Fig 3.6B). The c-FLIP expression in MEHP-treated C57BL/6J mice 
remained similar to that observed in non-treated mice (Fig 3.6C). However, its expression 







Fig 3.5 Western blot analyses of TRAIL and c-FLIP protein expression in PND 28 
FasL gene-deficient mice. Total cellular proteins from whole testis tissues were detected 
using primary antibodies against TRAIL (1:250) and c-FLIP (1:1000). FasL-/- mice 
showed a significant increase in TRAIL expression compared to C57BL/6J mice. TRAIL 
expression in C57BL/6J wild-type mice was enhanced by 12 h MEHP exposure while 
there was no significant difference between control or MEHP-treated FasL-/- mice. 
C57BL/6J mice had a very low expression level of c-FLIP. FasL-/- mice showed a higher 
level of c-FLIP protein after MEHP treatment. A: western blot; B: the quantified 
measurement of TRAIL expression level; C: the quantified measurement of c-FLIP 
expression level. Significant differences between groups are denoted by bars with 
different letters (p<0.05, ANOVA). For example, if any bar shows the same letter, it 












Fig 3.6 The expression and localization of c-FLIP in the seminiferous epithelium by 
immunofluorescence analysis. A: Non-treated C57BL/6J mice (PND 28), B: Non-
treated FasL-/- mice (PND 28), C: MEHP-treated C57BL/6J mice (PND 28), D: MEHP-
treated FasL-/- mice (PND 28). Testis cross-sections showed that c-FLIP is expressed in 
the cytoplasm of spermatocytes and spermatids. MEHP-treated FasL mice had a higher 







The FasL/Fas signaling pathway has been described by our laboratory 
[51,122,123,130] and others [43,102,131] to serve as a means to regulate germ cell 
apoptosis in the testis as part of a physiologic mechanism to match germ cell numbers to 
the Sertoli cell supportive capacity. In agreement with this concept are our previous 
observations that gld mice expressing a mutant form of the FasL protein show a 
decreased sensitivity to germ cell apoptosis triggered by MEHP-induced Sertoli cell 
injury, as compared to wild-type mice [51]. Nevertheless, despite this clear indication of 
the participation of the Fas-signaling system after toxicant-induced Sertoli cell injury, the 
gld mice are fertile and show normal spermatogenesis indicating that this mutant form of 
FasL does not drastically disrupt the physiological control of apoptosis and functional 
spermatogenesis [51]. It is possible that the single amino acid mutant form of FasL in gld 
mice retains a limited ability to bind to and trigger Fas-mediated apoptosis but cannot 
activate Fas-signaling robustly after toxicant-induced Sertoli cell injury. Therefore, the 
intent of this study was to evaluate if the complete loss of the FasL expression in the 
testis would influence the normal physiologic regulation of germ cell apoptosis as well as 
alter the ability of germ cells to undergo apoptosis after MEHP-induced Sertoli cell injury.  
Although adult FasL-/- mice were fertile and displayed typical testis histology (Fig 
3.2C and 3.2D), these mice surprisingly showed a significant reduction in the number of 
mature sperm they produced. In contrast, we discovered that peripubertal (PND 28) mice 




epithelium (Fig 3.1C and 3.1D). The histological analysis of these peripubertal FasL-/- 
mouse testis revealed a dramatic loss of germ cells (Fig 3.1C and 3.1D) in some 
seminiferous tubules as indicated by the absence of differentiating spermatocytes with 
only the presence of Sertoli cells and spermatogonia in the seminiferous epithelium. 
However, in adult FasL-/- mice, after the first wave of spermatogenesis was completed, a 
partial repopulation of these severely affected tubules apparently occurred (Fig 3.2C and 
3.2D) as indicated by near normal histology; although adult FasL-/- mice produced fewer 
mature elongated spermatids. These observations suggest a more prominent functional 
role of FasL in early testis development rather than in the adult testis and the maintenance 
of spermatogenesis.  
The incidence of germ cell apoptosis in FasL-/- (PND 28) mice is about 4 times 
higher than that of wild-type mice (Fig 3.1G). In adult FasL-/- (PND 44) mice, the basal 
germ cell apoptotic index (5.26) was lower than that seen in the peripubertal FasL-/- mice 
(20.58), but higher than age-matched adult wild-type C57BL/6J (PND 44) mice (1.5). 
This increase in the basal incidence of germ cell apoptosis may explain the slight 
decrease in testis weight measured in these peribuertal mice as well as the decrease in the 
number of spermatid produced in the adult FasL-/- mice (Table 3.1). On the other hand, 
these findings also suggest that compensatory mechanisms, such as other death 
ligands/receptors may exist in FasL-/- mice to regulate germ cell apoptosis, since it 
appears that MEHP exposure does not trigger the intrinsic apoptotic signaling (Fig 3.4).  
In order to understand how germ cell apoptosis is triggered in FasL-/- mice, we 




Western blot analysis revealed that TRAIL is strongly expressed in the testis of 
peripubertal FasL-/- mice, but at relatively low levels in wild-type mice (Fig 3.5A and 
3.5B). Therefore, it is plausible that the increased level of TRAIL in peripubertal FasL-/- 
mice may account for, and provide in vivo evidence for, the observed high basal levels of 
germ cell apoptosis seen in these mice.  
In order to assess the sensitivity of FasL-/- mice to toxicant-triggered apoptosis, the 
MEHP-induced exposure model of prepubertal mice was used. MEHP specifically injures 
the Sertoli cells of the testis, inducing FasL expression, which leads to initiation of germ 
cell apoptosis through the extrinsic signaling pathway [103]. In wild-type mice, the basal 
level of germ cell apoptosis is low and is significantly induced after MEHP exposure (Fig 
3.3), which is consistent with our previous studies [51,122]. Since no increase in the 
cleavage of caspase-9 occurred in the testis of FasL-/- mice after MEHP exposure (Fig 
3.4), it does not appear that the intrinsic pathway participates in the initiation of germ cell 
apoptosis in the FasL-/- mice after Sertoli cell injury. We have also previously shown that 
peripubertal gld mice have a similar basal germ cell apoptotic index as the wild-type 
controls. However, in gld mice, the increase in MEHP-induced germ cell apoptosis is 
significantly diminished as compared to wild-type mice [51], indicating that the 
expression of the single amino acid mutation in FasL affords these mice only partial 
protection against germ cell apoptosis. However, the germ cells of FasL-/- mice showed a 
much different response to MEHP exposure than either C57BL/6J or gld mice. After 
exposure of FasL-/- mice to MEHP, a dramatic decrease in the high basal germ cell AI of 




level for 24 hours (Fig 3.3). Since no significant changes in the levels of TRAIL protein 
were observed in FasL-/- mice after MEHP exposure (Fig 3.5), it would appear that the 
negative effect of MEHP on germ cell apoptosis in FasL-/- mice lies downstream of 
TRAIL.  
c-FLIP is a well-described inhibitor of caspase-8 [132], and we have previously 
suggested that c-FLIP is involved in regulating MEHP-triggered germ cell apoptosis 
[133]. The testis of the PND 28 C57BL/6J and FasL-/- mice were found to display low 
levels of c-FLIP, while large increases in the levels of c-FLIP were measured in the testis 
of only FasL-/- mice following MEHP treatment (Fig 3.5A, 3.5C and 3.6). Although 
increases in c-FLIP levels in FasL-/- mice after MEHP can provide a logical mechanism 
to account for the observed decreases in germ cell apoptosis, the mechanism underlying 
this specific increase in c-FLIP protein levels in these mice after MEHP exposure is not 
readily apparent.  
There are several intriguing reports suggesting that the FasL protein itself has an 
inverse influence on c-FLIP expression. These studies indicate that FasL induces the 
degradation of c-FLIP via the ubiquitin-proteasomal pathway after the simulation of 
nitric oxide (NO) or reactive oxygen species (ROS)[134,135]. Therefore, it would be 
expected that in FasL-/- mice, the absence of FasL and its negative influence on c-FLIP 
expression would allow for a buildup of c-FLIP in the cell. Moreover, our group 
previously reported that c-FLIP is induced in p53 gene-deficient (p53-/-) mice after 
MEHP exposure [136] and that c-FLIP is also induced as a result of the FasL/Fas 




positive regulator to stimulate the FasL/Fas signaling pathway which facilitates the 
activation of caspase-8 and the degradation of c-FLIP following MEHP exposure, leading 
to an increase in germ cell apoptosis [136]. These data suggest that linkages may exist in 
the testis by which FasL/Fas signaling can influence p53-dependent processes that 
subsequently act to modulate the levels of c-FLIP in germ cells and their sensitivity to 
undergo death-receptor mediated apoptosis.  
Taken together, the present study demonstrates that: 1) loss of FasL protein 
expression results in decreased production of mature spermatids in the adult testis, likely 
as a result of alterations in germ cell homeostatsis during the first wave of 
spermatogenesis, 2) the high baseline incidence of germ cell apoptosis in peripubertal 
FasL-/- mice is correlated with increases in the levels of TRAIL and/or the decrease in the 
levels of c-FLIP and, 3) a decline in germ cell apoptosis observed after MEHP treatment 
in FasL-/- mice closely corresponds to the occurrence of increased levels. These novel 
findings provide new insights into the functional roles of FasL in the testis at distinct 
developmental periods and further indicate that FasL itself is required for the regulation 





Chapter 4: TRAIL gene-deficient mice show a disorganization of spermatogenesis 
during the peripubertal period of testicular development 
 
 
4.1 Introductions and Rationale 
 
 We demonstrated in Chapter 3 a possible mechanism that increases the expression 
of FLAR in FasL gene-deficient mice to reduce the apoptotic index in the testis after 
MEHP treatment. In this chapter, the TRAIL gene-deficiency will be discussed to provide 
further information for a comparison with FasL gene-deficient mice.  
Another member of the TNF family, a tumor necrosis factor related to apoptosis-
inducing ligand (TRAIL/Apo2L/TNFSF10) [34], is expressed in human and rodent testis 
[35,36,37]. TRAIL is a Type II transmembrane protein that binds to two receptors in 
humans, DR4 (TRAIL-R1/TNFRSF10A) and DR5 (TRAIL-R2/ TNFRSF10B), whereas 
there is only one TRAIL death receptor in mice, called TRAIL-R (MK/mDR5), and it is 
equally homologous to both human death receptors. [38,39]. The interaction between 
TRAIL and DR5 triggers a signaling pathway similar to the Fas-FasL system by 
transmitting signals through DISC. [40]. In our lab, a previous study showed that the 
combined addition of recombinant TRAIL and anti-DR5 antibody (MD5) together caused 
significant increases in germ cell apoptosis in vitro, thereby implicating a role for TRAIL 
in testes [137]. Although recent studies have focused on the application of TRAIL in 




[142], the role of TRAIL in the immune system and its functional mechanisms are 
controversial [99]. TRAIL gene-deficient mice contain a partial deletion of exon 2 and a 
complete deletion in exon 3 in the TRAIL gene, resulting in spontaneous tumor formation 
[99,142,143,144]. 
In order to more rigorously define the role of the DR5/TRAIL signaling system in 
the physiological regulation of germ cells in the testis, we describe here the testicular 
phenotype of TRAIL gene-deficient mice. Since the highest level of “physiological” 
germ cell apoptosis in mice occurs during the peri-pubertal period, we include here a 
detailed evaluation of the testis of these gene-deficient mice both during the peri-pubertal 
period (28 days of age) as well as in adult mice (44 days of age). We also show in this 







4.2.1 Physiological characterization of the testis of  TRAIL-/- mice 
 
In order to understand the physiological differences between the wild type C57Bl/6J and 
TRAIL gene-deficient mice, the testis weight and body weight were recorded. At 28 days 
of age, C57BL/6J mice had a statistically higher testis/body weight ratio (g/kg) as 
compared with the TRAIL-/- mice (3.60.4, 3.30.2, and 3.50.1; respectively) (Figure 
4.1A, left group), while there were no differences in the body weight of the mice 
examined (Figure 4.1B, left group). In adults (44 days of age), no differences, however, 
were observed in the testis/body weight ratio in any of the mice examined (Figure 4.1A, 
right group). 
 
4.2.2 TRAIL-/- mice showed an increase in germ cell apoptosis 
 
Contrary to our expectations, TRAIL-/- mice were found to have a drastically greater 
increase in basal incidence in TUNEL-positive germ cells compared to wild-type 
C57BL/6J mice at both 28 days and 44 days of age (Figure 4.2). TRAIL-/- mice had a 
high germ cell apoptotic index at 28 days (21.54%) and continued to maintain a high 













Figure 4.1 Physiological parameters of the testis in wild-type C57BL/6J mice and 
TRAIL gene-deficient mice. The testis weight and body weight of various strains of 
mice at 28 and 44 days were measured. A: The testis/body weight ratio. B: The body 
















Figure 4.2 Apoptotic rate in germ cells of 28- and 44-day-old gene-deficient mice. 
The apoptotic rate in cross-sections from paraffin-embedded mouse testes was 
determined by TUNEL assay. At least two testicular cross-sections per mouse were 







4.2.3 Differences in FasL protein expression in wild-type and gene deficient mice  
 
A comparison between C57BL/6J and TRAIL gene-deficient mice revealed differences in 
the expression pattern of TRAIL mice at 28 days and 44 days of age. In 28-day-old mice, 
FasL expression was significantly increased in TRAIL-/- mice (1.56-fold) (Figure 4.3, left 
group). At 44 days of age, no significant differences in FasL expression were observed 
(Figure 4.3, right group).  
 
4.2.4 Testicular histology revealed a spermatogenic delay, cell cycle arrest, and high 
germ cell apoptotic index in the testis of TRAIL-/- mice 
 
Evaluation of the testicular histology in peri-pubertal mice with an increased incidence of 
spermatocytes showed an arrest during the meiotic phase and spermatogenic 
disorganization was observed in 28-day-old TRAIL-/- mice (Figure 4.4C and 4.4D) as 
compared with the wild-type C57BL/6J mice (Figure 4.4A and 4.4B). The testis of adult 
44 day-old TRAIL-/- mice showed cell cycle arrests and disorganization of germ cells was 
observed (Figure 4.4G and 4.4H).  
 
4.2.5 Decreased spermatid head formation in gene deficient mice 
 
Measurements of spermatid head counts revealed that adult (44 day-old) FasL- and 




spermatids compared with C57BL/6J mice (reduced to 51% and 39% of production in 
FasL-/- and TRAIL-/- mice, respectively) (Figure 4.5). 
 
4.2.6 TRAIL-/- mice had a prolonged pregnancy interval between litters 
 
In order to examine breeding success, the period of time between the day the mating cage 
was set up to the day of confirmed birth was recorded. The box-plot shows different 
pregnancy intervals among the gene-deficient mice. Wild-type C57BL/6J and FasL-/- 
mice showed similar pregnancy intervals (23 days and 21 days, respectively), while 













Figure 4.3 Differences in FasL expression in TRAIL-/- mice at PND28. FasL 
expression in total cellular proteins from whole testis homogenates at 28 and 44 days 
were detected using primary antibodies against FasL (1:500). -actin was the loading 
control.  






Figure 4.4 Testicular histopathology. Cross-sections (5 µm) of paraffin-embedded 
testis tissues were evaluated for morphological changes by using periodic acid-Schiffs-
Hematoxylin (PAS-H) staining. A, B, E, F: wild-type C57BL/6J mice; C D, G, H: 
TRAIL-/- mice. A-D: 28-day-old mice; and E-H: 44-day-old mice. Arrows indicate cell 













Figure 4.5 The number of mature spermatid heads at 44 days. Testes from 44-day-
old mice were homogenized in DMSO/saline solution, and spermatid heads were counted 










Figure 4.6 The pregnancy interval of gene deficient mice. The interval between two 
litters was evaluated by maintaining the breeding pairs of various gene deficient mice 
strains. Each breeding pair was established as mating 6-week-old mice, and continued 
breeding for at least 4 litters. The hollow circle spot indicates the out-of-range results that 







 In Chapter 3, we discussed how the extrinsic pathway plays an important role during 
normal testis development and requires FasL-Fas stimulated signaling to initiate germ 
cell apoptosis [50,144,145]. In Chapter 4, in order to define the functional contribution of 
TRAIL/DR5 on normal testis development, as well as in controlling apoptosis of germ 
cells in the testis during spermatogenesis, we evaluated the testis of TRAIL-gene 
deficient mice during the peri-pubertal period (28 days of age) and during adulthood (44 
days of age).  
The testes and body weights of wild-type C57BL/6J and TRAIL-/- mice were 
examined (Figure 4.1). C57BL/6J mice had a higher testis/body weight ratio at 28 days. 
No significant differences were observed in the body weight of the various 28-day-old 
mice, but FasL-/- mice showed a slight increase in body weight at 44 days (Table 3.1). 
Similarly, it was shown that the loss of Bax, another proapoptotic protein, caused no 
significant changes in the testis weight of young mice [146]. However, the loss of Bcl-2 
resulted in a dramatic decrease in testis weight [147]. These findings suggest that the loss 
of anti-apoptotic proteins may be more detrimental than the loss of pro-apoptotic proteins 
for developmental functions in the testis.  
TRAIL-/- mice carry a partial deletion of exon 2 and a complete deletion of exon 3 in 
the TRAIL gene [142]. Interestingly, others have reported that HeLa cell line transfected 
with two alternative splicing transcripts of TRAIL (TRAIL- and TRAIL-) that revealed 




resulting in a truncated TRAIL protein lacking the extracellular domain in both splicing 
variants [148]. Our results show a different observation in that the mutation in the TRAIL 
gene was caused by an increase in germ cell apoptosis. It is possible that this increase in 
germ cell apoptosis may result from another death receptor signaling family member or 
may point to the participation of the intrinsic apoptotic signaling pathway in order to 
compensate for the loss of TRAIL and to maintain homeostasis during testis development. 
On the other hand, there are differences in the basal apoptotic rates between the young 
and adult mice. The 44-day-old TRAIL-/- mice continued to maintain a high apoptotic 
index, while the adult FasL-/- mice showed a significant decrease in germ cell apoptosis 
compared with levels observed at 28 days. These observations suggest that TRAIL may 
play a more dominant role than FasL in controlling the population of germ cells after the 
first wave of spermatogenesis, while FasL may be more critical during the peri-pubertal 
period than during adulthood.  
Recent studies have indicated that Fas is an important regulator of spermatocyte 
apoptosis in rats during the first wave of spermatogenesis as a mechanism to maintain 
appropriate populations of spermatocytes [50]. Interestingly, FasL-deficient mice (gld 
mice), carrying a single mutation in the c-terminus of the FasL protein, show an increase 
in germ cell apoptosis in 8 weeks old adult mice [51], suggesting that Fas system is not 
required for spermatogenesis in adult mice.  
Our results here indicate that those gene-deficient mice that lack one death ligand 
display no obvious morphological changes and no protection from apoptosis of testicular 




determined by western blot analysis in the various deficient mice. Interestingly, at 28 
days, FasL-/- mice showed a higher level of TRAIL protein (Figure 3.5), while TRAIL-/- 
mice showed only a small increase in the FasL protein, a finding that is in agreement with 
the hypothesis that FasL and TRAIL can functionally compensate for the loss of the other 
in the testis during peri-pubertal age in vivo (Figure 4.3). Although these two death 
ligands appear to compensate for each other, we predicted that complete compensation 
would result in a wild type phenotype. However, the sperm counts were still lower 
compared to C57 (Figure 4.5). 
The histological analysis of testicular cross sections suggested that FasL and TRAIL 
expression may be critical for the development of germ cells during the peri-pubertal age. 
In 28-day-old FasL-/- mice, some seminiferous tubules showed a dramatic loss of germ 
cells (Figure 3.1, 4.4) that may have led to a delay in germ cell development. The 
abnormal spermatogenesis was caused by an absence of differential spermatocytes and 
only with Sertoli cells and spermatogonia in the seminiferous epithelium. However, at 44 
days old, after the first wave spermatogenesis, those immature tubules may have 
automatically repopulated in FasL-/- mice (Figure 3.2 and 4.4). An increase in cell cycle 
arrest was detected in spermatocytes in 28-day-old TRAIL-/- mice (Figure 4.4), but not in 
FasL-/- and wild-type mice (Figure 3.1 and 3.2). At 44 days, TRAIL-/- mice still showed 
cell cycle arrest and apoptosis (Figure 4.2 and 4.4) that were higher than C57BL/6J wild-
type or FasL-/- mice. These observations further suggest that TRAIL may be more 
important than FasL for long term maintenance of spermatogenesis by controlling germ 




Finally, in order to determine whether the loss of either FasL or TRAIL can alter the 
ability of reproduction, the numbers of mature spermatid heads were counted in the 
different gene-deficient mice. Adult (44-day-old) FasL-/- mice displayed a decrease in 
mature spermatid formation (Figure 4.5), which could be due to the increase in apoptosis 
seen at 28 days (Figure 4.2). Adult TRAIL-/- mice produced the lowest number of mature 
spermatid heads, possibly due to the continued high germ cell apoptotic rate as well as 
cell cycle arrest. The decreased number of spermatid heads did not dramatically influence 
the productivity of these death-ligands deficient mice. However, recent reports suggest a 
lower reproductive efficiency in humans with decreased sperm counts because humans 
require a minimum number of sperm in order to maintain a normal reproductive function 
[149,150]. Even though all of the gene-deficient mice were fertile, the female mice 
showed different intervals between pregnancies. TRAIL-/- female mice had the longest 
delay between pregnancies (~29 days) compared to C57BL/6J wild-type mice (~23 days) 
(Figure 4.6). These observations suggest that the loss of TRAIL causes difficulty in 
reproduction, possibly resulting from lower levels of mature spermatids, but how this 
processes influences of intervals between pregnancies in the female remains unknown.  
Taken together, the findings presented in this study provide evidence for the first time 
that FasL and TRAIL may partly compensate for each other to regulate germ cell 
apoptosis during the first wave of spermatogenesis. These findings also point to a more 
predominant role of FasL than TRAIL in controlling the proper number of germ cells 




more critical for maintaining long-term homeostasis of the germ cell population in the 






Chapter 5: A comparison of FasL and TRAIL gene deficient mice during 
development and following MEHP treatment 
 
5.1 Introduction and Rationale 
 
 In Chapter 3, we identified c-FLIP as a potential mechanism responsible for the 
decrease in apoptosis in FasL gene deficient mice after MEHP exposure.  We continued 
to examine the normal physiological function of another death ligand, TRAIL, using 
TRAIL gene deficient mice. To test whether TRAIL is also involved the regulation of c-
FLIP after MEHP exposure, the germ cell apoptosis were measured in TRAIL-/- mice 
with/without MEHP exposure.  
From previous results, both FasL and TRAIL gene deficient mice had decreased 
testis/body weight ratios and spermatid head counts, but showed an increase in germ cell 
apoptosis during the first wave of spermatogenesis. To further understand the delay in 
spermatogenesis in both FasL and TRAIL gene deficient mice, we performed a 







5.2.1 Germ cell apoptosis not significnat increased in TRAIL-/- mice after MEHP 
exposure  
 
To evaluate the effect of MEHP on germ cell apoptosis, PND 28 TRAIL-/-, FasL-/-, 
and C57BL/6J mice were treated with 1 g/kg of MEHP for various time periods. In 
TRAIL-/- mice, increases in the number of apoptotic germ cells were apparent in a time-
dependent manner starting from the high basal apoptotic index (AI) after MEHP exposure 
(Fig 5.1). Findings consistent with the previous study, an increased expression of FasL 
can increase germ cell apoptosis after MEHP exposure. [51,122].  As described in 
previous chapters (Chapters 3 and 4), the basal AI in the testis of FasL-/- and TRAIL-/- 
mice were significantly higher compared with C57BL/6J mice (20.58%, 21.54%, and 
5.16%, respectively). In response to MEHP exposure, the high basal AI in TRAIL-/- mice 
was found to increase significantly at 6 hours after exposure and remained at that high 
level at both the 12 and 24-hour time points (Fig 5.1). The maximal difference in the AI 
between the two types of gene deficient mice was observed at 12-hour time points with 
+/- ~50% difference (FasL-/- mice decreased from 20.58% to 10.09%; TRAIL-/- mice 
increased from 21.54% to 31.96%). The maximal difference in the AI between the FasL-/- 
and C57BL/6J mice was observed at the 12-hour time point with ~50% difference (10.09 




5.2.2 No obvious increase in c-FLIP expression in TRAIL-/- mice compared to FasL-/- 
mice following MEHP exposure 
 
Western blot analysis of testis samples from 28-day-old C57BL/6J, TRAIL-/- and 
FasL-/- mice indicated that the basal levels of c-FLIP were very low (Fig 5.2). As 
discussed in Chapter 3, FasL-/- mice responded to MEHP exposure with increased the 
levels of c-FLIP, while TRAIL-/- mice were found to have only slightly increased levels 













Figure 5.1 Germ cell apoptotic index (AI) in peri-pubertal TRAIL and FasL gene-
deficient mice after MEHP exposure. The AI in mouse paraffin-embedded testis cross 
sections were determined by TUNEL assay. PND 28 mice were treated with MEHP for 
various periods of time. C57BL/6J wild-type mice and TRAIL-/- mice displayed an 
increase in germ cell apoptosis at 12 hours of MEHP exposure. The apoptotic rate of 
germ cell in FasL-/- mice was significantly lower after MEHP exposure compared with 
C57BL/6J mice (* and # <0.05, Student t-test; * indicate FasL-/- vs C57; # indicate 














Figure 5.2 Western blot analyses of c-FLIP protein expression in PND 28 C57BL/6J, 
FasL gene-deficient, and TRAIL gene-deficient mice. Total cellular proteins from 
whole testis tissues were detected using primary antibodies against c-FLIP (1:1000). 
C57BL/6J mice had a very low expression level of c-FLIP. FasL-/- mice showed a higher 
level of c-FLIP protein after MEHP treatment, which   TRAIL-/- mice demonstrated only 




5.2.3 Microarray analysis of FasL and TRAIL gene deficient mice 
 
 Out of nearly 28,000 putative probes, there were 281 genes, with 99 genes 
unknown, in the FasL-/- mice that had a 4-fold difference as compared to C57BL/6J mice 
(Table 5.1). There were 200 genes, with 70 unknown, in TRAIL-/- mice that showed 4-
fold changes as compared with C57BL/6J mice (Table 5.2). FasL-/- and TRAIL-/- mice 
shared in common 169 genes with 4-fold changes, including 65 unknown genes, 
compared with C57BL/6J mice (Table 5.3). There were 104 genes grouped in 7 
categories by their functions in the testis, including biosynthesis, cytoskeletal, immune, 
metabolism, signal transduction, spermatogenesis/development, and unknown (Table 5.4 
and Fig 5.3). The delayed of spermatogenesis was observed in FasL and TRAIL gene 
deficient mice, as described in previous chapters. These results led us to check those 
genes that showed a difference with C57BL/6J and that may be involved in the 
spermatogenesis/development categories (Fig 5.4). 
 Among the 7 categories, spermatogenesis/development appears to be the major 
group to show strongly altered gene expression in death ligand gene deficient mice (Fig 
5.3). The genes include a disintergrin and metallopeptidase domain 7 (Adam7), arginine 
decarboxylase (Adc), complement component 4 binding protein (C4bp), CUB and zona 
pellucida-like domain 1 (Cuzd1), cyclin-dependent kinase 5, regulatory subunit 1 (p35) 
(cdk5r1), cyclin, basic protein of sperm head cytoskeleton 2 (cylc2), cysteine-rich 
secretory protein 1 (Crisp1), fascin homolog 3, actin-bundling protein, testicular  (Fscn3), 




3B (Odf3b), REX1, RNA exonulcease 1 homolog (Rexo1), serine peptidase inhibitor, 
Kazal type 8 (Spink8), serine peptidase inhibitor, Kunitz type 3(Spint3), sperm 
maturation 1 (Spem1), spermatogenesis and centriole associated 1 (Spatc1), 
spermatogenesis associated 18 (Spata 18), spermatogenesis associated 3 (Spata3), tctex1 
domain containing 1 (Tcte1d1), testicular haploid expressed gene (Theg), testis-specific 
serine kinase 3 (Tssk3), testis-specific serine kinase 6 (Tssk6), ubiquitin-like (Ubqlnl), 









Genes significantly different between C57BL/6J and FasL gene deficient mice 
Fold change 




PH_mM_0008100 Agpat2 67512 -3.11 0.00 NM_026212.1 
PH_mM_0013901 Oxct2a 64059 -3.35 0.00 NM_022033.3 
PH_mM_0014490 Adam4 11498 -2.00 0.00 NM_009620.1 
mMC019261 Adam7 11500 5.23 0.00 NM_007402.2 
PH_mM_0007832 Abhd16b 241850 -2.61 0.00 NM_183181.2 
mMC018239 Acta1 11459 2.39 0.00 NM_009606.2 
PH_mM_0007685 Acbd7 78245 3.31 0.00 NM_030063.2 
PH_mM_0012448 Arl2bp 107566 -2.24 0.00 NM_024269.3 
mMR026559 Arl9 384185 -2.85 0.00 NM_206935.1 
mMC010060 Akr1b7 11997 2.70 0.00 NM_009731.2 
PH_mM_0004216 Ahsg 11625 2.36 0.00 NM_013465.1 
PH_mM_0001251 Agt 11606 -2.33 0.00 NM_007428.3 
mMC005531 Adc 242669 -3.40 0.00 NM_172875.2 
mMR026859 Atg4a 666468 2.11 0.00 NM_174875.3 
PH_mM_0014216 Bcmo1 63857 -2.66 0.00 NM_001163028.1 
mMC013786 Calml4 75600 -2.54 0.00 NM_138304.2 
mMC010796 Cad 69719 2.11 0.00 NM_023525.1 
PH_mM_0014563 Ces5a 67935 6.64 0.00 NM_001003951.1 
mMC013527 Ceacam10 26366 3.80 0.00 NM_007675.4 
mMC003243 Casp7 12369 -3.39 0.00 NM_007611.2 
mMC024713 Ctnna3 216033 -2.14 0.00 NM_001164376.1 
PH_mM_0003640 Cd164l2 69655 -2.02 0.00 NM_027152.1 
mMC026451 Cd52 23833 6.64 0.00 NM_013706.2 
mMC000821 Cd96 84544 -2.09 0.00 NM_032465.2 
PH_mM_0004772 Cwh43 231293 3.60 0.00 NM_181323.2 
PH_mM_0011226 Cby3 76653 -3.97 0.00 XM_484016.4 
PH_mM_0009165 Ch25h 12642 3.38 0.00 NM_009890.1 
PH_mM_0012528 Cpsf4l 52670 -2.38 0.00 NM_029794.2 
PH_mM_0009005 Cdrt4 66338 -2.61 0.00 NM_025496.1 
PH_mM_0003221 Ccdc159 67119 -2.14 0.00 NM_025977.3 
PH_mM_0008848 Ccdc57 71276 -2.59 0.00 NM_027745.1 
PH_mM_0009593 Col1a2 12843 3.10 0.00 NM_007743.2 
PH_mM_0004326 C4bp 12269 3.43 0.00 NM_007576.3 
mMC009101 Cuzd1 16433 4.96 0.00 NM_008411.3 
mMR031232 Cux2 13048 -2.28 0.00 NM_007804.2 


















PH_mM_0000031 Cylc2 74914 -2.03 0.00 NM_001162865.1
mMC018400 Cstl1 228756 -3.19 0.00 NM_177655.3 
PH_mM_0003392 Crisp1 11571 6.64 0.00 NM_009638.3 
PH_mM_0013099 Cyp2a12 13085 -3.06 0.00 NM_133657.1 
PH_mM_0005867 Defb2 13215 5.38 0.00 NM_010030.1 
PH_mM_0008623 Defb21 403172 -2.86 0.00 NM_207276.2 
mMC007896 Defb37 353320 5.64 0.00 NM_181683.2 
PH_mM_0009190 Defb38 360212 5.51 0.00 NM_183036.1 
mMC002785 Defb40 360217 6.56 0.00 NM_183039.3 
PH_mM_0005654 Defb42 619548 4.20 0.00 NM_001034910.3
PH_mM_0008476 Dnajb8 56691 -2.52 0.00 NM_019964.1 
PH_mM_0009718 Dnajc5b 66326 -2.28 0.00 NM_001163537.1
PH_mM_0007033 Dydc2 71200 -3.38 0.00 NM_027717.1 
mMC023498 Elf3 13710 2.01 0.00 NM_001163131.1
PH_mM_0005876 Efcab1 66793 -2.28 0.00 NM_025769.3 
PH_mM_0009631 Eddm3b 219026 2.07 0.00 NM_203508.1 
mMC006344 Esrp1 207920 2.00 0.00 NM_194055.2 
mMC013655 Fasl 14103 -2.34 0.00 NM_010177.3 
PH_mM_0003129 Fez1 235180 -2.24 0.00 NM_183171.4 
PH_mM_0007905 Fscn3 56223 -3.33 0.00 NM_019569.2 
PH_mM_0016216 Fbxo39 628100 -2.41 0.00 NM_001099688.2
PH_mM_0008011 Fcrla 98752 2.10 0.00 NM_145141.2 
PH_mM_0008087 Fxyd3 17178 2.24 0.00 NM_008557.2 
PH_mM_0017479 Gprc5c 70355 2.47 0.00 NM_001110337.1
PH_mM_0006150 Gsdmd 69146 -2.47 0.00 NM_026960.4 
PH_mM_0016293 Gsg1 14840 -2.76 0.00 NM_010352.2 
PH_mM_0001002 Gpx3 14778 4.32 0.00 NM_001083929.1
PH_mM_0016195 Gpx4 625249 -2.23 0.00 NM_001037741.2
PH_mM_0006314 Gstcd 67553 -2.40 0.00 NM_026231.2 
PH_mM_0006326 Gapdhs 14447 -2.07 0.00 NM_008085.1 
mMC017921 1700022A21Rik 72252 -2.02 0.00 NR_003953.1 
PH_mM_0003574 Gp1bb 14724 -2.12 0.00 NM_010327.2 
PH_mM_0006445 Glt6d1 71103 -2.86 0.00 NM_001039095.1
PH_mM_0005506 Gramd2 546134 -2.58 0.00 NM_001033498.1
PH_mM_0001530 Gmps 229363 3.91 0.00 NM_001033300.2
PH_mM_0000197 Gucy2d 14918 -2.13 0.00 NM_001130693.1
mMC001823 Hspa1l 15482 -2.20 0.00 NM_013558.2 
PH_mM_0014524 Hbb-b1 15129 2.48 0.00 NM_008220.4 














PH_mM_0015866 LOC100047146 100047146 -2.90 0.00 XM_001473694.2
PH_mM_0003363 Irgc1 210145 -2.00 0.00 NM_199013.2 
mMC025253 Ido1 15930 2.62 0.00 NM_008324.1 
PH_mM_0006924 Iqcf6 100041096 -2.10 0.00 NM_001101628.1
PH_mM_0003498 Ica1 15893 -2.13 0.00 NM_010492.3 
PH_mM_0008043 Klhl24 75785 -2.06 0.00 NM_029436.3 
mMC020164 Krt15 16665 2.45 0.00 NM_008469.2 
PH_mM_0000659 Klc3 232943 -2.22 0.00 NM_146182.3 
PH_mM_0006784 Kcnip2 80906 -3.12 0.00 NM_030716.2 
PH_mM_0007225 Lelp1 69332 -3.08 0.00 NM_027042.1 
mMC021607 Lemd1 213409 -2.05 0.00 NM_001033250.4
PH_mM_0009010 Lrrc69 73314 -2.28 0.00 NM_028499.2 
PH_mM_0005345 Lrrc8b 433926 -2.92 0.00 NM_001033550.2
mMR026555 Lhx1 16869 -2.23 0.00 NM_008498.2 
mMC014819 Lcn2 16819 -2.34 0.00 NM_008491.1 
PH_mM_0003059 Lum 17022 2.16 0.00 NM_008524.2 
mMC011770 Ly6g6c 68468 -2.27 0.00 NM_023463.3 
mMC022185 Mboat1 218121 2.54 0.00 NM_153546.4 
mMC006485 Mgst2 211666 -2.04 0.00 NM_174995.2 
mMC011249 Mical3 194401 -2.64 0.00 NM_153396.2 
PH_mM_0016111 Map2k7 26400 -2.26 0.00 NM_001042557.2
PH_mM_0010566 LOC100047953 100047953 -2.27 0.00 XM_001479514.2
PH_mM_0012595 Mlf1 17349 -3.28 0.00 NM_001039543.2
PH_mM_0015068 Nqo2 18105 -3.09 0.00 NM_001163241.1
PH_mM_0016090 Naca 17938 -2.21 0.00 NM_013608.3 
PH_mM_0015482 Neurl1b 240055 2.08 0.06 NM_001081656.2
mMC013235 Npy 109648 6.12 0.00 NM_023456.2 
PH_mM_0009408 Nos2 18126 -2.40 0.00 NM_010927.3 
mMC025836 Nfe2 18022 -2.45 0.00 NM_008685.2 
PH_mM_0007159 Odam 69592 3.79 0.00 NM_027128.2 
mMC005441 Odf3b 70113 -3.14 0.00 NM_001013022.1
mMR026715 Osgin1 71839 -2.70 0.00 NM_027950.1 
PH_mM_0001494 Ptx4 68509 -2.67 0.00 NM_026747.1 
mMC007063 Padi6 242726 -2.29 0.00 NM_153106.2 
mMC008262 Ptrh1 329384 -2.13 0.00 NM_178595.3 
PH_mM_0008786 Perp 64058 2.56 0.00 NM_022032.4 
PH_mM_0004075 Phospho1 237928 -2.59 0.00 NM_153104.3 
PH_mM_0014989 Pldi 73616 -2.04 0.00 NR_033616.1 
mMC020960 Kctd16 383348 -2.07 0.00 NM_026135.1 














PH_mM_0015888 Paqr9 75552 -2.14 0.00 NM_198414.2 
PH_mM_0009053 Ptgs1 19224 2.80 0.00 NM_008969.3 
PH_mM_0003579 Pate2 330921 2.04 0.00 NM_001033421.3
mMC015224 Prss37 67690 -2.11 0.00 NM_026317.2 
PH_mM_0009328 Prss52 73382 -2.27 0.00 NM_028525.2 
mMC022760 Prss55 71037 -2.11 0.00 NM_001081063.1
mMC016079 Proc 19123 -2.40 0.00 NM_008934.2 
PH_mM_0016190 Pwwp2b 101631 -2.16 0.00 NM_001033206.2
mMR029146 Pdpr 319518 -2.04 0.00 NM_198308.1 
mMC011943 Rabgef1 56715 -2.96 0.00 NM_019983.2 
mMC008409 Reep6 70335 -2.45 0.00 NM_139292.1 
PH_mM_0010144 Rgsl1 240816 -2.19 0.00 XM_994482.3 
PH_mM_0012710 Rexo1 66932 -2.68 0.00 NM_025852.3 
PH_mM_0002842 Rnase12 497106 5.97 0.00 NM_001011875.1
PH_mM_0008304 Rnase9 328401 2.64 0.00 NM_183032.2 
PH_mM_0007365 Rnf148 71300 -2.02 0.00 NM_027754.1 
PH_mM_0006463 Rundc3a 51799 -3.06 0.00 NM_016759.3 
mMC006813 S100a14 66166 2.39 0.00 NM_001163525.2
mMC016579 Slfnl1 194219 -2.45 0.00 NM_177570.3 
PH_mM_0006920 Scpppq1 100271704 -2.84 0.00 NM_001163772.1
PH_mM_0004314 Serpina3a 74069 -2.12 0.00 NM_001167705.1
PH_mM_0001660 Spink13 100038417 2.36 0.00 NM_001168423.2
PH_mM_0007762 Spink8 78709 6.49 0.00 NM_183136.2 
PH_mM_0005443 Spint3 629747 4.11 0.00 NM_001177401.1
mMC021428 LOC100504162 100504162 -3.04 0.00 XM_003085010.1
mMR031068 Sh3d20 70559 -2.06 0.00 NM_183288.2 
PH_mM_0007777 Slamf9 98365 -2.00 0.00 NM_029612.4 
PH_mM_0005970 Srgap1 117600 -2.59 0.00 NM_001081037.1
mMC002188 Spem1 74288 -3.28 0.00 NM_028855.1 
PH_mM_0003210 Spert 67926 -2.09 0.00 NM_001164140.1
PH_mM_0004196 Spatc1 74281 -3.22 0.00 NM_028852.1 
mMC004094 Spata18 73472 -2.53 0.00 NM_178387.3 
PH_mM_0012342 Spata3 70060 -3.00 0.00 NM_027029.2 
PH_mM_0014840 Sat1 20229 2.06 0.00 NM_009121.3 
PH_mM_0004702 St6galnac2 20446 -2.14 0.00 NM_009180.3 
mMC012015 St8sia5 225742 -2.34 0.00 NM_013666.2 
mMC018552 Soat1 20652 3.13 0.00 NM_009230.3 
PH_mM_0016223 Synj2 20975 -2.08 0.00 NM_001113351.1
PH_mM_0014001 Tctex1d1 67344 -2.85 0.00 NM_001163767.1














mMC023686 Tspy-ps 22109 -2.01 0.00 NR_027507.1 
mMR027860 Tssk3 58864 -2.20 0.00 NM_080442.2 
mMC014962 Tssk6 83984 -3.00 0.00 NM_032004.1 
PH_mM_0013088 Gm5334 384639 -2.79 0.00 NR_003648.2 
mMC015309 Ttc24 214191 -3.43 0.00 NM_172526.3 
PH_mM_0007513 Tmsb15a 78478 -2.29 0.00 NM_030106.2 
mMC015474 Trp53tg5 73603 -2.18 0.00 XR_035042.2 
mMC020942 Trpm5 56843 -2.03 0.00 NM_020277.2 
mMC006780 Tm4sf4 229302 -2.17 0.00 NM_145539.2 
PH_mM_0015434 Tmem156 243025 -2.08 0.00 XM_144292.8 
mMC003564 Trim42 78911 -2.39 0.00 NM_030219.2 
mMC016927 Tmod4 50874 -3.17 0.00 NM_016712.3 
PH_mM_0002232 Tppp2 219038 -3.17 0.00 NM_001128634.1
PH_mM_0013731 Tuba4a 22145 -2.70 0.00 NM_009447.3 
PH_mM_0000965 Tuba8 53857 -2.18 0.00 NM_017379.1 
mMC024820 Ubqlnl 244179 -3.11 0.00 NM_198624.3 
PH_mM_0013440 Ubl4b 67591 -3.20 0.00 NM_026261.2 
PH_mM_0008023 B3gnt3 72297 -2.36 0.00 NM_028189.3 
PH_mM_0010872 LOC100503879 100503879 -2.22 0.00 XM_003084721.1
mMC011659 Vasp 22323 -2.49 0.00 NM_009499.2 
PH_mM_0000489 Wfdc13 408190 3.92 0.00 NM_001012704.1
PH_mM_0008282 Wfdc15b 192201 5.81 0.00 NM_001045554.1
PH_mM_0006159 Wbp2nl 74716 -2.19 0.00 NM_029066.1 
mMC005905 Wdr64 75820 -2.26 0.00 NM_029453.2 
PH_mM_0007047 Wbscr28 76629 -2.24 0.00 NM_194065.2 



























PH_mM_0008100	 Agpat2 67512 ‐2.55	 0.00	 NM_026212.1 
PH_mM_0013901	 Oxct2a	 64059	 ‐2.80	 0.00	 NM_022033.3 
PH_mM_0009512	 Adam21 56622 ‐2.18	 0.00	 NM_020330.4 
mMC019261	 Adam7 11500 3.12	 0.00	 NM_007402.2 
PH_mM_0012476	 Adamts20 223838 ‐2.08	 0.00	 NM_001164786.1 
PH_mM_0007832	 Abhd16b 241850 ‐2.17	 0.00	 NM_183181.2 
PH_mM_0006457	 Acsbg2 328845 ‐2.26	 0.00	 NM_001039114.1 
mMR026559	 Arl9 384185 ‐2.74	 0.00	 NM_206935.1 
PH_mM_0004216	 Ahsg 11625 2.80	 0.00	 NM_013465.1 
PH_mM_0013352	 Agt 11606 ‐2.29	 0.00	 NM_007428.3 
mMC017518	 Ankrd53 75305 ‐2.12	 0.00	 NM_029245.3 
mMC005531	 Adc 242669 ‐3.01	 0.00	 NM_172875.2 
mMC022312	 Bcl2l14 66813 ‐2.01	 0.00	 NM_025778.3 
PH_mM_0014216	 Bcmo1 63857 ‐2.44	 0.00	 NM_001163028.1,NM_021486.3 
PH_mM_0004515	 Bhmt 12116 ‐2.14	 0.00	 NM_016668.3 
PH_mM_0014563	 Ces5a 67935 5.17	 0.00	 NM_001003951.1 
mMC013527	 Ceacam10 26366 2.03	 0.00	 NM_007675.4 
mMC023526	 Csnka2ip 224291 ‐2.16	 0.00	 NM_173861.2 
mMC003243	 Casp7 12369 ‐2.95	 0.00	 NM_007611.2 
mMC026451	 Cd52 23833 4.52	 0.00	 NM_013706.2 
PH_mM_0004772	 Cwh43 231293 2.35	 0.00	 NM_181323.2 
PH_mM_0011226	 Cby3 76653 ‐2.63	 0.00	 XM_484016.4 
PH_mM_0012528	 Cpsf4l 52670 ‐2.08	 0.00	 NM_029794.2 
PH_mM_0009005	 Cdrt4 66338 ‐2.18	 0.00	 NM_025496.1 
PH_mM_0008848	 Ccdc57 71276 ‐2.44	 0.00	 NM_027745.1 
PH_mM_0005353	 Ccdc70 67929 ‐2.17	 0.00	 NM_026459.3 
PH_mM_0009593	 Col1a2 12843 2.45	 0.00	 NM_007743.2 
PH_mM_0004326	 C4bp 12269 2.27	 0.00	 NM_007576.3 
mMC009101	 Cuzd1 16433 3.34	 0.00	 NM_008411.3 







 Fold change 
Array ID Gene Entrez_gene (Log2 scale) P-value RefSeq 
PH_mM_0001409	 Cdk5r1 12569 2.01	 0.00	 NM_009871.2 
PH_mM_0000031	 Cylc2 74914 ‐2.82	 0.00	 NM_001162865.1 
mMC018400	 Cstl1 228756 ‐2.61	 0.00	 NM_177655.3 
PH_mM_0003392	 Crisp1 11571 6.64	 0.00	 NM_009638.3 
PH_mM_0013099	 Cyp2a12	 13085	 ‐2.42	 0.00	 NM_133657.1 
PH_mM_0005867	 Defb2 13215 2.89	 0.00	 NM_010030.1 
PH_mM_0008623	 Defb21 403172 ‐2.71	 0.00	 NM_207276.2 
mMC007896	 Defb37 353320 4.28	 0.00	 NM_181683.2 
PH_mM_0009190	 Defb38 360212 4.01	 0.00	 NM_183036.1 
mMC002785	 Defb40 360217 4.09	 0.00	 NM_183039.3 
PH_mM_0005654	 Defb42 619548 2.02	 0.00	 NM_001034910.3 
PH_mM_0008476	 Dnajb8 56691 ‐2.23	 0.00	 NM_019964.1 
PH_mM_0007033	 Dydc2 71200 ‐2.33	 0.00	 NM_027717.1 
PH_mM_0005876	 Efcab1 66793 ‐2.03	 0.00	 NM_025769.3 
PH_mM_0002521	 BB014433 434285 ‐2.08	 0.00	 NM_001007591.2 
PH_mM_0016323	 Fam71d 70897 ‐2.26	 0.00	 NM_027597.4 
PH_mM_0002154	 Fam71f2 245884 ‐2.89	 0.00	 NM_001101486.1 
PH_mM_0003129	 Fez1 235180 ‐2.08	 0.00	 NM_183171.4 
PH_mM_0007905	 Fscn3 56223 ‐2.95	 0.00	 NM_019569.2 
PH_mM_0016216	 Fbxo39 628100 ‐2.12	 0.00	 NM_001099688.2 
mMC007046	 Fxyd2 11936 ‐2.57	 0.00	 NM_007503.3 
PH_mM_0016293	 Gsg1 14840 ‐2.42	 0.00	 NM_010352.2 
PH_mM_0001002	 Gpx3 14778 2.65	 0.00	 NM_001083929.1 
PH_mM_0016195	 Gpx4 625249 ‐2.05	 0.00	 NM_001037741.2 
PH_mM_0006314	 Gstcd 67553 ‐2.27	 0.00	 NM_026231.2 
PH_mM_0006445	 Glt6d1 71103 ‐2.05	 0.00	 NM_001039095.1 
PH_mM_0001530	 Gmps 229363 2.50	 0.00	 NM_001033300.2 
PH_mM_0014524	 Hbb‐b1	 15129	 2.47	 0.00	 NM_008220.4 
mMR001167	 Hk1 15275 ‐2.32	 0.00	 NM_010438.3 
PH_mM_0003363	 Irgc1 210145 ‐2.06	 0.00	 NM_199013.2 
mMC023153	 Ifltd1 74071 ‐2.06	 0.00	 NM_028742.2 
mMC008241	 Iqcf4 67320 ‐2.04	 0.00	 NM_026090.2 
PH_mM_0003498	 Ica1 15893 ‐2.10	 0.00	 NM_010492.3 









 Fold change 




PH_mM_0007225	 Lelp1 69332 ‐2.91	 0.00	 NM_027042.1 
PH_mM_0009010	 Lrrc69 73314 ‐2.12	 0.00	 NM_028499.2 
PH_mM_0005345	 Lrrc8b 433926 ‐2.84	 0.00	 NM_001033550.2 
mMC014819	 Lcn2 16819 ‐2.19	 0.00	 NM_008491.1 
mMC011770	 Ly6g6c 68468 ‐2.45	 0.00	 NM_023463.3 
PH_mM_0014286	 Ms4a14 383435 ‐2.02	 0.00	 XM_357051.5 
mMC011249	 Mical3 194401 ‐2.64	 0.00	 NM_153396.2 
PH_mM_0016111	 Map2k7 26400 ‐2.22	 0.00	 NM_001042557.2 
PH_mM_0010566	 LOC100047953 100047953 ‐2.20	 0.00	 XM_001479514.2 
mMC003608	 Mpzl2 14012 2.09	 0.00	 NM_007962.4 
PH_mM_0012595	 Mlf1 17349 ‐2.53	 0.00	 NM_001039543.2 
PH_mM_0015068	 Nqo2 18105 ‐2.32	 0.00	 NM_001163241.1 
PH_mM_0016090	 Naca 17938 ‐2.37	 0.00	 NM_013608.3 
mMC013235	 Npy 109648 4.11	 0.00	 NM_023456.2 
PH_mM_0001706	 Olfr59 18359 3.00	 0.01	 NM_011002.2 
mMC005441	 Odf3b 70113 ‐2.39	 0.00	 NM_001013022.1 
mMR026715	 Osgin1 71839 ‐2.42	 0.00	 NM_027950.1 
mMC017452	 Pdzk1 59020 ‐2.11	 0.00	 NM_001146001.1, 
PH_mM_0004075	 Phospho1 237928 ‐2.44	 0.00	 NM_153104.3 
mMC015166	 Plcz1 114875 ‐2.12	 0.00	 NM_054066.4 
PH_mM_0014989	 Pldi 73616 ‐2.44	 0.00	 NR_033616.1 
PH_mM_0009071	 Prnd 26434 ‐2.16	 0.00	 NM_023043.2 
PH_mM_0015888	 Paqr9 75552 ‐2.28	 0.00	 NM_198414.2 
mMC014816	 Ptgds 19215 ‐2.94	 0.00	 NM_008963.2 
mMC016079	 Proc 19123 ‐2.04	 0.00	 NM_008934.2 
mMC023111	 Ppp2r2b 72930 ‐2.39	 0.00	 NM_027531.1 
mMC011943	 Rabgef1 56715 ‐2.31	 0.00	 NM_019983.2 
mMC008409	 Reep6 70335 ‐2.20	 0.00	 NM_139292.1 
PH_mM_0010144	 Rgsl1 240816 ‐2.33	 0.00	 XM_994482.3 
PH_mM_0012710	 Rexo1	 66932	 ‐2.45	 0.00	 NM_025852.3 
PH_mM_0002842	 Rnase12 497106 4.21	 0.00	 NM_001011875.1 
PH_mM_0007365	 Rnf148 71300 ‐2.11	 0.00	 NM_027754.1 
PH_mM_0006463	 Rundc3a 51799 ‐2.98	 0.00	 NM_016759.3 
mMC016579	 Slfnl1 194219 ‐2.29	 0.00	 NM_177570.3 
	





 Fold change 




PH_mM_0006920	 Scpppq1 100271704 ‐2.13	 0.00	 NM_001163772.1 
PH_mM_0007762	 Spink8 78709 4.54	 0.00	 NM_183136.2 
PH_mM_0005443	 Spint3 629747 2.87	 0.00	 NM_001177401.1 
mMC021428	 LOC100504162 100504162 ‐2.26	 0.00	 XM_003085010.1 
PH_mM_0005970	 Srgap1 117600 ‐2.13	 0.00	 NM_001081037.1 
mMC002188	 Spem1 74288 ‐2.91	 0.00	 NM_028855.1 
PH_mM_0004196	 Spatc1 74281 ‐2.82	 0.00	 NM_028852.1 
mMC004094	 Spata18 73472 ‐2.49	 0.00	 NM_178387.3 
mMC009674	 Spata3 70060 ‐2.23	 0.00	 NM_001122732.1 
PH_mM_0012342	 Spata3 70060 ‐2.90	 0.00	 NM_027029.2 
PH_mM_0004702	 St6galnac2 20446 ‐2.36	 0.00	 NM_009180.3 
PH_mM_0005808	 Sult1e1 20860 ‐2.32	 0.00	 NM_023135.2 
PH_mM_0014001	 Tctex1d1 67344 ‐2.62	 0.00	 NM_001163767.1 
PH_mM_0012549	 Theg 21830 ‐2.42	 0.00	 NM_011583.3 
mMR027860	 Tssk3 58864 ‐2.06	 0.00	 NM_080442.2 
mMC014962	 Tssk6 83984 ‐2.49	 0.00	 NM_032004.1 
PH_mM_0013088	 Gm5334 384639 ‐2.46	 0.00	 NR_003648.2 
mMC015309	 Ttc24 214191 ‐2.89	 0.00	 NM_172526.3 
mMC016927	 Tmod4 50874 ‐2.50	 0.00	 NM_016712.3 
PH_mM_0002232	 Tppp2 219038 ‐2.71	 0.00	 NM_001128634.1 
PH_mM_0013731	 Tuba4a 22145 ‐2.41	 0.00	 NM_009447.3 
mMC024820	 Ubqlnl 244179 ‐3.05	 0.00	 NM_198624.3 
mMC013491	 Usp50 75083 ‐2.01	 0.00	 NM_029163.3 
PH_mM_0013440	 Ubl4b 67591 ‐2.90	 0.00	 NM_026261.2 
PH_mM_0008023	 B3gnt3 72297 ‐2.27	 0.00	 NM_028189.3 
mMC011659	 Vasp 22323 ‐2.46	 0.00	 NM_009499.2 
PH_mM_0000489	 Wfdc13 408190 3.01	 0.00	 NM_001012704.1 
PH_mM_0008282	 Wfdc15b 192201 4.04	 0.00	 NM_001045554.1 
PH_mM_0004833	 Wdr38 76646 ‐2.12	 0.00	 NM_029687.3 
mMC005905	 Wdr64 75820 ‐2.03	 0.00	 NM_029453.2 
PH_mM_0007047	 Wbscr28 76629 ‐2.42	 0.00	 NM_194065.2 










Genes significantly different between C57BL/6J and FasL/TRAIL gene deficient mice 
Fold Change 
log2 (Ratio) P value 
ID Gene Entrez_gene F/C T/C F/C T/C RefSeq 
PH_mM_0008100 Agpat2 67512 -3.11 -2.55 0.00 0.00 NM_026212.1 
PH_mM_0013901 Oxct2a 64059 -3.35 -2.80 0.00 0.00 NM_022033.3 
mMC019261 Adam7 11500 5.23 3.12 0.00 0.00 NM_007402.2 
PH_mM_0007832 Abhd16b 241850 -2.61 -2.17 0.00 0.00 NM_183181.2 
mMR026559 Arl9 384185 -2.85 -2.74 0.00 0.00 NM_206935.1 
PH_mM_0004216 Ahsg 11625 2.36 2.80 0.00 0.00 NM_013465.1 
PH_mM_0013352 Agt 11606 -2.48 -2.29 0.00 0.00 NM_007428.3 
mMC005531 Adc 242669 -3.40 -3.01 0.00 0.00 NM_172875.2 
PH_mM_0014216 Bcmo1 63857 -2.66 -2.44 0.00 0.00 NM_001163028.1 
PH_mM_0014563 Ces5a 67935 6.64 5.17 0.00 0.00 NM_001003951.1 
mMC013527 Ceacam10 26366 3.80 2.03 0.00 0.00 NM_007675.4 
mMC003243 Casp7 12369 -3.39 -2.95 0.00 0.00 NM_007611.2 
mMC026451 Cd52 23833 6.64 4.52 0.00 0.00 NM_013706.2 
PH_mM_0004772 Cwh43 231293 3.60 2.35 0.00 0.00 NM_181323.2 
PH_mM_0011226 Cby3 76653 -3.97 -2.63 0.00 0.00 XM_484016.4 
PH_mM_0012528 Cpsf4l 52670 -2.38 -2.08 0.00 0.00 NM_029794.2 
PH_mM_0009005 Cdrt4 66338 -2.61 -2.18 0.00 0.00 NM_025496.1 
PH_mM_0008848 Ccdc57 71276 -2.59 -2.44 0.00 0.00 NM_027745.1 
PH_mM_0009593 Col1a2 12843 3.10 2.45 0.00 0.00 NM_007743.2 
PH_mM_0004326 C4bp 12269 3.43 2.27 0.00 0.00 NM_007576.3 
mMC009101 Cuzd1 16433 4.96 3.34 0.00 0.00 NM_008411.3 
mMR031232 Cux2 13048 -2.28 -2.06 0.00 0.00 NM_007804.2 
PH_mM_0001409 Cdk5r1 12569 3.25 2.01 0.00 0.00 NM_009871.2 
PH_mM_0000031 Cylc2 74914 -2.03 -2.82 0.00 0.00 NM_001162865.1 
mMC018400 Cstl1 228756 -3.19 -2.61 0.00 0.00 NM_177655.3 
PH_mM_0013099 Cyp2a12 13085 -3.06 -2.42 0.00 0.00 NM_133657.1 
PH_mM_0005867 Defb2 13215 5.38 2.89 0.00 0.00 NM_010030.1 
PH_mM_0008623 Defb21 403172 -2.86 -2.71 0.00 0.00 NM_207276.2 
mMC007896 Defb37 353320 5.64 4.28 0.00 0.00 NM_181683.2 
PH_mM_0009190 Defb38 360212 5.51 4.01 0.00 0.00 NM_183036.1 
mMC002785 Defb40 360217 6.56 4.09 0.00 0.00 NM_183039.3 
PH_mM_0005654 Defb42 619548 4.20 2.02 0.00 0.00 NM_001034910.3 
PH_mM_0008476 Dnajb8 56691 -2.52 -2.23 0.00 0.00 NM_019964.1 
PH_mM_0007033 Dydc2 71200 -3.38 -2.33 0.00 0.00 NM_027717.1 
PH_mM_0005876 Efcab1 66793 -2.28 -2.03 0.00 0.00 NM_025769.3 
PH_mM_0003129 Fez1 235180 -2.24 -2.08 0.00 0.00 NM_183171.4 
PH_mM_0007905 Fscn3 56223 -3.33 -2.95 0.00 0.00 NM_019569.2 
PH_mM_0016216 Fbxo39 628100 -2.41 -2.12 0.00 0.00 NM_001099688.2 
PH_mM_0016293 Gsg1 14840 -2.76 -2.42 0.00 0.00 NM_010352.2 
 
 







log2 (Ratio) P value 
ID Gene Entrez_gene F/C T/C F/C T/C RefSeq 
PH_mM_0001002 Gpx3 14778 4.32 2.65 0.00 0.00 NM_001083929.1 
PH_mM_0016195 Gpx4 625249 -2.23 -2.05 0.00 0.00 NM_001037741.2 
PH_mM_0006314 Gstcd 67553 -2.40 -2.27 0.00 0.00 NM_026231.2 
PH_mM_0006445 Glt6d1 71103 -2.86 -2.05 0.00 0.00 NM_001039095.1 
PH_mM_0001530 Gmps 229363 3.91 2.50 0.00 0.00 NM_001033300.2 
PH_mM_0014524 Hbb-b1 15129 2.48 2.47 0.00 0.00 NM_008220.4 
mMR001167 Hk1 15275 -2.10 -2.32 0.00 0.00 NM_010438.3 
PH_mM_0003363 Irgc1 210145 -2.00 -2.06 0.00 0.00 NM_199013.2 
PH_mM_0003498 Ica1 15893 -2.13 -2.10 0.00 0.00 NM_010492.3 
PH_mM_0006784 Kcnip2 80906 -3.12 -2.79 0.00 0.00 NM_030716.2 
PH_mM_0007225 Lelp1 69332 -3.08 -2.91 0.00 0.00 NM_027042.1 
PH_mM_0009010 Lrrc69 73314 -2.28 -2.12 0.00 0.00 NM_028499.2 
PH_mM_0005345 Lrrc8b 433926 -2.92 -2.84 0.00 0.00 NM_001033550.2 
mMC014819 Lcn2 16819 -2.34 -2.19 0.00 0.00 NM_008491.1 
mMC011770 Ly6g6c 68468 -2.27 -2.45 0.00 0.00 NM_023463.3 
mMC011249 Mical3 194401 -2.64 -2.64 0.00 0.00 NM_153396.2 
PH_mM_0016111 Map2k7 26400 -2.26 -2.22 0.00 0.00 NM_001042557.2 
PH_mM_0010566 LOC100047953 100047953 -2.27 -2.20 0.00 0.00 XM_001479514.2 
PH_mM_0012595 Mlf1 17349 -3.28 -2.53 0.00 0.00 NM_001039543.2 
PH_mM_0015068 Nqo2 18105 -3.09 -2.32 0.00 0.00 NM_001163241.1 
PH_mM_0016090 Naca 17938 -2.21 -2.37 0.00 0.00 NM_013608.3 
mMC013235 Npy 109648 6.12 4.11 0.00 0.00 NM_023456.2 
mMC005441 Odf3b 70113 -3.14 -2.39 0.00 0.00 NM_001013022.1 
mMR026715 Osgin1 71839 -2.70 -2.42 0.00 0.00 NM_027950.1 
PH_mM_0004075 Phospho1 237928 -2.59 -2.44 0.00 0.00 NM_153104.3 
PH_mM_0014989 Pldi 73616 -2.04 -2.44 0.00 0.00 NR_033616.1 
PH_mM_0015888 Paqr9 75552 -2.14 -2.28 0.00 0.00 NM_198414.2 
mMC016079 Proc 19123 -2.40 -2.04 0.00 0.00 NM_008934.2 
mMC011943 Rabgef1 56715 -2.96 -2.31 0.00 0.00 NM_019983.2 
mMC008409 Reep6 70335 -2.45 -2.20 0.00 0.00 NM_139292.1 
PH_mM_0010144 Rgsl1 240816 -2.19 -2.33 0.00 0.00 XM_994482.3 
PH_mM_0012710 Rexo1| 66932| -2.68 -2.45 0.00 0.00 NM_025852.3 
PH_mM_0002842 Rnase12 497106 5.97 4.21 0.00 0.00 NM_001011875.1 
PH_mM_0007365 Rnf148 71300 -2.02 -2.11 0.00 0.00 NM_027754.1 
PH_mM_0006463 Rundc3a 51799 -3.06 -2.98 0.00 0.00 NM_016759.3 
mMC016579 Slfnl1 194219 -2.45 -2.29 0.00 0.00 NM_177570.3 
PH_mM_0006920 Scpppq1 100271704 -2.84 -2.13 0.00 0.00 NM_001163772.1 
PH_mM_0007762 Spink8 78709 6.49 4.54 0.00 0.00 NM_183136.2 
PH_mM_0005443 Spint3 629747 4.11 2.87 0.00 0.00 NM_001177401.1 








log2 (Ratio) P value 
ID Gene Entrez_gene F/C T/C F/C T/C RefSeq 
PH_mM_0005970 Srgap1 117600 -2.59 -2.13 0.00 0.00 NM_001081037.1 
mMC002188 Spem1 74288 -3.28 -2.91 0.00 0.00 NM_028855.1 
PH_mM_0004196 Spatc1 74281 -3.22 -2.82 0.00 0.00 NM_028852.1 
mMC004094 Spata18 73472 -2.53 -2.49 0.00 0.00 NM_178387.3 
PH_mM_0012342 Spata3 70060 -3.00 -2.90 0.00 0.00 NM_027029.2 
PH_mM_0004702 St6galnac2 20446 -2.14 -2.36 0.00 0.00 NM_009180.3 
PH_mM_0014001 Tctex1d1 67344 -2.85 -2.62 0.00 0.00 NM_001163767.1 
PH_mM_0012549 Theg 21830 -2.46 -2.42 0.00 0.00 NM_011583.3 
mMR027860 Tssk3 58864 -2.20 -2.06 0.00 0.00 NM_080442.2 
mMC014962 Tssk6 83984 -3.00 -2.49 0.00 0.00 NM_032004.1 
PH_mM_0013088 Gm5334 384639 -2.79 -2.46 0.00 0.00 NR_003648.2 
mMC015309 Ttc24 214191 -3.43 -2.89 0.00 0.00 NM_172526.3 
mMC016927 Tmod4 50874 -3.17 -2.50 0.00 0.00 NM_016712.3 
PH_mM_0002232 Tppp2 219038 -3.17 -2.71 0.00 0.00 NM_001128634.1 
PH_mM_0013731 Tuba4a 22145 -2.70 -2.41 0.00 0.00 NM_009447.3 
mMC024820 Ubqlnl 244179 -3.11 -3.05 0.00 0.00 NM_198624.3 
PH_mM_0013440 Ubl4b 67591 -3.20 -2.90 0.00 0.00 NM_026261.2 
PH_mM_0008023 B3gnt3 72297 -2.36 -2.27 0.00 0.00 NM_028189.3 
mMC011659 Vasp 22323 -2.49 -2.46 0.00 0.00 NM_009499.2 
PH_mM_0000489 Wfdc13 408190 3.92 3.01 0.00 0.00 NM_001012704.1 
PH_mM_0008282 Wfdc15b 192201 5.81 4.04 0.00 0.00 NM_001045554.1 
mMC005905 Wdr64 75820 -2.26 -2.03 0.00 0.00 NM_029453.2 
PH_mM_0007047 Wbscr28 76629 -2.24 -2.42 0.00 0.00 NM_194065.2 











Agpat2 PH_mM_0008100 Biosynthesis 
Ces5a PH_mM_0014563 Biosynthesis 
Cstl1 mMC018400 Biosynthesis 
Fbxo39 PH_mM_0016216 Biosynthesis 
Mical3 mMC011249 Biosynthesis 
Tppp2 PH_mM_0002232 Biosynthesis 
Wfdc13 PH_mM_0000489 Biosynthesis 
Wfdc15b PH_mM_0008282 Biosynthesis 
Wwp2 PH_mM_0013579 Biosynthesis 
Ceacam10 mMC013527 Cytoskeletal 
Cwh43 PH_mM_0004772 Cytoskeletal 
Col1a2 PH_mM_0009593 Cytoskeletal 
Dnajb8 PH_mM_0008476 Cytoskeletal 
Fez1 PH_mM_0003129 Cytoskeletal 
Gmps PH_mM_0001530 Cytoskeletal 
Lrrc8b PH_mM_0005345 Cytoskeletal 
St6galnac2 PH_mM_0004702 Cytoskeletal 
Gm5334 PH_mM_0013088 Cytoskeletal 
Tuba4a PH_mM_0013731 Cytoskeletal 
Vasp mMC011659 Cytoskeletal 
Cd52 mMC026451 Immune 
Defb2 PH_mM_0005867 Immune 
Defb21 PH_mM_0008623 Immune 
Defb37 mMC007896 Immune 
Defb38 PH_mM_0009190 Immune 
Defb40 mMC002785 Immune 
Defb42 PH_mM_0005654 Immune 
Ly6g6c mMC011770 Immune 
Naca PH_mM_0016090 Immune 
Rnase12 PH_mM_0002842 Immune 
Oxct2a PH_mM_0013901 Metabolism 








Gpx4 PH_mM_0016195 Metabolism 
Glt6d1 PH_mM_0006445 Metabolism 
Hk1 mMR001167 Metabolism 
Nqo2 PH_mM_0015068 Metabolism 
Casp7 mMC003243 Signal transducer activity 
Arl9 mMR026559 Signal transducer activity 
Ahsg PH_mM_0004216 Signal transducer activity 
Cux2 mMR031232 Signal transducer activity 
Ica1 PH_mM_0003498 Signal transducer activity 
Map2k7 PH_mM_0016111 Signal transducer activity 
Osgin1 mMR026715 Signal transducer activity 
Rundc3a PH_mM_0006463 Signal transducer activity 
B3gnt3 PH_mM_0008023 Signal transducer activity 
Adam7 mMC019261 Spermatogenesis/development 
Adc mMC005531 Biosynthesis 
C4bp PH_mM_0004326 Spermatogenesis/development 
Cuzd1 mMC009101 unknown 
Cdk5r1 PH_mM_0001409 Spermatogenesis/development 
Cylc2 PH_mM_0000031 Spermatogenesis/development 
Crisp1 PH_mM_0003392 Spermatogenesis/development 
Fscn3 PH_mM_0007905 Spermatogenesis/development 
Gsg1 PH_mM_0016293 Spermatogenesis/development 
Npy mMC013235 Spermatogenesis/development 
Odf3b mMC005441 Spermatogenesis/development 
Rexo1| PH_mM_0012710 cell signal 
Spink8 PH_mM_0007762 Spermatogenesis/development 
Spint3 PH_mM_0005443 Spermatogenesis/development 
Spem1 mMC002188 Spermatogenesis/development 
Spatc1 PH_mM_0004196 Spermatogenesis/development 
Spata18 mMC004094 Spermatogenesis/development 
Spata3 PH_mM_0012342 Spermatogenesis/development 








Theg PH_mM_0012549 Spermatogenesis/development 
Tssk3 mMR027860 Spermatogenesis/development 
Ubqlnl mMC024820 Metabolism 
Ubl4b PH_mM_0013440 Spermatogenesis/development 
Abhd16b PH_mM_0007832 Unknown 
Agt PH_mM_0013352 Unknown 
Cby3 PH_mM_0011226 Unknown 
Cpsf4l PH_mM_0012528 Unknown 
Cdrt4 PH_mM_0009005 Unknown 
Ccdc57 PH_mM_0008848 Unknown 
Cyp2a12 PH_mM_0013099 Unknown 
Dydc2 PH_mM_0007033 Unknown 
Efcab1 PH_mM_0005876 Unknown 
Gstcd PH_mM_0006314 Unknown 
Hbb-b1 PH_mM_0014524 Unknown 
Irgc1 PH_mM_0003363 Unknown 
Lelp1 PH_mM_0007225 Unknown 
Lrrc69 PH_mM_0009010 Unknown 
Lcn2 mMC014819 Unknown 
Mlf1 PH_mM_0012595 Unknown 
Phospho1 PH_mM_0004075 Unknown 
Pldi PH_mM_0014989 Unknown 
Paqr9 PH_mM_0015888 Unknown 
Proc mMC016079 Unknown 
Rabgef1 mMC011943 Unknown 
Reep6 mMC008409 Unknown 
Rgsl1 PH_mM_0010144 Unknown 
Rnf148 PH_mM_0007365 Unknown 
Slfnl1 mMC016579 Unknown 
Scpppq1 PH_mM_0006920 Unknown 
Srgap1 PH_mM_0005970 Unknown 
Ttc24 mMC015309 Unknown 

















Figure 5.3 Categories of differential gene expression between death ligands gene 
deficient and C57BL/6J wild type mice. There are 104 differentially expressed genes 
(more than 4-fold) in C57BL/6J mice compared to FasL/TRAIL gene deficient mice. 
























Figure 5.4 Microarray analysis of the gene expression profile in C57BL/6J and 
FasL/TRAIL gene deficient mice. There were19 differentially expressed genes (more 
than 4-fold) in C57BL/6J mice compared to FasL/TRAIL gene deficient mice. These 




5.3 Discussion  
 
In Chapter 3 we hypothesized that different death ligands may have the ability to 
compensate for each other when either FasL or TRAIL is missing in the testis. In our 
toxicant model, we identified c-FLIP as an important regulator of germ cell apoptosis in 
FasL gene deficient mice after MEHP exposure.  FasL may be responsible for regulating 
the expression of c-FLIP in TRAIL gene deficient mice, as in the model of degradation of 
c-FLIP after nitric oxide (NO) or reactive oxygen species (ROS)[134,135].  TRAIL gene 
deficient mice, however, do not reveal a similar reduction of AI following MEHP 
exposure, as observed in FasL gene deficient mice (Fig 5.1).  This may be due to TRAIL 
not being involved in regulating the levels of c-FLIP in our toxicant model (Fig 5.2), as 
we discussed in Chapter 3. At the same time, the TRAIL gene deficient mice were found 
to have higher AI than FasL gene deficient mice or C57BL/6J mice, and that increase 
may be due to the presence of FasL in the testis without efficient levels of c-FLIP to 
reduce germ cells apoptosis. Therefore, the results in this study agree with our previous 
hypothesis that FasL is the primary factor that accounts for the increased germ cell 
apoptosis in the testis after MEHP treatment.  
Most studies have focused on how death ligands play a role in apoptosis in germ 
cells, but little is known about the non-apoptotic role of FasL or TRAIL in the testis. 
Based on our observations in FasL/TRAIL gene deficient mice, we found morphological 
alterations that may not be directly connected to apoptosis. For example, there is a delay 




metaphase cell cycle arrest was observed during spermatogenesis in the TRAIL gene 
deficient mice. These observations led us to explore the possible non-apoptotic roles of 
FasL and TRAIL in the testis, which may influence development of regulation in 
spermatogenesis. Therefore, we performed a microarray analysis to gain more 
information about the gene alteration when FasL or TRAIL is lost in the testis.  
We categorized 169 genes with 4-fold changes in 7 categories (Fig 5.3). To 
explore how genes alter spermatogenesis in FasL and TRAIL gene deficient mice, we 
will discuss the 19 genes involving spermatogenesis and testis development. The 
following discussion will present gene functions in their order as part of the whole 
process of spermatogenesis and development of spermatocyte, spermatid, and 
spermatozoa.  
Three of these 19 genes that are involved in spermatogenesis include 
neuropeptide Y (Npy), Spermatogenesis and centriole associated 1 (Spatc1), and 
spermatogenesis-associated 18 (Spata18). Npy is a neuropeptide that is widely expressed 
in the central nervous system and influences many physiological processes, including 
cortical excitability, stress response, food intake, circadian rhythms, and cardiovascular 
function. Recently, Npy has been added to the list of secretagogues that influence 
reproductive functions [151], and it can influence Leydig cell activity by inhibiting 
testosterone secretion [113]. This may infer that death ligand gene deficient mice may 
have altered levels of testosterone, which result in delayed spermatogenesis. Spatc1, also 
known as speriolin, is a novel centrosomal protein present in the connecting piece region 




throughout the first mitotic division by regulating or stabilizing the folding of Cdc20 
during meiosis in spermatogenic cells. [152,153]. Spata18 is a novel p53 transcriptional 
target that is expressed in seminiferous tubules, and reports indicate that Spata18 may be 
regulated by p53 and p63,and that deficiency may cause spermatogenesis defects [154].  
Cyclin-dependent kinase 5 regulatory subunit 1(P35) (Cdk5r1) and 
Spermatogenesis-associated 3 (Spata3) may have important influence during 
spermatocyte development. Cdk5r1(P35) is a neuron specific activator of CDK5[155], 
which is known to be involved in the control of the cell cycle, and it is also found in 
Sertoli cells, Leydig cells, and metaphase spermatocytes[156]. The possible function of 
CDK5 in the testis may as a regulator of the luteinizing hormone (LH), follicle-
stimulating hormone (FSH), and epidermal growth factor (EGF)[157]. P35 activity is 
observed in isolated elongated spermatids and at the time when elongated spermatids 
appear in the developing testis, suggesting a role for Cdk5 [158]. Spata3, also known as 
the musculus testis and spermatogenesis cell apoptosis-related gene 1 (Mtsarg1), is 
mainly located in spermatocyte, and it may have an important role in spermatocyte 
development [159]. 
When spermatocytes gradually form spermatids, Cylicin, basic protein of sperm 
head cytoskeleton 2 (Cylc2), spermatid-specific murine paralog of the actin-bundling 
protein fascin (FSCN1), germ cell-specific gene 1 (GSG1), spermatid maturation 1 
(Spem 1), and ubiquitin-like protein 4B (Ubl4b) may affect the development and 
differentiation in this step. Cylc2 may play a role to format the structure of spermatids 




terminal elongation of the spermatid head and in the microfilament rearrangements that 
accompany fertilization [161]. GSG1 is a protein that interacts with testis-specific poly(A) 
polymerase (TPAP), which is highly expressed in round spermatids [162]. TPAP 
deficient mice were shown to have impaired expression of haploid-specific genes that are 
required for the morphogenesis of germ cells [163]. Spem 1 is a protein exclusively 
expressed in the cytoplasm of elongated spermatids in the testis, and loss of Spem 1 
results in sperm deformation and male infertility in mice [164]. Theg is 42 kDa protein 
specifically expressed in spermatid cells. Although its function is not clearly understood, 
it may interact with Sertoli cells during spermatogenesis [165]. It also can be a good 
marker for spermatid cells. Ubl4b is a testis-specific autosomal gene, and it is restricted 
to post-meiotic germ cells and can be detected only in elongated spermatids but not in 
spermatocytes [166].  
 The last step for spermatogenesis is to form spermatozoa to transfer sperm to the 
epididymis. A disintegrin and metallopeptidase domain 7 (Adam7) is one member of the 
ADAMs family of zinc proteases, which are expressed in the caput region of the 
epididymis and on the surface of the spermatozoa, and can be redistributed in the sperm 
head during the acrosome reaction [167].  Complement C4b-binding protein (C4BP) is a 
plasma protein synthesized in the liver that plays a regulatory role in the host defense 
complement system. Recently, it was also found in epididymis epithelial cells and the 
surfaces of spermatozoa, and may be an androgen-dependent promoter binding protein. 
C4bp may be involved in sperm maturation [168,169]. Cysteine-Rich Secretory Protein 1 




(CRISP) family, and can  play a role in the mammalian fertilization process by 
participating in both sperm-zona pellucida interaction and gamete fusion by binding to 
egg-complementary sites [170]. The outer dense fibers 3B (Odf3b) is a member of the 
Odf family of proteins.  In animals with internal fecundation, Odfs are the main 
cytoskeletal structures of the sperm tail and an expanding group of proteins co-assembled 
along the axoneme during the development of the sperm tail [171]. 
Serine peptidase inhibitor, Kazal type3 and 8 (Spink 8 and Spint3) belong to the 
Kazal protease inhibitors and may have a function for the regulation of sperm maturation 
by regulating the proteolytic processing of the sperm membrane during epididymal transit 
[172,173]. Testis-specific serine/threonine kinase 3 and 6 (Tssk3 and Tssk6) are members 
of the testis-specific serine/threonine kinases (Tssk) family and may regulate sperm 
differentiation in the testis and/or fertilization [174]. Tssk-3 is induced at puberty, persists 
during adulthood and is restricted to the interstitial Leydig cells of post-pubertal males 
[175]. 
 Taken together, this chapter demonstrates that: 1) FasL is the main death ligand to 
regulate the level of c-FLIP in the testis in response to MEHP exposure. 2) Loss of one 
death ligand may cause impairment of the first wave of spermatogenesis and further 
reduce sperm counts in the testis.  3) There are several possible genes involved in the 
altered spermatogenesis and development in the testis of gene-deficient mice. If we can 
confirm that these candidate genes have similar results at RNA and protein levels, this 
information will help us to understand more about the non-apoptotic roles in FasL and 




Chapter 6: MEHP promotes invasion and migration of testicular embryonic 
carcinoma cells 
 
6.1 Introduction and Rationale 
 
We previously discovered that MEHP exposure induces the activation of matrix 
metalloproteinase-2 (MMP-2) in the seminiferous tubule [122], consequently leading to 
impaired spermatogenesis. The ratio between MMP-2 and its endogenous inhibitor, tissue 
inhibitor of matrix metalloproteinase-2 (TIMP-2), is critical for maintaining normal germ 
cell development [122,176] and also for influencing the tumor progression in different 
types of tumors [177,178]. Interestingly, it has been shown that the serum level of MMP-
2 increases in patients diagnosed with testicular germ cell tumors [179]. These findings 
led us to test whether MEHP-activated MMP-2 in the testis plays a role in regulating 
testicular cancer progression. We show that MEHP-induced c-Myc is partially 
responsible for the down-regulation of TIMP-2 in the testis [180]. It has been widely 
appreciated that c-Myc functions as a switch on tumor promotion by regulating 
proliferation or tumor suppression by modulating apoptosis [181]. Therefore, studying 
the functional significance of c-Myc on testicular cancer progression in response to 
phthalate is a logical extension of this work.  
 In this chapter, the effect of MEHP on stimulating cell invasion and migration of 
testicular embryonal carcinoma cells is investigated in vitro using the NT2/D1 teratoma 




migration following MEHP exposure is through the MMP-2 activation. Microarray 
analysis also demonstrates that cell adhesion molecules and transcription factors may also 









6.2.1 MEHP treatment up-regulates MMP-2 and c-Myc expression in NT2/D1 cells   
 
 The changes in MMP-2, MMP-9, and c-Myc expression in response to MEHP 
exposure were determined by western blots. The MMP-2 protein level in NT2/D1 cells 
was found to increase significantly at 3 hours after MEHP exposure and remain steady 
until 24 hours of incubation (2.53-fold, compared to non-treated group) (Fig 6.1A). Low 
doses of MEHP treatment showed no significant effects on MMP-2 expression, while 200 
μM of MEHP strongly induced MMP-2 protein levels after 12 hours of incubation (2.38-
fold, compared to non-treated group) (Fig 6.1B). No significant changes in MMP-9 
expression were observed after MEHP exposure. The protein level of c-Myc in NT2/D1 
cells was up-regulated shortly after MEHP treatment (1.52-fold, compared to non-treated 
cells), decreased at 3 hours and then increased after 12 hours of incubation (Fig 6.1A). In 
addition, high doses of MEHP treatment significantly enhanced c-Myc levels (3.22-fold 
at 200 μM, compared to the non-treated cells) (Fig 6.1B), indicating that the induction of 
c-Myc by MEHP exposure is dose-dependent. 
 
6.2.2 MEHP treatment up-regulates MMP-2 activity in NT2/D1 cells   
 
The amount of soluble MMP-2 secreted from NT2/D1 cells was measured by 




level after MEHP exposure (4.89-fold at 24 hours of incubation, compared to the non-
treated group). High doses of MEHP treatment stimulated significant production of 
soluble MMP-2 (3.97-fold at 200 μM, compared to the non-treated group), even though 
soluble MMP-2 production decreased at 400 μM of dosage (2.06-fold, compared to the 
non-treated group). The activities of MMP-2 and MMP-9 in vitro were determined by 
gelatin zymography (Fig 6.3A and Fig 6.3B), indicating that MMP-2 is time- and dose-
dependently activated by MEHP treatment. The MMP-9 level was relatively low to 
MMP-2 and was slightly increased by MEHP, suggesting that MEHP exposure has major 
effects on MMP-2 activity, but not on MMP-9.  
 
6.2.3 SB-3CT suppressed MEHP-induced MMP-2 activation in NT2/D1 cells   
 
    Specific gelatinase inhibitor, SB-3CT, and MEHP were applied to NT2/D1 cells. After 
12 hours of incubation, conditioned media were collected and MMP-2 activity were 
further analyzed. ELISA results indicated that low doses of SB-3CT treatment (5 μM) 
significantly reduced the amount of soluble MMP-2 compared to MEHP treatment alone 
(Fig 6.4A). Fig 6.4B reveals that MMP-2 gelatinase activity was enhanced by MEHP, but 














Figure 6.1 MMP-2 protein expression in NT2/D1 cells is increased with MEHP 
exposure. Total protein (30 μg) from NT2/D1 cells treated with or without MEHP was 
analyzed by western blot analysis. Time dependent inductions of MMP-2 were detected 
following MEHP exposure (Figure 6-1A). Dose-dependent induction of MMP-2 was 
detected following MEHP exposure (Figure 6-1B). Actin served as the loading control. 
The quantified relative protein levels of MMP-2 and MMP-9 are shown under the blot 
images. Values represent the mean ± SEM. Asterisks denote significant differences 







Figure 6.2 MMP-2 activity in NT2/D1 cells increased after MEHP exposure. The 
amount of soluble MMP-2 released from NT2/D1 cells was measured by ELISA. Time- 
and dose-dependent inductions of soluble MMP-2 were detected in response to MEHP 
exposure (Figure 6-2A and 6-2B), respectively. Values represent the mean ± SEM. 
Asterisks denote significant differences between the treatment and control groups 





















Figure 6.3 MMP-2 Gelatinolytic activity in NT2/D1 cells increased with MEHP 
exposure. Gelatinolytic activities of MMP-2 and MMP-9 in the media were determined 
by gelatin zymography. Clear bends shown on the blue background indicate the enzyme 
activity. MEHP treatment caused an increase in MMP-2 activity in a time- and dose-
dependent manner. MMP-9 activity was relatively weaker than MMP-2, while it 








Figure 6.4 SB-3CT inhibited MEHP-induced MMP-2 activation in NT2/D1 cells. 
NT2/D1 cells were treated with various doses of SB-3CT and 200 μM of MEHP for 12 
hours, and the conditioned media were collected. (A) The amount of soluble MMP-2 
released from NT2/D1 cells was measured by ELISA. SB-3CT treatment slightly 
decreased the amount of free MMP-2. Values represent the mean ± SEM. Asterisks 
denote significant differences between the treatment and control groups (*p<0.05, 
**p<0.01, Student t-test). (B) Gelatinolytic activities of MMP-2 and MMP-9 in the media 
were determined by gelatin zymography. MMP-2 activity was reduced by SB-3CT and 
MEHP co-treatment compared to MEHP treatment only in a dose dependent manner. No 




6.2.4 MEHP exposure promoted the invasive activity and the migration capability of 
NT2/D1 cells  
 In order to estimate the effect of MEHP treatment on cell invasion, non-treated or 
MEHP-treated NT2/D1 cells were tested by transwell invasion assay. Interestingly, after 
MEHP exposure, NT2/D1 cells had a stronger ability to digest and pass through Matrigel. 
Fig 6.5 shows that the number of invasive cells significantly increased in the MEHP-
treated group (3.23-fold) compared to the non-treated group. In addition to invasive 
ability, the number of cells that migrated into the cell-free zone were counted. More cells 
were observed in the cell-free zone after MEHP treatment (1.59-fold at 36 hours, 
compared to the control group), indicating that MEHP facilitates the migration of 
NT2/D1 cells (Fig 6.6).  
 
6.2.5 SB-3CT showed inhibitory effects on MEHP-enhanced invasion and migration in 
Nt2/D1 cells   
To determine whether the activated MMP-2 was necessary for MEHP-enhanced cell 
invasion and migration, SB-3CT was applied to NT2/D1 cells in the presence of MEHP. 
The addition of SB-3CT and MEHP co-treatment suppressed the number of invasive cells 
(down to 0.68-fold compared to MEHP-treated groups, Fig 6.5). SB-3CT treatment was 
also able to decrease the number of migrated cells in the presence of MEHP (down to 
0.81-fold compared to MEHP-treated group, Fig 6.6). These results suggest that 







Figure 6.5 The invasion activities of NT2/D1 cells were enhanced by MEHP 
exposure and suppressed by SB-3CT, showing the compensation effect on MEHP 
treatment. (A) In vitro invasion assays were performed using transwell chambers (8 μm 
pore size) coated with Matrigel. Non-treated, MEHP-treated and SB-3CT/MEHP co-
treated cells (2x105) were seeded on the Matrigel and incubated overnight. Invasive cells 
were stained with 20% Giemsa solution. Cells attached to the lower surface of the filter 
were photographed by Canon-5D digital camera attached to a light microscope (x200). (B) 
The quantified number of cells penetrating Matrigel was counted. Values represent the 
mean ± SEM. Asterisks denote significant differences between the treatment and control 










Figure 6.6 The migration activities of NT2/D1 cells were enhanced by MEHP 
exposure and suppressed by SB-3CT, showing the compensation effect on MEHP 
treatment. (A) Wound-healing migration assay was performed to determine the change 
in migration rate of NT2/D1 cells after MEHP treatment or SB-3CT/MEHP co-treatment. 
Cells were photographed by Canon-5D digital camera attached to a light microscope 
(x200). (B) The number of cells migrating into the cell-free zone was evaluated. Values 
represent the mean ± SEM. Asterisks denote significant differences between the 




6.2.6 Microarray analysis of gene expression in NT2/D1 cells following MEHP exposure  
 
 Of nearly 30,000 putative probes, 1,289 genes in the testicular embryonic 
carcinoma cell line, NT2/D1, were significantly altered by MEHP exposure. There were 
45 genes that displayed more than 2-fold changes in mRNA levels following MEHP 
exposure (Fig 6.7). The genes are grouped in 7 categories on the bases of their biological 
functions, including adhesion molecules, metabolism modifiers, transcription factors, 
translation components, cell-cycle regulators, signal transduction mediators, and 
miscellanea (Fig 6.8). Among these categories, cell adhesion molecules (9 genes out of 
45, 19%) appear to be the major group that is strongly altered in response to MEHP 
treatment. These genes include pleckstrin homology domain containing family O member 
1 (PLEKHO1), vinculin (VCL), gap junction protein alpha 1 (GJA1), WD repeat domain 
1 (WD1), leucine rich repeat containing 8 family member A (LRC8A), N-cadherin 
(CDH2), claudin 6 (CLDN6), catenin-beta 1 (CTNNB1) and matrix metalloproteinase-2 
(MMP-2). Seven genes (16%) are grouped as transcription factors, including inhibitor of 
DNA binding 1 (ID1), inhibitor of DNA binding 2 (ID2), inhibitor of DNA binding 3 
(ID3), TEA domain family member 4 (TEAD4), polyhomeotic homolog 1 (PHC1), zinc 
finger protein 429 (ZHF429) and DNA-damage-inducible transcript 3 (DDIT3). 
Semi-quantitative RT-PCR was performed to verify the mRNA expression of 11 
MEHP-regulated genes (6 for down-regulation and 5 for up-regulation) which were 
randomly selected from microarray results, including NTS, ID1, VCL, GJA1, LFNG, 




molecules, semi-quantitative RT-PCR confirmed that GJA1 is significantly down-
regulated by MEHP treatment (0.54-fold, at 24 hours, compared with 0 hour group), 
while CLDN6 and CTNNB1 were up-regulated (2.77- and 1.38-fold, at 24 h). RT-PCR 
confirmed that VCL expression is reduced by MEHP at 3 hours (0.79-fold), while no 
changes were observed at 24 hours that is not consistent with microarray data. Among 
transcription factors, RT-PCR results showed that ID1 and PHC decreased after MEHP 
treatment (0.45- and 0.78-fold, at 3 hours), and DDIT3 increased (1.81-fold, at 3 hours). 
However, NTS expression pattern was not consistent according to microarray and RT-
PCR results. Microarray analysis and RT-PCR data both revealed that MMP-2 mRNA 
expression in NT2/D1 cells was significantly increased at 24 hours after MEHP 
stimulation (2.87- and 1.61-fold, respectively). Even though RT-PCR showed that MMP-
2 level was strongly induced at 3 hours of incubation, microarray analysis indicated that 




















Figure 6.7 Microarray analysis of the gene expression 
profile in NT2/D1 cells treated with or without MEHP. 
Microarray analysis was performed using Human Whole 
Genome One Array Chips v.5 produced by Phalanx Biotech 
Group, carrying 29,187 human genome probes and 1,088 
experimental control probes. NT2/D1 cells were treated with 
MEHP for 0, 3 and 24 hours. (A) There were 45 differentially 
expressed genes (more than 2-fold) in response to MEHP 
exposure that were identified and their mRNA levels were 
shown as hierarchical clustering. Relative expression levels 

















Figure 6.8 The categories of gene expression profiles in microarray analysis.  There 















Figure 6.9 Semi-quantitative RT-PCR was performed in order to confirm the results 
derived from the microarray analysis. There were 7 randomly selected genes assayed 
and GAPDH served as a control. Values represent the mean ± SEM. Significant 







Testicular dysgenesis syndrome (TDS) is a common human health problem that 
refers to symptoms including poor semen quality, undescended testis (cryptorchidism), 
hypospadias, and testicular cancer. The incidence of these diseases has dramatically 
increased over the past 50 years, and it has been hypothesized that environmental 
influences rather than genetic defects account for this increase [182,183,184]. Phthalate 
exposure has been linked to reproductive dysfunction and has been shown to adversely 
affect normal germ cell development. Exposure to high levels of DEHP results in liver 
lesions and an increased incidence of hepatocellular carcinoma in rodents [185,186], and 
studies also suggest that DHEP is a potential tumor promoter but not genotoxic. A recent 
study indicates that di-(n-butyl) phthalate (DBP) exposure promotes the vulnerability of 
fetal germ cells, and is possibly related to testicular germ cell tumor formation [187]. 
Therefore, the effect of phthalate exposure on the regulation of testicular cancer 
progression is of interest. 
We previously identified several important molecular factors that are critical for 
controlling normal germ cell development, including c-Myc and MMP-2, which are 
altered following phthalate exposure [122,180] and have been shown to be tightly 
associated with tumor metastasis and tumor progression [188,189,190]. Since c-Myc 
controls cell proliferation, cell differentiation and self-renewal [191,192], the up-
regulation of c-Myc seen in testicular embryonal carcinoma following MEHP exposure 




development. Matrigel invasion and wound-healing migration assays are well-developed 
methods to observe the ability of tumor cells to metastasize, and are strongly related to 
MMP-2 and MMP-9 activities [193,194,195]. In this study, after MEHP exposure, 
NT2/D1 cells had the stronger ability to digest and pass through the Matrigel. In addition, 
our data also show that MEHP promotes the migration of cancer cells. These results 
suggest that MEHP exposure may enhance the potential of testicular cancer cells to 
become more metastatic and malignant. It is then reasonable to conclude that the 
molecular mechanism that accounts for this alteration can be explained by the activation 
of MMP-2. Using specific a MMP-2 inhibitor, SB-3CT, we were able to suppress 
endogenous MMP-2 activity stimulated by MEHP both in vitro and in vivo [122,176]. 
We found that the addition of SB-3CT to NT2/D1 cells partially inhibited MEHP-induced 
invasion and migration. Therefore, MEHP-induced MMP-2 activation appears to be 
important in regulating the metastasis status of testicular germ cell tumors.  
 In addition to MMP-2 and c-Myc activation, we performed microarray analysis in 
order to examine the gene expression patterns altered by MEHP exposure on a genome-
wide basis. Phthalate exposure has been demonstrated to impair junctional connection in 
the seminiferous tubule by altering the junctional protein expression [176,196]. 
Interestingly, MEHP primarily influences cell adhesion molecules and transcription 
factors, which are also closely related to tumorigenesis. Hence, we further discuss the 
functional significance of distinct genes in testicular cancers following toxicant exposure.  
Gap junctional intercellular communication (GJIC) controls cell growth, 




has been proposed to be related to tumor promotion [198,199]. GJA1 gene encodes 
protein connexin 43 (Cx43), forming the main structure of gap junction. Mutation or 
deficiency in GJA1 gene leads to a variety of human diseases or disorders [200,201]. 
Interestingly, it has been shown that the reduction of Cx43 enhances the invasion 
capacity of human glioblastoma cells [202]. In the mouse testis, a decrease in Cx43 
protein level and the change in Cx43 localization have been observed after DEHP 
exposure [196]. Similar results also have demonstrated that DEHP treatment inhibits gap 
junctional communication in vitro [203]. Our current results indicate that MEHP 
exposure leads to a decrease in GJA1 mRNA expression in NT2/D1 cells. The reduction 
of GJA1 following MEHP exposure may partially explain the mechanism of MEHP-
enhanced invasion in NT2/D1 cells. On the other hand, although DEHP-induced 
tumorigenesis in the liver is strongly correlated with the inhibition of gap junctional 
communication in rodents, it appears that this phenomenon is species-specific [112,204]. 
Therefore, the role of suppressed GJA1 in human testicular cancer progression by 
phthalates remains an open question. 
The focal adhesion molecule, vinculin, is important for maintaining the structure of 
adherens junction through the interaction with actin filament and integrin [205,206]. We 
previously showed that MEHP exposure breaks down laminin/integrin complex at the 
ectoplasmic specialization [176]. In this study, we further found that MEHP treatment 
reduces vinculin mRNA levels in the testicular cancer cells, suggesting that phthalate 
primarily impairs the junctional connection in the testis. Overexpression of vinculin has 




demonstrate that vinculin expression is negatively correlated with the metastasis of 
squamous cell tumor [208], indicating that reduced cellular adhesiveness is strongly 
associated with the metastasis of malignant tumors. Therefore, MEHP-decreased viculin 
may be involved in regulating the invasive and migration ability of testicular cancer cells 
in parallel to the activation of MMP-2.  
β1-catenin, an oncogene, has been demonstrated to be involved in various biological 
processes, including cell adhesion, cell growth, and tumorigenesis. The accumulation of 
β1-catenin in the germ cell nuclei associated with the abnormal OCT3/4 expression leads 
to the malignant transformation of seminoma [209]. The activation of β1-catenin 
signaling may cause Sertoli cell tumor formation [210]. DEHP induces the up-regulation 
of α-catenin and N-cadherin in rat testes [211]. Fetal exposure to DEHP in mice causes 
the delay in liver development and the alteration of glycogen metabolism through the 
activation of Wnt/β1-catenin signaling [212]. Here, we show that the β1-catenin mRNA 
level is up-regulated by MEHP in NT2/D1 cells, demonstrating that phthalate has the 
potential to promote tumor progression by up-regulation of oncogenes. In addition, c-
Myc expression can be regulated by the Wnt/β1-catenin/TCF signaling pathway, 
resulting in colorectal and skin carcinogenesis [213,214]. Therefore, we speculate that 
MEHP-induced β1-catenin up-regulation may play a role in modulating the 
differentiation status of testicular cells by influencing c-Myc expression. 
Claudin-6, which belongs to the claudin superfamily, is a key component of tight 
junctions. Several studies have suggested that claudin-6 functions as a tumor suppressor 




frequency of epigenetic silencing in the claudin-6 gene by methylation is increased in 
esophageal squamous cell carcinomas [218]. However, overexpression of claudin-6 
increases the invasiveness, migration and proliferation rate of human gastric 
adenocarcinoma cell line [219]. Claudin-6 is also potentially a diagnostic marker for 
atypical teratoid/rhabdoid tumors (AT/RT) [220]. These observations demonstrate that 
the function of claudin-6 in promoting or suppressing tumor progression may be cell-
specific. In testicular embryonal carcinoma, we found that MEHP exposure increased the 
mRNA level of clausin-6. Interestingly, claudin-6 expression appears to be limited in 
some testicular embryonal carcinoma and immature epithelial teratocarcinoma [221], and 
developmentally regulates adipogenesis and epithelialization of embryos [222,223,224]. 
Therefore, claudin-6 not only serves as a basis of tight junction structure, but also is 
important for cell differentiation that may be c-Myc-dependent. 
Inhibitor of DNA binding (ID) proteins are transcription factors, which are 
important for cell cycle, cell development, and tumorigenesis [225,226]. Surprisingly, 
MEHP exposure significantly reduces the mRNA level of three ID proteins in testicular 
embryonal carcinoma, demonstrating that phthalates influence the dynamic expression of 
transcriptomes in the tumor. In the murine testis, ID3 expression is regulated by the 
follicle-stimulating hormone (FSH) [227]. MEHP has been shown to disrupt FSH 
signaling [89,228]. Hence, impaired FSH signaling may be responsible for decreases in 
ID proteins after MEHP exposure. 
The findings of the current study indicate cellular mechanisms triggered by MEHP 




carcinoma cells (NT2/D1). We observed that: 1) NT2/D1 cells have an increased ability 
to digest and migrate into the Matrigel matrix following MEHP exposure and that this 
was dependent on increased activity of MMP2, as the enhancing effects of MEHP 
exposure can be partially inhibited by addition of the specific MMP2 inhibitor SB-3CT. 2) 
We showed that MEHP not only increases the activation of MMP2, but also down-
regulates the expression of both the tight-junction (GJA1) and adherens junction (VCL) 
genes, which could further aid in the capacity for the invasion and migration of the 
NT2/D1 cells. Finally, 3) we described the activation of the MYC transcription factor 
after MEHP exposure. Since MYC plays a role in promoting the expression of CLDN6 
and inhibits TIMP2 expression, disruption in MYC expression could provide an 
underlying mechanism to account for MMP2 activation after MEHP treatment. Taken 
together, these novel findings provide important mechanistic insights by which exposure 
to environmental toxicants, such as the phthalates, can enhance testicular cancer 




Chapter 7: Concluding Remarks 
 
Spermatogenesis is an important physiological process in the male reproductive 
system. The number of spermatozoa that can be formed depend on the supportive 
capacity of Sertoli cells that provide an adaptive environment and nutrition for germ cells 
growth and development but that may be disrupted by genetic effects and environmental 
stresses. In this research, a toxicant exposure model (MEHP treatment) test was used to 
determine if loss of death ligands can protect or reduce the impact from MEHP exposure. 
The results revealed a partial reduction of germ cell apoptosis after toxicant treatment; 
however, the reduction of apoptosis may not occur directly through the original 
mechanism that we hypothesized. The lack of FasL expression maybe not be the main 
factor to reduce germ cell apoptosis in the testes because even before MEHP treatment a 
high apoptotic rate was observed in FasL gene deficient mice. Apoptosis was greatly 
decreased after treatment that led to the assumption that FasL may directly contribute to 
bind Fas to form DISC and, further, regulate levels of cFLIP to enhance the process of 
apoptosis. Based on that observation, it was important to examine in detail the 
mechanism by which cFLIP is regulated by FasL via gene expression/inhibition or 
protein degradation. In order to answer that question, a cell model was employed but is 
still under design because it was not a good fit for the experiment. Future research will 
focus on development of a better method to understand the mechanism. 
TG-interacting factor (TGIF), originally identified for its ability to bind a specific 




receptors   for   binding   to   this   element [229]. Subsequent studies found that TGIF 
represses transcription in different biological processes through its ability as a DNA-
binding repressor or as a co-repressor in association   with   other   DNA-binding   
proteins.   For example, TGIF   can   interact   with   the   transcriptional   factor Smad2 
to restrict the expression of transforming growth factor beta   (TGF-b)-responsive   genes 
[230] . More recently, TGIF has been identified as a component of the TNF-a   signaling   
pathway   that   integrates  cytotoxicity [231].   TGIF is demonstrated to act in concert 
with the E3 ubiquitin ligase   Itch   to   promote   ubiquitin-dependent   degradation of 
cFLIP. Itch can enhance the stability of TGIF, which in turn facilitates the access of 
cFLIP for ubiquitin-dependent degradation by Itch.  In order to investigate in detail the 
mechanism by which cFLIP is regulated in FasL gene deficient mice, we performed IHF 
to detect the expression of TGIF in C57BL/6J and FasL gene deficient mice with MEHP 
treatment. The preliminary results (data not presented in this dissertation) show that 
C57BL/6J has a higher expression than FasL gene deficient mice after MEHP treatment, 
and in terms of cFLIP may be partially controlled by TGIF. The upstream genes of TGIF 
are cJun and cFos, and the expression of cJun and cFos was shown to increase also in 
C57BL/6J mice with MEHP treatment, but no significant expression was observed in 
FasL gene deficient mice. The phosphorylation of ERK also increased in C57BL/6J, and 
the results indicate that the MAPK pathway may involve regulation of cFLIP. More 
research is needed to to confirm that the MAPK pathway is an upstream regulatory factor 




The delay of spermatogenesis and development of abnormal germ cells were 
found in FasL and TRAIL gene deficient mice. Most of our previous research focused 
mainly on how death ligands influence the extrinsic pathway during germ cell apoptosis, 
but those death ligands may also play different roles in early testes development as well 
as in later homeostatsis of the spermatogenesis. In order to gain more information about 
non-apoptosis roles of death ligands, we performed a microarray analysis of the testis of 
FasL or TRAIL gene deficient mouse to gain more gene information, which may be 
important for regulating spermatogenesis. Many genes were found to be involved in 
spermatogenesis and may be influenced by the loss of one of the death ligands in the 
testes. However, more research is needed, for example, to confirm gene expressions by 
real-time RTPCR and western blot and to verify gene expression alteration due to loss of 
one of the death ligands. Further, samples of different age gene deficient mice samples 
need to be compared for changes during development. The number of Sertoli cells need 
to be counted and the concentration of testosterone need to be measured to understand 
whether the reduction of spermatid head counts is due to a decrease in the number of 
Sertoli cells or quantity of testosterone. Those results can provide a better understanding 
about the non-apoptosis role of FasL/TRAIL death ligands in the testes. 
In our study about ways that MEHP influences male reproduction, we found that 
several genes are involved tumor progression. Most toxicology research has focused on 
adverse effects of chemical compounds to learn how substances may harm humans, for 
example, cause cancer. However, other studies that have sought to determine if a 




progression. This an important area of research because our environment includes many 
different types of chemical compounds defined as non-carcinogens. We need to avoid 
exposure to both carcinogens as well as non-carcinogens that may promote tumor 
progression. For example, primary tumors may become more aggressive in testicular 
cancer patients, who are exposed to phthalate products that may promote tumorigenesis.  
In Chapter 6, we discussed how our hypothesis was tested in a cell model and our 
findings that MEHP enhanced tumor progression, leading to the question of whether dose 
phthalate may account for tumor promotion in vivo. To answer that question, we need to 
test our hypothesis in an animal model and with other types of cancer cells that may share 
a similar pathway to tumor progression. For example, up-regulation in c-Myc is 
commonly found in many types of cancer cells, such as skin, lung, breast, and others. In 
addition, it is important to know whether phthalates impact male reproduction and 
enhance tumor progression in  testicular cancer.  
The goal of toxicology research is identify toxicants in the environment and to 
prevent human disease and provide better treatment without adverse effects. The research 
on which this dissertation is based represents a small contribution to our understanding 
about how toxicants impact male reproduction.  As a toxicologist, I hope my work will 
help prevent humans disease caused by environmental toxicants and reduce adverse 











1. Lonnie D. Russell, Robert A. Ettlin, Amiya P. Sinha Hikim, Clegg ED (1990) 
Histological and histopathological evaluation of the testis: Cache River Press. 
2. Nicander L (1967) An electron microscopical study of cell contacts in the seminiferous 
tubules of some mammals. Z Zellforsch Mikrosk Anat 83: 375-397. 
3. Kerr JB, Loveland, K.L., O'Bryan. & de Kretser, D. M. (2005) Cytology of the testis 
and intrinsic control mechanisms. In Knobil and Neill's physiology of 
reproduction. New York: NY: Elsevier. 827-947 p. 
4. Wessel GM (2011) Accessorizing the testis. Enrico Sertoli and the "mother cell" of the 
testis. Mol Reprod Dev 78: Fmi. 
5. Skinner MK, Griswold MD (2005) Sertoli cell biology. San Diego: CA: Elsevier 
Academic Press. 
6. Sertoli E (1865) Dell’esistenza di particolari cellule ramificate nei canalicoli seminiferi 
del testicolo umano. Morgagni 7: 3. 
7. Skinner MK, Griswold MD (2005) Sertoli cell biology. Amsterdam ; Boston: Elsevier 
Academic Press. xv, 494 p. p. 
8. de Rooij DG, Russell LD (2000) All you wanted to know about spermatogonia but 
were afraid to ask. J Androl 21: 776-798. 
9. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with 
wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257. 
10. Xu G, Shi Y (2007) Apoptosis signaling pathways and lymphocyte homeostasis. Cell 
Res 17: 759-771. 
11. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, et al. (2000) The combined 
functions of proapoptotic Bcl-2 family members bak and bax are essential for 
normal development of multiple tissues. Mol Cell 6: 1389-1399. 
12. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, et al. (2001) 
Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction 




13. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, et al. (2001) BCL-2, BCL-X(L) 
sequester BH3 domain-only molecules preventing BAX- and BAK-mediated 
mitochondrial apoptosis. Mol Cell 8: 705-711. 
14. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X (1997) Apaf-1, a human protein 
homologous to C. elegans CED-4, participates in cytochrome c-dependent 
activation of caspase-3. Cell 90: 405-413. 
15. Zou H, Li Y, Liu X, Wang X (1999) An APAF-1.cytochrome c multimeric complex 
is a functional apoptosome that activates procaspase-9. J Biol Chem 274: 11549-
11556. 
16. Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL (1996) Cloning and 
expression of apoptosis inhibitory protein homologs that function to inhibit 
apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl 
Acad Sci U S A 93: 4974-4978. 
17. Duckett CS, Nava VE, Gedrich RW, Clem RJ, Van Dongen JL, et al. (1996) A 
conserved family of cellular genes related to the baculovirus iap gene and 
encoding apoptosis inhibitors. EMBO J 15: 2685-2694. 
18. Chai J, Du C, Wu JW, Kyin S, Wang X, et al. (2000) Structural and biochemical basis 
of apoptotic activation by Smac/DIABLO. Nature 406: 855-862. 
19. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, et al. (2000) 
Identification of DIABLO, a mammalian protein that promotes apoptosis by 
binding to and antagonizing IAP proteins. Cell 102: 43-53. 
20. Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor 
superfamilies: integrating mammalian biology. Cell 104: 487-501. 
21. Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, et al. (2006) Mechanisms of 
cytochrome c release from mitochondria. Cell Death Differ 13: 1423-1433. 
22. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of 
cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. 
Science 275: 1132-1136. 
23. Gogvadze V, Orrenius S, Zhivotovsky B (2006) Multiple pathways of cytochrome c 
release from mitochondria in apoptosis. Biochim Biophys Acta 1757: 639-647. 





25. Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 
281: 1305-1308. 
26. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM (1995) FADD, a novel death 
domain-containing protein, interacts with the death domain of Fas and initiates 
apoptosis. Cell 81: 505-512. 
27. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, et al. (1995) 
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-
inducing signaling complex (DISC) with the receptor. Embo J 14: 5579-5588. 
28. Lavrik I, Golks A, Krammer PH (2005) Death receptor signaling. J Cell Sci 118: 265-
267. 
29. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, et al. (1997) FLICE is 
activated by association with the CD95 death-inducing signaling complex (DISC). 
Embo J 16: 2794-2804. 
30. Thome M, Tschopp J (2001) Regulation of lymphocyte proliferation and death by 
FLIP. Nat Rev Immunol 1: 50-58. 
31. Krueger A, Baumann S, Krammer PH, Kirchhoff S (2001) FLICE-inhibitory proteins: 
regulators of death receptor-mediated apoptosis. Mol Cell Biol 21: 8247-8254. 
32. Hyer ML, Samuel T, Reed JC (2006) The FLIP-side of Fas signaling. Clin Cancer 
Res 12: 5929-5931. 
33. Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber AO, et al. (2007) The CD95 
receptor: apoptosis revisited. Cell 129: 447-450. 
34. Wu GS, Burns TF, Zhan Y, Alnemri ES, El-Deiry WS (1999) Molecular cloning and 
functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis 
factor-related apoptosis-inducing ligand (TRAIL) death receptor. cancer research 
59: 2770-2775. 
35. Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, et al. (1997) Death 
receptor 5, a new member of the TNFR family, and DR4 induce FADD-
dependent apoptosis and activate the NF-kappaB pathway. Immunity 7: 821-830. 
36. Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, et al. (1997) TRAIL 
receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate 




37. Kuang AA, Diehl GE, Zhang J, Winoto A (2000) FADD is required for DR4- and 
DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient 
mouse embryonic fibroblasts. Journal of Biological Chemistry 275: 25065-25068. 
38. McKee CM, Ye Y, Richburg JH (2006) Testicular germ cell sensitivity to TRAIL-
induced apoptosis is dependent upon p53 expression and is synergistically 
enhanced by DR5 agonistic antibody treatment. Apoptosis 11: 2237-2250. 
39. Schaefer U, Voloshanenko O, Willen D, Walczak H (2007) TRAIL: a multifunctional 
cytokine. Front Biosci 12: 3813-3824. 
40. Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, Peschon J, Chen YH (2003) 
Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- 
mice. Nature Immunology 4: 255-260. 
41. Russell LD, Goh JC, Rashed RM, Vogl AW (1988) The consequences of actin 
disruption at Sertoli ectoplasmic specialization sites facing spermatids after in 
vivo exposure of rat testis to cytochalasin D. Biol Reprod 39: 105-118. 
42. Print CG, Loveland KL (2000) Germ cell suicide: new insights into apoptosis during 
spermatogenesis. Bioessays 22: 423-430. 
43. Lee J, Richburg JH, Younkin SC, Boekelheide K (1997) The Fas system is a key 
regulator of germ cell apoptosis in the testis. Endocrinology 138: 2081-2088. 
44. Wang RA, Nakane PK, Koji T (1998) Autonomous cell death of mouse male germ 
cells during fetal and postnatal period. Biol Reprod 58: 1250-1256. 
45. Shaha C, Tripathi R, Mishra DP (2010) Male germ cell apoptosis: regulation and 
biology. Philos Trans R Soc Lond B Biol Sci 365: 1501-1515. 
46. Rucker EB, 3rd, Dierisseau P, Wagner KU, Garrett L, Wynshaw-Boris A, et al. (2000) 
Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during 
embryogenesis. Mol Endocrinol 14: 1038-1052. 
47. Furuchi T, Masuko K, Nishimune Y, Obinata M, Matsui Y (1996) Inhibition of 
testicular germ cell apoptosis and differentiation in mice misexpressing Bcl-2 in 
spermatogonia. Development 122: 1703-1709. 
48. Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ (1995) Bax-





49. Russell LD, Chiarini-Garcia H, Korsmeyer SJ, Knudson CM (2002) Bax-dependent 
spermatogonia apoptosis is required for testicular development and 
spermatogenesis. Biol Reprod 66: 950-958. 
50. Lizama C, Alfaro I, Reyes JG, Moreno RD (2007) Up-regulation of CD95 (Apo-
1/Fas) is associated with spermatocyte apoptosis during the first round of 
spermatogenesis in the rat. Apoptosis 12: 499-512. 
51. Richburg JH, Nanez A, Williams LR, Embree ME, Boekelheide K (2000) Sensitivity 
of testicular germ cells to toxicant-induced apoptosis in gld mice that express a 
nonfunctional form of Fas ligand. Endocrinology 141: 787-793. 
52. Kim SK, Yoon YD, Park YS, Seo JT, Kim JH (2007) Involvement of the Fas-Fas 
ligand system and active caspase-3 in abnormal apoptosis in human testes with 
maturation arrest and Sertoli cell-only syndrome. Fertil Steril 87: 547-553. 
53. Francavilla S, D'Abrizio P, Cordeschi G, Pelliccione F, Necozione S, et al. (2002) Fas 
expression correlates with human germ cell degeneration in meiotic and post-
meiotic arrest of spermatogenesis. Mol Hum Reprod 8: 213-220. 
54. Blount BC, Silva MJ, Caudill SP, Needham LL, Pirkle JL, et al. (2000) Levels of 
seven urinary phthalate metabolites in a human reference population. Environ 
Health Perspect 108: 979-982. 
55. Heudorf U, Mersch-Sundermann V, Angerer J (2007) Phthalates: toxicology and 
exposure. Int J Hyg Environ Health 210: 623-634. 
56. Castle L, Mercer AJ, Startin JR, Gilbert J (1988) Migration from plasticized films 
into foods. 3. Migration of phthalate, sebacate, citrate and phosphate esters from 
films used for retail food packaging. Food Addit Contam 5: 9-20. 
57. Hubinger JC (2010) A survey of phthalate esters in consumer cosmetic products. J 
Cosmet Sci 61: 457-465. 
58. Hubinger JC, Havery DC (2006) Analysis of consumer cosmetic products for 
phthalate esters. J Cosmet Sci 57: 127-137. 
59. Bornehag CG, Sundell J, Weschler CJ, Sigsgaard T, Lundgren B, et al. (2004) The 
association between asthma and allergic symptoms in children and phthalates in 
house dust: a nested case-control study. Environ Health Perspect 112: 1393-1397. 
60. Lovekamp-Swan T, Davis BJ (2003) Mechanisms of phthalate ester toxicity in the 




61. Gentry PR, Clewell HJ, Clewell R, Campbell J, Van Landingham C, et al. (2011) 
Challenges in the application of quantitative approaches in risk assessment: a case 
study with di-(2-ethylhexyl)phthalate. Critical Reviews in Toxicology 41: 1-72. 
62. Pak VM, McCauley LA, Pinto-Martin J (2011) Phthalate exposures and human health 
concerns: A review and implications for practice. AAOHN J 59: 228-233; quiz 
234-225. 
63. Wittassek M, Koch HM, Angerer J, Bruning T (2011) Assessing exposure to 
phthalates - the human biomonitoring approach. Mol Nutr Food Res 55: 7-31. 
64. Kavlock R, Barr D, Boekelheide K, Breslin W, Breysse P, et al. (2006) NTP-CERHR 
Expert Panel Update on the Reproductive and Developmental Toxicity of di(2-
ethylhexyl) phthalate. Reprod Toxicol 22: 291-399. 
65. Grande SW, Andrade AJ, Talsness CE, Grote K, Golombiewski A, et al. (2007) A 
dose-response study following in utero and lactational exposure to di-(2-
ethylhexyl) phthalate (DEHP): reproductive effects on adult female offspring rats. 
Toxicology 229: 114-122. 
66. Andrade AJ, Grande SW, Talsness CE, Gericke C, Grote K, et al. (2006) A dose 
response study following in utero and lactational exposure to di-(2-ethylhexyl) 
phthalate (DEHP): reproductive effects on adult male offspring rats. Toxicology 
228: 85-97. 
67. Andrade AJ, Grande SW, Talsness CE, Grote K, Chahoud I (2006) A dose-response 
study following in utero and lactational exposure to di-(2-ethylhexyl)-phthalate 
(DEHP): non-monotonic dose-response and low dose effects on rat brain 
aromatase activity. Toxicology 227: 185-192. 
68. Andrade AJ, Grande SW, Talsness CE, Grote K, Golombiewski A, et al. (2006) A 
dose-response study following in utero and lactational exposure to di-(2-
ethylhexyl) phthalate (DEHP): effects on androgenic status, developmental 
landmarks and testicular histology in male offspring rats. Toxicology 225: 64-74. 
69. Grande SW, Andrade AJ, Talsness CE, Grote K, Chahoud I (2006) A dose-response 
study following in utero and lactational exposure to di(2-ethylhexyl)phthalate: 
effects on female rat reproductive development. Toxicol Sci 91: 247-254. 
70. Akingbemi BT, Ge R, Klinefelter GR, Zirkin BR, Hardy MP (2004) Phthalate-
induced Leydig cell hyperplasia is associated with multiple endocrine 




71. Akingbemi BT, Youker RT, Sottas CM, Ge R, Katz E, et al. (2001) Modulation of rat 
Leydig cell steroidogenic function by di(2-ethylhexyl)phthalate. Biol Reprod 65: 
1252-1259. 
72. Ge RS, Chen GR, Dong Q, Akingbemi B, Sottas CM, et al. (2007) Biphasic effects of 
postnatal exposure to diethylhexylphthalate on the timing of puberty in male rats. 
J Androl 28: 513-520. 
73. Pant N, Shukla M, Kumar Patel D, Shukla Y, Mathur N, et al. (2008) Correlation of 
phthalate exposures with semen quality. Toxicol Appl Pharmacol 231: 112-116. 
74. Swan SH (2008) Environmental phthalate exposure in relation to reproductive 
outcomes and other health endpoints in humans. Environ Res 108: 177-184. 
75. Lottrup G, Andersson AM, Leffers H, Mortensen GK, Toppari J, et al. (2006) 
Possible impact of phthalates on infant reproductive health. Int J Androl 29: 172-
180; discussion 181-175. 
76. Thomas JA, Thomas MJ (1984) Biological effects of di-(2-ethylhexyl) phthalate and 
other phthalic acid esters. Crit Rev Toxicol 13: 283-317. 
77. Albro PW, Thomas R, Fishbein L (1973) Metabolism of diethylhexyl phthalate by 
rats. Isolation and characterization of the urinary metabolites. J Chromatogr 76: 
321-330. 
78. Ito Y, Yokota H, Wang R, Yamanoshita O, Ichihara G, et al. (2005) Species 
differences in the metabolism of di(2-ethylhexyl) phthalate (DEHP) in several 
organs of mice, rats, and marmosets. Arch Toxicol 79: 147-154. 
79. Sjoberg P, Bondesson U, Gray TJ, Ploen L (1986) Effects of di-(2-ethylhexyl) 
phthalate and five of its metabolites on rat testis in vivo and in in vitro. Acta 
Pharmacol Toxicol (Copenh) 58: 225-233. 
80. Hauser R (2008) Urinary phthalate metabolites and semen quality: a review of a 
potential biomarker of susceptibility. Int J Androl 31: 112-117. 
81. Hoppin JA, Brock JW, Davis BJ, Baird DD (2002) Reproducibility of urinary 
phthalate metabolites in first morning urine samples. Environ Health Perspect 110: 
515-518. 
82. Hauser R, Meeker JD, Park S, Silva MJ, Calafat AM (2004) Temporal variability of 
urinary phthalate metabolite levels in men of reproductive age. Environ Health 




83. Cater BR, Cook MW, Gangolli SD, Grasso P (1977) Studies on dibutyl phthalate-
induced testicular atrophy in the rat: effect on zinc metabolism. Toxicol Appl 
Pharmacol 41: 609-618. 
84. Fukuoka M, Tanimoto T, Zhou Y, Kawasaki N, Tanaka A, et al. (1989) Mechanism 
of testicular atrophy induced by di-n-butyl phthalate in rats. Part 1. J Appl Toxicol 
9: 277-283. 
85. Creasy DM, Beech LM, Gray TJ, Butler WH (1987) The ultrastructural effects of di-
n-pentyl phthalate on the testis of the mature rat. Exp Mol Pathol 46: 357-371. 
86. Gray TJ, Beamand JA (1984) Effect of some phthalate esters and other testicular 
toxins on primary cultures of testicular cells. Food Chem Toxicol 22: 123-131. 
87. Foster PM, Foster JR, Cook MW, Thomas LV, Gangolli SD (1982) Changes in 
ultrastructure and cytochemical localization of zinc in rat testis following the 
administration of di-n-pentyl phthalate. Toxicol Appl Pharmacol 63: 120-132. 
88. Dostal LA, Chapin RE, Stefanski SA, Harris MW, Schwetz BA (1988) Testicular 
toxicity and reduced Sertoli cell numbers in neonatal rats by di(2-
ethylhexyl)phthalate and the recovery of fertility as adults. Toxicol Appl 
Pharmacol 95: 104-121. 
89. Grasso P, Heindel JJ, Powell CJ, Reichert LE, Jr. (1993) Effects of mono(2-
ethylhexyl) phthalate, a testicular toxicant, on follicle-stimulating hormone 
binding to membranes from cultured rat Sertoli cells. Biol Reprod 48: 454-459. 
90. Li LH, Jester WF, Jr., Laslett AL, Orth JM (2000) A single dose of Di-(2-ethylhexyl) 
phthalate in neonatal rats alters gonocytes, reduces sertoli cell proliferation, and 
decreases cyclin D2 expression. Toxicol Appl Pharmacol 166: 222-229. 
91. Heindel JJ, Powell CJ (1992) Phthalate ester effects on rat Sertoli cell function in 
vitro: effects of phthalate side chain and age of animal. Toxicol Appl Pharmacol 
115: 116-123. 
92. Heindel JJ, Chapin RE (1989) Inhibition of FSH-stimulated cAMP accumulation by 
mono(2-ethylhexyl) phthalate in primary rat Sertoli cell cultures. Toxicol Appl 
Pharmacol 97: 377-385. 
93. Williams J, Foster PM (1989) The effects of 1,3-dinitrobenzene and mono-(2-
ethylhexyl)phthalate on hormonally stimulated lactate and pyruvate production by 




94. Chapin RE, Gray TJ, Phelps JL, Dutton SL (1988) The effects of mono-(2-
ethylhexyl)-phthalate on rat Sertoli cell-enriched primary cultures. Toxicol Appl 
Pharmacol 92: 467-479. 
95. Thysen B, Morris PL, Gatz M, Bloch E (1990) The effect of mono(2-ethylhexyl) 
phthalate on Sertoli cell transferrin secretion in vitro. Toxicol Appl Pharmacol 
106: 154-157. 
96. Gray TJ, Gangolli SD (1986) Aspects of the testicular toxicity of phthalate esters. 
Environ Health Perspect 65: 229-235. 
97. Svechnikov K, Svechnikova I, Soder O (2008) Inhibitory effects of mono-ethylhexyl 
phthalate on steroidogenesis in immature and adult rat Leydig cells in vitro. 
Reprod Toxicol 25: 485-490. 
98. Gunnarsson D, Leffler P, Ekwurtzel E, Martinsson G, Liu K, et al. (2008) Mono-(2-
ethylhexyl) phthalate stimulates basal steroidogenesis by a cAMP-independent 
mechanism in mouse gonadal cells of both sexes. Reproduction 135: 693-703. 
99. Rodriguez I, Ody C, Araki K, Garcia I, Vassalli P (1997) An early and massive wave 
of germinal cell apoptosis is required for the development of functional 
spermatogenesis. Embo Journal 16: 2262-2270. 
100. Moreno RD, Lizama C, Urzua N, Vergara SP, Reyes JG (2006) Caspase activation 
throughout the first wave of spermatogenesis in the rat. Cell Tissue Res 325: 533-
540. 
101. Fuchs Y, Steller H (2011) Programmed Cell Death in Animal Development and 
Disease. Cell 147: 742-758. 
102. Lee J, Richburg JH, Shipp EB, Meistrich ML, Boekelheide K (1999) The Fas 
system, a regulator of testicular germ cell apoptosis, is differentially up-regulated 
in Sertoli cell versus germ cell injury of the testis. Endocrinology 140: 852-858. 
103. Richburg JH, Nanez A, Gao H (1999) Participation of the Fas-signaling system in 
the initiation of germ cell apoptosis in young rat testes after exposure to mono-(2-
ethylhexyl) phthalate. Toxicol Appl Pharmacol 160: 271-278. 
104. Giammona CJ, Sawhney P, Chandrasekaran Y, Richburg JH (2002) Death receptor 
response in rodent testis after mono-(2-ethylhexyl) phthalate exposure. Toxicol 
Appl Pharmacol 185: 119-127. 
105. Richburg JH, Johnson KJ, Schoenfeld HA, Meistrich ML, Dix DJ (2002) Defining 
the cellular and molecular mechanisms of toxicant action in the testis. Toxicol 




106. Holmes L, Jr., Escalante C, Garrison O, Foldi BX, Ogungbade GO, et al. (2008) 
Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting 
racial paradigm? Public Health 122: 862-872. 
107. Bosl GJ, Motzer RJ (1997) Testicular germ-cell cancer. N Engl J Med 337: 242-253. 
108. Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, et al. (2010) 
International trends in the incidence of testicular cancer, 1973-2002. Cancer 
Epidemiol Biomarkers Prev 19: 1151-1159. 
109. Skakkebaek NE, Rajpert-De Meyts E, Main KM (2001) Testicular dysgenesis 
syndrome: an increasingly common developmental disorder with environmental 
aspects. Hum Reprod 16: 972-978. 
110. Cook MB, Trabert B, McGlynn KA (2011) Organochlorine compounds and 
testicular dysgenesis syndrome: human data. Int J Androl 34: e68-84; discussion 
e84-65. 
111. Salvatore M, Lorenzetti S, Maranghi F, Mantovani A, Taruscio D (2008) Molecular 
link(s) between hepatoblastoma pathogenesis and exposure to di-(2-
ethylhexyl)phthalate: a hypothesis. Folia Med (Plovdiv) 50: 17-23. 
112. McKee RH (2000) The role of inhibition of gap junctional intercellular 
communication in rodent liver tumor induction by phthalates: review of data on 
selected phthalates and the potential relevance to man. Regul Toxicol Pharmacol 
32: 51-55. 
113. Allen CD, Waser B, Korner M, Reubi JC, Lee S, et al. (2011) Neuropeptide Y acts 
within the rat testis to inhibit testosterone secretion. Neuropeptides 45: 55-61. 
114. Fisher JS, Macpherson S, Marchetti N, Sharpe RM (2003) Human 'testicular 
dysgenesis syndrome': a possible model using in-utero exposure of the rat to 
dibutyl phthalate. Hum Reprod 18: 1383-1394. 
115. Hutchison GR, Scott HM, Walker M, McKinnell C, Ferrara D, et al. (2008) Sertoli 
cell development and function in an animal model of testicular dysgenesis 
syndrome. Biol Reprod 78: 352-360. 
116. Ge RS, Chen GR, Tanrikut C, Hardy MP (2007) Phthalate ester toxicity in Leydig 
cells: developmental timing and dosage considerations. Reprod Toxicol 23: 366-
373. 
117. Hu GX, Lian QQ, Ge RS, Hardy DO, Li XK (2009) Phthalate-induced testicular 





118. Karray S, Kress C, Cuvellier S, Hue-Beauvais C, Damotte D, et al. (2004) Complete 
loss of Fas ligand gene causes massive lymphoproliferation and early death, 
indicating a residual activity of gld allele. The Journal of Immunology 172: 2118-
2125. 
119. Sedger LM, Glaccum MB, Schuh JC, Kanaly ST, Williamson E, et al. (2002) 
Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing 
ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice. Eur J Immunol 
32: 2246-2254. 
120. Richburg JH, Boekelheide K (1996) Mono-(2-ethylhexyl) phthalate rapidly alters 
both Sertoli cell vimentin filaments and germ cell apoptosis in young rat testes. 
Toxicol Appl Pharmacol 137: 42-50. 
121. Bhattacharya N, Dufour JM, Vo MN, Okita J, Okita R, et al. (2005) Differential 
effects of phthalates on the testis and the liver. Biol Reprod 72: 745-754. 
122. Yao PL, Lin YC, Richburg JH (2009) TNF alpha-mediated disruption of 
spermatogenesis in response to Sertoli cell injury in rodents is partially regulated 
by MMP2. Biol Reprod 80: 581-589. 
123. Yao PL, Lin YC, Sawhney P, Richburg JH (2007) Transcriptional regulation of 
FasL expression and participation of sTNF-alpha in response to sertoli cell injury. 
Journal of Biological Chemistry 282: 5420-5431. 
124. Robb GW, Amann RP, Killian GJ (1978) Daily sperm production and epididymal 
sperm reserves of pubertal and adult rats. Journal of Reproduction and 
Fertilization 54: 103-107. 
125. Chen JJ, Lin YC, Yao PL, Yuan A, Chen HY, et al. (2005) Tumor-associated 
macrophages: the double-edged sword in cancer progression. J Clin Oncol 23: 
953-964. 
126. Tao P, Fisher JF, Mobashery S, Schlegel HB (2009) DFT studies of the ring-opening 
mechanism of SB-3CT, a potent inhibitor of matrix metalloproteinase 2. Org Lett 
11: 2559-2562. 
127. Park HM (2008) Hypothesis Testing and Statistical Power of a Test. The University 
Information Technology Services (UITS) Center for Statistical and Mathematical 
Computing, Indiana University. 
128. Cleophas TJ, Cleophas, T. J., Zwinderman, A. H., Zwinderman, A. H., Cleophas, T. 




129. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, et al. (1994) 
Generalized lymphoproliferative disease in mice, caused by a point mutation in 
the Fas ligand. Cell 76: 969-976. 
130. Richburg JH (2000) The relevance of spontaneous- and chemically-induced 
alterations in testicular germ cell apoptosis to toxicology. Toxicol Lett 112-113: 
79-86. 
131. Pentikainen V, Erkkila K, Dunkel L (1999) Fas regulates germ cell apoptosis in the 
human testis in vitro. Am J Physiol 276: E310-316. 
132. Peter ME (2004) The flip side of FLIP. Biochem J 382: e1-3. 
133. Chandrasekaran Y, McKee CM, Ye Y, Richburg JH (2006) Influence of TRP53 
status on FAS membrane localization, CFLAR (c-FLIP) ubiquitinylation, and 
sensitivity of GC-2spd (ts) cells to undergo FAS-mediated apoptosis. Biol Reprod 
74: 560-568. 
134. Chanvorachote P, Nimmannit U, Wang L, Stehlik C, Lu B, et al. (2005) Nitric oxide 
negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-
proteasome-mediated degradation of FLICE inhibitory protein. J Biol Chem 280: 
42044-42050. 
135. Wang L, Azad N, Kongkaneramit L, Chen F, Lu Y, et al. (2008) The Fas death 
signaling pathway connecting reactive oxygen species generation and FLICE 
inhibitory protein down-regulation. J Immunol 180: 3072-3080. 
136. Chandrasekaran Y, Richburg JH (2005) The p53 protein influences the sensitivity of 
testicular germ cells to mono-(2-ethylhexyl) phthalate-induced apoptosis by 
increasing the membrane levels of Fas and DR5 and decreasing the intracellular 
amount of c-FLIP. Biol Reprod 72: 206-213. 
137. Zerafa N, Westwood JA, Cretney E, Mitchell S, Waring P, et al. (2005) Cutting edge: 
TRAIL deficiency accelerates hematological malignancies. The Journal of 
Immunology 175: 5586-5590. 
138. Lamhamedi-Cherradi SE, Zheng S, Tisch RM, Chen YH (2003) Critical roles of 
tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes. 
Diabetes 52: 2274-2278. 
139. Cretney E, Uldrich AP, Berzins SP, Strasser A, Godfrey DI, et al. (2003) Normal 
thymocyte negative selection in TRAIL-deficient mice. Journal of Experimental 




140. Corazza N, Brumatti G, Jakob S, Villunger A, Brunner T (2004) TRAIL and 
thymocyte apoptosis: not so deadly? Cell death and differentiation 11 Suppl 2: 
S213-215. 
141. Corazza N, Brumatti G, Schaer C, Cima I, Wasem C, et al. (2004) TRAIL and 
immunity: more than a license to kill tumor cells. Cell death and differentiation 11 
Suppl 2: S122-125. 
142. Sedger LM, Glaccum MB, Schuh JC, Kanaly ST, Williamson E, et al. (2002) 
Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing 
ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice. European 
Journal of Immunology 32: 2246-2254. 
143. Jahnukainen K, Chrysis D, Hou M, Parvinen M, Eksborg S, et al. (2004) Increased 
apoptosis occurring during the first wave of spermatogenesis is stage-specific and 
primarily affects midpachytene spermatocytes in the rat testis. Biol Reprod 70: 
290-296. 
144. Moreno RD, Lizama C, Urzua N, Vergara SP, Reyes JG (2006) Caspase activation 
throughout the first wave of spermatogenesis in the rat. Cell and Tissue Research 
325: 533-540. 
145. Boekelheide K, Lee J, Shipp EB, Richburg JH, Li G (1998) Expression of Fas 
system-related genes in the testis during development and after toxicant exposure. 
Toxicology Letters 102-103: 503-508. 
146. Russell LD, Chiarini-Garcia H, Korsmeyer SJ, Knudson CM (2002) Bax-dependent 
spermatogonia apoptosis is required for testicular development and 
spermatogenesis. Biology of Reproduction 66: 950-958. 
147. Russell LD, Warren J, Debeljuk L, Richardson LL, Mahar PL, et al. (2001) 
Spermatogenesis in Bclw-deficient mice. Biology of Reproduction 65: 318-332. 
148. Krieg A, Krieg T, Wenzel M, Schmitt M, Ramp U, et al. (2003) TRAIL-beta and 
TRAIL-gamma: two novel splice variants of the human TNF-related apoptosis-
inducing ligand (TRAIL) without apoptotic potential. British Journal of Cancer 88: 
918-927. 
149. Chong AP, Walters CA, Weinrieb SA (1983) The neglected laboratory test. The 
semen analysis. Journal of Andrology 4: 280-282. 
150. Keel BA, Stembridge TW, Pineda G, Serafy NT, Sr. (2002) Lack of standardization 
in performance of the semen analysis among laboratories in the United States. 




151. Pedrazzini T, Pralong F, Grouzmann E (2003) Neuropeptide Y: the universal soldier. 
Cell Mol Life Sci 60: 350-377. 
152. Goto M, O'Brien DA, Eddy EM (2010) Speriolin is a novel human and mouse sperm 
centrosome protein. Hum Reprod 25: 1884-1894. 
153. Goto M, Eddy EM (2004) Speriolin is a novel spermatogenic cell-specific 
centrosomal protein associated with the seventh WD motif of Cdc20. J Biol Chem 
279: 42128-42138. 
154. Bornstein C, Brosh R, Molchadsky A, Madar S, Kogan-Sakin I, et al. (2011) 
SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of 
p53 and p63. Mol Cell Biol 31: 1679-1689. 
155. Tsai LH, Delalle I, Caviness VS, Jr., Chae T, Harlow E (1994) p35 is a neural-
specific regulatory subunit of cyclin-dependent kinase 5. Nature 371: 419-423. 
156. Session DR, Fautsch MP, Avula R, Jones WR, Nehra A, et al. (2001) Cyclin-
dependent kinase 5 is expressed in both Sertoli cells and metaphase spermatocytes. 
Fertil Steril 75: 669-673. 
157. Musa FR, Takenaka I, Konishi R, Tokuda M (2000) Effects of luteinizing hormone, 
follicle-stimulating hormone, and epidermal growth factor on expression and 
kinase activity of cyclin-dependent kinase 5 in Leydig TM3 and Sertoli TM4 cell 
lines. J Androl 21: 392-402. 
158. Rosales JL, Lee BC, Modarressi M, Sarker KP, Lee KY, et al. (2004) Outer dense 
fibers serve as a functional target for Cdk5.p35 in the developing sperm tail. J 
Biol Chem 279: 1224-1232. 
159. Li L, Liu G, Fu JJ, Li LY, Tan XJ, et al. (2009) Molecular cloning and 
characterization of a novel transcript variant of Mtsarg1 gene. Mol Biol Rep 36: 
1023-1032. 
160. Hess H, Heid H, Zimbelmann R, Franke WW (1995) The protein complexity of the 
cytoskeleton of bovine and human sperm heads: the identification and 
characterization of cylicin II. Exp Cell Res 218: 174-182. 
161. Tubb B, Mulholland DJ, Vogl W, Lan ZJ, Niederberger C, et al. (2002) Testis fascin 
(FSCN3): a novel paralog of the actin-bundling protein fascin expressed 
specifically in the elongate spermatid head. Exp Cell Res 275: 92-109. 
162. Choi HS, Lee SH, Kim H, Lee Y (2008) Germ cell-specific gene 1 targets testis-
specific poly(A) polymerase to the endoplasmic reticulum through protein-protein 




163. Kashiwabara S, Noguchi J, Zhuang T, Ohmura K, Honda A, et al. (2002) Regulation 
of spermatogenesis by testis-specific, cytoplasmic poly(A) polymerase TPAP. 
Science 298: 1999-2002. 
164. Zheng H, Stratton CJ, Morozumi K, Jin J, Yanagimachi R, et al. (2007) Lack of 
Spem1 causes aberrant cytoplasm removal, sperm deformation, and male 
infertility. Proc Natl Acad Sci U S A 104: 6852-6857. 
165. Nayernia K, von Mering MH, Kraszucka K, Burfeind P, Wehrend A, et al. (1999) A 
novel testicular haploid expressed gene (THEG) involved in mouse spermatid-
sertoli cell interaction. Biol Reprod 60: 1488-1495. 
166. Yang F, Skaletsky H, Wang PJ (2007) Ubl4b, an X-derived retrogene, is specifically 
expressed in post-meiotic germ cells in mammals. Gene Expr Patterns 7: 131-136. 
167. Cornwall GA, Hsia N (1997) ADAM7, a member of the ADAM (a disintegrin and 
metalloprotease) gene family is specifically expressed in the mouse anterior 
pituitary and epididymis. Endocrinology 138: 4262-4272. 
168. Nonaka MI, Hishikawa Y, Moriyama N, Koji T, Ogata RT, et al. (2003) 
Complement C4b-binding protein as a novel murine epididymal secretory protein. 
Biol Reprod 69: 1931-1939. 
169. Nonaka MI, Wang G, Mori T, Okada H, Nonaka M (2001) Novel androgen-
dependent promoters direct expression of the C4b-binding protein alpha-chain 
gene in epididymis. J Immunol 166: 4570-4577. 
170. Da Ros VG, Maldera JA, Willis WD, Cohen DJ, Goulding EH, et al. (2008) 
Impaired sperm fertilizing ability in mice lacking Cysteine-RIch Secretory Protein 
1 (CRISP1). Dev Biol 320: 12-18. 
171. Petersen C, Aumuller G, Bahrami M, Hoyer-Fender S (2002) Molecular cloning of 
Odf3 encoding a novel coiled-coil protein of sperm tail outer dense fibers. Mol 
Reprod Dev 61: 102-112. 
172. Jalkanen J, Kotimaki M, Huhtaniemi I, Poutanen M (2006) Novel epididymal 
protease inhibitors with Kazal or WAP family domain. Biochem Biophys Res 
Commun 349: 245-254. 
173. Clauss A, Persson M, Lilja H, Lundwall A (2011) Three genes expressing Kunitz 
domains in the epididymis are related to genes of WFDC-type protease inhibitors 
and semen coagulum proteins in spite of lacking similarity between their protein 




174. Li Y, Sosnik J, Brassard L, Reese M, Spiridonov NA, et al. (2011) Expression and 
localization of five members of the testis-specific serine kinase (Tssk) family in 
mouse and human sperm and testis. Mol Hum Reprod 17: 42-56. 
175. Zuercher G, Rohrbach V, Andres AC, Ziemiecki A (2000) A novel member of the 
testis specific serine kinase family, tssk-3, expressed in the Leydig cells of 
sexually mature mice. Mech Dev 93: 175-177. 
176. Yao PL, Lin YC, Richburg JH (2010) Mono-(2-ethylhexyl) phthalate-induced 
disruption of junctional complexes in the seminiferous epithelium of the rodent 
testis is mediated by MMP2. Biol Reprod 82: 516-527. 
177. Theret N, Musso O, Turlin B, Lotrian D, Bioulac-Sage P, et al. (2001) Increased 
extracellular matrix remodeling is associated with tumor progression in human 
hepatocellular carcinomas. Hepatology 34: 82-88. 
178. Ara T, Kusafuka T, Inoue M, Kuroda S, Fukuzawa M, et al. (2000) Determination of 
imbalance between MMP-2 and TIMP-2 in human neuroblastoma by reverse-
transcription polymerase chain reaction and its correlation with tumor progression. 
J Pediatr Surg 35: 432-437. 
179. Diamantopoulos N, Boutis AL, Koratzis I, Andreadis C, Galaktidou G, et al. (2010) 
Matrix metalloproteinases and proangiogenic factors in testicular germ cell 
tumors. J Buon 15: 116-121. 
180. Yao PL, Lin YC, Richburg JH (2011) Transcriptional Suppression of Sertoli Cell 
Timp2 in Rodents Following Mono-(2-Ethylhexyl) Phthalate Exposure Is 
Regulated by CEBPA and MYC. Biol Reprod. 
181. Larsson LG, Henriksson MA (2010) The Yin and Yang functions of the Myc 
oncoprotein in cancer development and as targets for therapy. Exp Cell Res 316: 
1429-1437. 
182. Sonne SB, Hoei-Hansen CE, Fisher JS, Leffers H, Rajpert-de Meyts E, et al. (2004) 
Do environmental factors play a role in the aetiology of carcinoma in situ testis 
and the testicular dysgenesis syndrome? Verh Dtsch Ges Pathol 88: 144-151. 
183. Bay K, Asklund C, Skakkebaek NE, Andersson AM (2006) Testicular dysgenesis 
syndrome: possible role of endocrine disrupters. Best Pract Res Clin Endocrinol 
Metab 20: 77-90. 
184. Toppari J, Virtanen HE, Main KM, Skakkebaek NE (2010) Cryptorchidism and 
hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental 




185. Doull J, Cattley R, Elcombe C, Lake BG, Swenberg J, et al. (1999) A cancer risk 
assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk 
Assessment Guidelines. Regul Toxicol Pharmacol 29: 327-357. 
186. Ashby J, Brady A, Elcombe CR, Elliott BM, Ishmael J, et al. (1994) 
Mechanistically-based human hazard assessment of peroxisome proliferator-
induced hepatocarcinogenesis. Hum Exp Toxicol 13 Suppl 2: S1-117. 
187. Jobling MS, Hutchison GR, van den Driesche S, Sharpe RM (2011) Effects of di(n-
butyl) phthalate exposure on foetal rat germ-cell number and differentiation: 
identification of age-specific windows of vulnerability. Int J Androl. 
188. Jezierska A, Motyl T (2009) Matrix metalloproteinase-2 involvement in breast 
cancer progression: a mini-review. Med Sci Monit 15: RA32-40. 
189. Wolfer A, Ramaswamy S (2011) MYC and metastasis. Cancer Res 71: 2034-2037. 
190. Mook OR, Frederiks WM, Van Noorden CJ (2004) The role of gelatinases in 
colorectal cancer progression and metastasis. Biochim Biophys Acta 1705: 69-89. 
191. Dony C, Kessel M, Gruss P (1985) Post-transcriptional control of myc and p53 
expression during differentiation of the embryonal carcinoma cell line F9. Nature 
317: 636-639. 
192. Sejersen T, Jin P, Rahm M, Ringertz NR (1989) Changes in c-onc expression during 
embryonal carcinoma cell differentiation. Environ Health Perspect 80: 247-256. 
193. Wang CC, Tsai MF, Hong TM, Chang GC, Chen CY, et al. (2005) The 
transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 
expression and inhibits cancer cell invasion. Oncogene 24: 4081-4093. 
194. Chen HW, Yu SL, Chen JJ, Li HN, Lin YC, et al. (2004) Anti-invasive gene 
expression profile of curcumin in lung adenocarcinoma based on a high 
throughput microarray analysis. Mol Pharmacol 65: 99-110. 
195. Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, et al. (2006) A new tumor 
suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-
small-cell lung carcinoma. J Natl Cancer Inst 98: 825-838. 
196. Sobarzo CM, Lustig L, Ponzio R, Suescun MO, Denduchis B (2009) Effects of di(2-
ethylhexyl) phthalate on gap and tight junction protein expression in the testis of 




197. Weider K, Bergmann M, Brehm R (2011) Connexin 43: its regulatory role in 
testicular junction dynamics and spermatogenesis. Histol Histopathol 26: 1343-
1352. 
198. Kandouz M, Batist G (2010) Gap junctions and connexins as therapeutic targets in 
cancer. Expert Opin Ther Targets 14: 681-692. 
199. Leithe E, Sirnes S, Omori Y, Rivedal E (2006) Downregulation of gap junctions in 
cancer cells. Crit Rev Oncog 12: 225-256. 
200. Paznekas WA, Karczeski B, Vermeer S, Lowry RB, Delatycki M, et al. (2009) 
GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the 
oculodentodigital dysplasia phenotype. Hum Mutat 30: 724-733. 
201. Song YN, Zhang H, Zhao JY, Guo XL (2009) Connexin 43, a new therapeutic target 
for cardiovascular diseases. Pharmazie 64: 291-295. 
202. Strale PO, Clarhaut J, Lamiche C, Cronier L, Mesnil M, et al. (2011) Down-
regulation of connexin43 expression reveals the involvement of caveolin-1 
containing lipid rafts in human U251 glioblastoma cell invasion. Mol Carcinog. 
203. Kang KS, Lee YS, Kim HS, Kim SH (2002) DI-(2-ethylhexyl) phthalate-induced 
cell proliferation is involved in the inhibition of gap junctional intercellular 
communication and blockage of apoptosis in mouse Sertoli cells. J Toxicol 
Environ Health A 65: 447-459. 
204. Isenberg JS, Kamendulis LM, Smith JH, Ackley DC, Pugh G, Jr., et al. (2000) 
Effects of Di-2-ethylhexyl phthalate (DEHP) on gap-junctional intercellular 
communication (GJIC), DNA synthesis, and peroxisomal beta oxidation (PBOX) 
in rat, mouse, and hamster liver. Toxicol Sci 56: 73-85. 
205. Ziegler WH, Liddington RC, Critchley DR (2006) The structure and regulation of 
vinculin. Trends Cell Biol 16: 453-460. 
206. Carisey A, Ballestrem C (2011) Vinculin, an adapter protein in control of cell 
adhesion signalling. Eur J Cell Biol 90: 157-163. 
207. Rodriguez Fernandez JL, Geiger B, Salomon D, Sabanay I, Zoller M, et al. (1992) 
Suppression of tumorigenicity in transformed cells after transfection with vinculin 
cDNA. J Cell Biol 119: 427-438. 
208. Lifschitz-Mercer B, Czernobilsky B, Feldberg E, Geiger B (1997) Expression of the 
adherens junction protein vinculin in human basal and squamous cell tumors: 




209. Palma I, Pena RY, Contreras A, Ceballos-Reyes G, Coyote N, et al. (2008) 
Participation of OCT3/4 and beta-catenin during dysgenetic gonadal malignant 
transformation. Cancer Lett 263: 204-211. 
210. Chang H, Guillou F, Taketo MM, Behringer RR (2009) Overactive beta-catenin 
signaling causes testicular sertoli cell tumor development in the mouse. Biol 
Reprod 81: 842-849. 
211. Sobarzo CM, Lustig L, Ponzio R, Denduchis B (2006) Effect of di-(2-ethylhexyl) 
phthalate on N-cadherin and catenin protein expression in rat testis. Reprod 
Toxicol 22: 77-86. 
212. Maranghi F, Lorenzetti S, Tassinari R, Moracci G, Tassinari V, et al. (2010) In utero 
exposure to di-(2-ethylhexyl) phthalate affects liver morphology and metabolism 
in post-natal CD-1 mice. Reprod Toxicol 29: 427-432. 
213. Bhatia N, Spiegelman VS (2005) Activation of Wnt/beta-catenin/Tcf signaling in 
mouse skin carcinogenesis. Mol Carcinog 42: 213-221. 
214. Yochum GS, Sherrick CM, Macpartlin M, Goodman RH (2010) A beta-
catenin/TCF-coordinated chromatin loop at MYC integrates 5' and 3' Wnt 
responsive enhancers. Proc Natl Acad Sci U S A 107: 145-150. 
215. Osanai M, Murata M, Chiba H, Kojima T, Sawada N (2007) Epigenetic silencing of 
claudin-6 promotes anchorage-independent growth of breast carcinoma cells. 
Cancer Sci 98: 1557-1562. 
216. Wu Q, Liu Y, Ren Y, Xu X, Yu L, et al. (2010) Tight junction protein, claudin-6, 
downregulates the malignant phenotype of breast carcinoma. Eur J Cancer Prev 
19: 186-194. 
217. Yafang L, Qiong W, Yue R, Xiaoming X, Lina Y, et al. (2011) Role of Estrogen 
Receptor-alpha in the Regulation of Claudin-6 Expression in Breast Cancer Cells. 
J Breast Cancer 14: 20-27. 
218. Oka D, Yamashita S, Tomioka T, Nakanishi Y, Kato H, et al. (2009) The presence 
of aberrant DNA methylation in noncancerous esophageal mucosae in association 
with smoking history: a target for risk diagnosis and prevention of esophageal 
cancers. Cancer 115: 3412-3426. 
219. Zavala-Zendejas VE, Torres-Martinez AC, Salas-Morales B, Fortoul TI, Montano 
LF, et al. (2011) Claudin-6, 7, or 9 overexpression in the human gastric 
adenocarcinoma cell line AGS increases its invasiveness, migration, and 




220. Birks DK, Kleinschmidt-DeMasters BK, Donson AM, Barton VN, McNatt SA, et al. 
(2010) Claudin 6 is a positive marker for atypical teratoid/rhabdoid tumors. Brain 
Pathol 20: 140-150. 
221. Vare P, Soini Y (2010) Twist is inversely associated with claudins in germ cell 
tumors of the testis. Apmis 118: 640-647. 
222. Turksen K, Troy TC (2002) Permeability barrier dysfunction in transgenic mice 
overexpressing claudin 6. Development 129: 1775-1784. 
223. Hong YH, Hishikawa D, Miyahara H, Nishimura Y, Tsuzuki H, et al. (2005) Up-
regulation of the claudin-6 gene in adipogenesis. Biosci Biotechnol Biochem 69: 
2117-2121. 
224. Turksen K, Troy TC (2001) Claudin-6: a novel tight junction molecule is 
developmentally regulated in mouse embryonic epithelium. Dev Dyn 222: 292-
300. 
225. Ruzinova MB, Benezra R (2003) Id proteins in development, cell cycle and cancer. 
Trends Cell Biol 13: 410-418. 
226. Perk J, Iavarone A, Benezra R (2005) Id family of helix-loop-helix proteins in 
cancer. Nat Rev Cancer 5: 603-614. 
227. Sadate-Ngatchou PI, Pouchnik DJ, Griswold MD (2004) Follicle-stimulating 
hormone induced changes in gene expression of murine testis. Mol Endocrinol 18: 
2805-2816. 
228. Treinen KA, Dodson WC, Heindel JJ (1990) Inhibition of FSH-stimulated cAMP 
accumulation and progesterone production by mono(2-ethylhexyl) phthalate in rat 
granulosa cell cultures. Toxicol Appl Pharmacol 106: 334-340. 
229. Bertolino E, Reimund B, Wildt-Perinic D, Clerc RG (1995) A novel homeobox 
protein which recognizes a TGT core and functionally interferes with a retinoid-
responsive motif. J Biol Chem 270: 31178-31188. 
230. Wotton D, Lo RS, Lee S, Massague J (1999) A Smad transcriptional corepressor. 
Cell 97: 29-39. 
231. Demange C, Ferrand N, Prunier C, Bourgeade M-F, Atfi A (2009) A model of 
partnership co-opted by the homeodomain protein TGIF and the Itch/AIP4 
ubiquitin ligase for effective execution of TNF-alpha cytotoxicity. Molecular Cell 
36: 1073-1158. 
 
